[{"path":"https://rfhb.github.io/ctrdata/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"MIT License","title":"MIT License","text":"Copyright (c) 2017 Ralf Herold Permission hereby granted, free charge, person obtaining copy software associated documentation files (“Software”), deal Software without restriction, including without limitation rights use, copy, modify, merge, publish, distribute, sublicense, /sell copies Software, permit persons Software furnished , subject following conditions: copyright notice permission notice shall included copies substantial portions Software. SOFTWARE PROVIDED “”, WITHOUT WARRANTY KIND, EXPRESS IMPLIED, INCLUDING LIMITED WARRANTIES MERCHANTABILITY, FITNESS PARTICULAR PURPOSE NONINFRINGEMENT. EVENT SHALL AUTHORS COPYRIGHT HOLDERS LIABLE CLAIM, DAMAGES LIABILITY, WHETHER ACTION CONTRACT, TORT OTHERWISE, ARISING , CONNECTION SOFTWARE USE DEALINGS SOFTWARE.","code":""},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_install.html","id":"install-package-ctrdata-on-a-r-system","dir":"Articles","previous_headings":"","what":"Install package ctrdata on a R system","title":"Install R package ctrdata","text":"R Project website (https://www.r-project.org/) provides installers R system. can used software products graphical user interfaces R Studio, Microsoft R Open, Visual Studio Code. General information ctrdata package available : https://github.com/rfhb/ctrdata. R, execute: using development version package ctrdata, install GitHub: Either install package ctrdata user’s library.","code":"install.packages(\"ctrdata\") # install preparatory package install.packages(c(\"devtools\", \"httr\")) devtools::install_github(\"rfhb/ctrdata\")"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_install.html","id":"internet-access-via-proxy","dir":"Articles","previous_headings":"Install package ctrdata on a R system","what":"Internet access via proxy","title":"Install R package ctrdata","text":"Functions package ctrdata start ctr... require access trial registers internet via https protocol. Many organisastions use transparent proxies may require users configurations. However, necessary, package ctrdata can use proxy settings set users R session follows:","code":"Sys.setenv(https_proxy = \"your_proxy.server.domain:8080\") # if needed Sys.setenv(https_proxy_user = \"your_userid:your_password\") # if needed"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_install.html","id":"additional-installation-aspects","dir":"Articles","previous_headings":"Install package ctrdata on a R system","what":"Additional installation aspects","title":"Install R package ctrdata","text":"command line tools perl, sed php (5.2 higher) required ctrLoadQueryIntoDb(), main function package ctrdata. function package requirement.","code":""},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_install.html","id":"ms-windows","dir":"Articles","previous_headings":"Install package ctrdata on a R system > Additional installation aspects","what":"MS Windows","title":"Install R package ctrdata","text":"requirement MS Windows, Cygwin environment installed, local directory c:\\cygwin (folder corresponding c:\\cygw*). installation minimal Cygwin environment MS Windows can done help package ctrdata R follows: update correct Cygwin installation: internet access requires specify proxy (see ): install Cygwin manually, download setup executable . MS Windows command window Powershell window, use following command line. parameters explained .","code":"ctrdata::installCygwinWindowsDoInstall() ctrdata::installCygwinWindowsDoInstall(force = TRUE) ctrdata::installCygwinWindowsDoInstall(proxy = \"proxy.server.domain:8080\") setup-x86_64.exe --no-admin --quiet-mode --verbose --upgrade-also --root c:/cygwin --site http://www.mirrorservice.org/sites/sourceware.org/pub/cygwin/ --packages perl,php-jsonc,php-simplexml"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_install.html","id":"macos-linux-and-other-operating-systems","dir":"Articles","previous_headings":"Install package ctrdata on a R system > Additional installation aspects","what":"macOS, Linux and other operating systems","title":"Install R package ctrdata","text":"command line tools perl, sed php (5.2 higher) may already available default Linux macOS systems. checked running ctrLoadQueryIntoDb(); alternatively, check (ctrdata:::checkBinary()). macOS, homebrew can used install php may needed starting macOS 12 Monterey: first install homebrew run Terminal command: brew install php. Linux, tools installation vary distribution (e.g., sudo apt install php php-xml php-json)","code":""},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_install.html","id":"databases-to-use","dir":"Articles","previous_headings":"Install package ctrdata on a R system","what":"Databases to use","title":"Install R package ctrdata","text":"time, PostgreSQL, SQLite remote local MongoDB database can used package ctrdata. full SQLite database provided R package RSQLite. Suggested installation instructions PostgreSQL local MongoDB server ; remote MongoDB database server accessible . available, PostgreSQL MongoDB local server recommended notably faster performance SQLite.","code":""},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_install.html","id":"attach-package-ctrdata","dir":"Articles","previous_headings":"Install package ctrdata on a R system","what":"Attach package ctrdata","title":"Install R package ctrdata","text":"completing installation, attach package user’s library. also check availability additional installation requirements mentioned : Remember respect registers’ terms conditions (see ctrOpenSearchPagesInBrowser(copyright = TRUE)). Please cite package publication follows: Ralf Herold (2022). ctrdata: Retrieve Analyze Clinical Trials Public Registers. R package version 1.9.0. https://cran.r-project.org/package=ctrdata","code":"library(ctrdata)"},{"path":[]},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"attach-package-ctrdata","dir":"Articles","previous_headings":"Get started","what":"Attach package ctrdata","title":"Retrieve clinical trial information","text":"Remember respect registers’ terms conditions (see ctrOpenSearchPagesInBrowser(copyright = TRUE)). Please cite package publication follows: Ralf Herold (2022). ctrdata: Retrieve Analyze Clinical Trials Public Registers. R package version 1.9.0. https://cran.r-project.org/package=ctrdata","code":"library(ctrdata) citation(\"ctrdata\")"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"open-registers-advanced-search-page-in-browser","dir":"Articles","previous_headings":"Get started","what":"Open register’s advanced search page in browser","title":"Retrieve clinical trial information","text":"functions open browser, user can start searching trials interest.","code":"# Please review and respect register copyrights: ctrOpenSearchPagesInBrowser(   copyright = TRUE ) # Open browser with example search: ctrOpenSearchPagesInBrowser(   url = \"cancer&age=under-18\",   register = \"EUCTR\" )"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"adjust-search-parameters-and-execute-search-in-browser","dir":"Articles","previous_headings":"Get started","what":"Adjust search parameters and execute search in browser","title":"Retrieve clinical trial information","text":"Refine search trials interest listed browser. total number trials can retrieved package ctrdata intentionally limited queries 10000 result records.","code":""},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"copy-address-from-browser-address-bar-to-clipboard","dir":"Articles","previous_headings":"Get started","what":"Copy address from browser address bar to clipboard","title":"Retrieve clinical trial information","text":"Use functions keyboard shortcuts according operating system.","code":""},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"get-address-from-clipboard","dir":"Articles","previous_headings":"Get started","what":"Get address from clipboard","title":"Retrieve clinical trial information","text":"next steps executed R environment:","code":"q <- ctrGetQueryUrl() # * Using clipboard content as register query URL: https://www.clinicaltrialsregister.eu/ctr-search/search?query=cancer&age=under-18&status=completed&phase=phase-one # * Found search query from EUCTR: query=cancer&age=under-18&status=completed&phase=phase-one  q #                                                   query-term  query-register # 1 query=cancer&age=under-18&status=completed&phase=phase-one           EUCTR  # To check, this opens a browser with the query ctrOpenSearchPagesInBrowser(url = q)"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"retrieve-protocol-related-information-transform-save-to-database-check","dir":"Articles","previous_headings":"Get started","what":"Retrieve protocol-related information, transform, save to database, check","title":"Retrieve clinical trial information","text":"file-base SQLite database, takes 20 seconds 300 records, time needed internet-retrieval slow register. Speed higher registers, using MongoDB memory-based SQLite.","code":"# Count number of trial records ctrLoadQueryIntoDb(   queryterm = q,   only.count = TRUE )$n # (1/3) Checking trials in EUCTR: # Retrieved overview, multiple records of 71 trial(s) from 4 page(s) to be downloaded # [1] 71  # Connect to a database and chose a table / collection db <- nodbi::src_sqlite(   dbname = \"sqlite_file.sql\",   collection = \"test\" )  # Retrieve records, download into database ctrLoadQueryIntoDb(   queryterm = q,   con = db ) # Checking helper binaries: done # (1/3) Checking trials in EUCTR: # Retrieved overview, multiple records of 71 trial(s) from 4 page(s) to be downloaded # Downloading trials (4 pages in parallel)... # Note: register server cannot compress data, transfer takes longer, about 0.4s per trial # Pages: 4 done, 0 ongoing # (2/3) Converting to JSON, 281 records converted # (3/3) Importing JSON records into database... # = Imported or updated 281 records on 71 trial(s) # Updated history (\"meta-info\" in \"test\")  # Show which queries have been downloaded into database dbQueryHistory(con = db) #       query-timestamp query-register query-records # 1 2022-03-19 09:41:36          EUCTR           281 #                                                   query-term # 1 query=cancer&age=under-18&status=completed&phase=phase-one"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"repeat-and-update-a-previous-query","dir":"Articles","previous_headings":"","what":"Repeat and update a previous query","title":"Retrieve clinical trial information","text":"Instead “last”, integer number can specified querytoupdate corresponds number using dbQueryHistory(). Depending register, update (differential update) possible original query executed fully .","code":"ctrLoadQueryIntoDb(   querytoupdate = \"last\",   con = db )"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"retrieve-results","dir":"Articles","previous_headings":"","what":"Retrieve results","title":"Retrieve clinical trial information","text":"EUCTR, result-related trial information requested retrieved, take longer download store. CTGOV, results always included retrieval. file-base SQLite database, takes 4 minutes 300 records, time needed merging result- protocol-related information SQLite; much faster MongoDB PostgreSQL. download presence results recorded dbQueryHistory() availability results increases time.","code":"ctrLoadQueryIntoDb(   queryterm = q,   euctrresults = TRUE,   con = db ) # Checking helper binaries: done # (1/3) Checking trials in EUCTR: # Retrieved overview, multiple records of 71 trial(s) from 4 page(s) to be downloaded # Downloading trials (4 pages in parallel)... # Note: register server cannot compress data, transfer takes longer, about 0.2s per trial # Pages: 4 done, 0 ongoing # (2/3) Converting to JSON, 281 records converted # (3/3) Importing JSON records into database... # = Imported or updated 281 records on 71 trial(s) # Retrieving results if available from EUCTR for 71 trials: # (1/4) Downloading results (max. 10 trials in parallel): # 71 downloaded, extracting x x x x x . x . PDF . . . x . . . x PDF . PDF . . PDF . x . . # x . . x x . . x . . . . . . . . . . . . . . x . . . . . . PDF . . . . . . . . . . . . # PDF . . . . . PDF . PDF . # (2/3) Converting to JSON, 57 records converted # (3/4) Importing JSON into database... # (4/4) Results history: not retrieved (euctrresultshistory = FALSE) # = Imported or updated results for 57 trials # Updated history (\"meta-info\" in \"test\")"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"add-information-from-another-register","dir":"Articles","previous_headings":"","what":"Add information from another register","title":"Retrieve clinical trial information","text":"collection can used store (analyse) trial information different registers. moment, ctrdata supports three registers: https://ClinicalTrials.Gov/, https://ClinicalTrialsRegister.EU/ https://www.ISRCTN.com/. Example: file-base SQLite database, takes 10 seconds 200 records. Note example, warning message issued importing NDJSON file trial records. warning arises high level complexity XML content trial records. issue can resolved increasing operating system stack size available R, see: https://github.com/rfhb/ctrdata/issues/22","code":"ctrLoadQueryIntoDb(   queryterm = \"https://clinicaltrials.gov/ct2/results?cond=neuroblastoma&recrs=e&age=0&intr=Drug\",   con = db ) # * Found search query from CTGOV: cond=neuroblastoma&recrs=e&age=0&intr=Drug # Checking helper binaries: done # (1/3) Checking trials in CTGOV: # Retrieved overview, records of 200 trial(s) are to be downloaded (estimate: 1.6 MB) # Downloading: 1.4 MB # (2/3) Converting to JSON, 200 records converted # (3/3) Importing JSON records into database... # = Imported or updated 175 trial(s) # Updated history (\"meta-info\" in \"test\")  # Warning message: # [...]/ctrDATA15bc13c33351a/ctgov_trials_7.ndjson: Error : C stack usage  8342562 is too close to the limit"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"add-personal-annotations","dir":"Articles","previous_headings":"","what":"Add personal annotations","title":"Retrieve clinical trial information","text":"downloading trial information, user can specify annotation records downloaded. default, annotations accumulated trial records loaded updated; alternatively, annotations can replaced. Annotations useful analyses, example specially identify subsets records database.","code":"ctrLoadQueryIntoDb(   queryterm = \"https://clinicaltrials.gov/ct2/results?cond=neuroblastoma&recrs=e&age=0&intr=Drug&cntry=DE\",   annotation.text = \"site_DE \",   annotation.mode = \"append\",   con = db ) # * Found search query from CTGOV: cond=neuroblastoma&recrs=e&age=0&intr=Drug&cntry=DE # Checking helper binaries: done # (1/3) Checking trials in CTGOV: # Retrieved overview, records of 11 trial(s) are to be downloaded (estimate: 0.088 MB) # Downloading: 69 kB      # (2/3) Converting to JSON, 11 records converted # (3/3) Importing JSON records into database... # = Imported or updated 11 trial(s)                 # = Annotated retrieved records (11 records) # Updated history (\"meta-info\" in \"test\")"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"find-synonyms-of-active-substance-names","dir":"Articles","previous_headings":"","what":"Find synonyms of active substance names","title":"Retrieve clinical trial information","text":"registers automatically expand search terms include alternative terms, codes names active substances. obtain character vector synonyms active substance name, use: names can used queries register.","code":"ctrFindActiveSubstanceSynonyms(   activesubstance = \"imatinib\" ) # [1] \"imatinib\"  \"gleevec\" \"sti 571\" \"glivec\" \"CGP 57148\" \"st1571\""},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_retrieve.html","id":"using-a-mongodb-database","dir":"Articles","previous_headings":"","what":"Using a MongoDB database","title":"Retrieve clinical trial information","text":"example works free service . Note user name password need encoded. format connection string documented https://docs.mongodb.com/manual/reference/connection-string/.","code":"# Specify base uri for remote MongoDB server, #  as part of the encoded connection string db <- nodbi::src_mongo(   # Note: this provides read-only access   url = \"mongodb+srv://DWbJ7Wh:bdTHh5cS@cluster0-b9wpw.mongodb.net\",   db = \"dbperm\",   collection = \"dbperm\")  # Since the above access is read-only, # just obtain fields of interest: dbGetFieldsIntoDf(   fields = c(\"a2_eudract_number\",              \"e71_human_pharmacology_phase_i\"),   con = db) #                  _id a2_eudract_number e71_human_pharmacology_phase_i # 1 2010-024264-18-3RD    2010-024264-18                           TRUE # 2  2010-024264-18-AT    2010-024264-18                           TRUE # 3  2010-024264-18-DE    2010-024264-18                           TRUE # 4  2010-024264-18-GB    2010-024264-18                           TRUE # 5  2010-024264-18-IT    2010-024264-18                           TRUE # 6  2010-024264-18-NL    2010-024264-18                           TRUE"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"preparations","dir":"Articles","previous_headings":"","what":"Preparations","title":"Summarise and analyse clinical trial information","text":"using MongoDB, faster SQLite, can handle credentials, provides access remote servers can directly retrieve nested elements paths. See README.md Retrieve clinical trial information examples using SQLite. Also PostgreSQL can used database, see Install R package ctrdata. See Retrieve clinical trial information details.","code":"db <- nodbi::src_mongo(   url = \"mongodb://localhost\",   db = \"my_database_name\",   collection = \"my_collection_name\") db # MongoDB 5.0.6 (uptime: 387411s) # URL: mongodb://localhost # Database: my_database_name # Collection: my_collection_name library(ctrdata)  # These two queries are similar, for completed interventional (drug) # trials with children with a neuroblastoma from either register ctrLoadQueryIntoDb(   # using queryterm and register ...   queryterm = \"query=neuroblastoma&age=under-18&status=completed\",   register = \"EUCTR\",   euctrresults = TRUE,   con = db ) ctrLoadQueryIntoDb(   # or using full URL of search results   queryterm =     \"https://clinicaltrials.gov/ct2/results?cond=neuroblastoma&recrs=e&age=0&intr=Drug\",   con = db ) dbQueryHistory(con = db) #       query-timestamp query-register query-records                                        query-term # 1 2022-03-19 10:53:29          EUCTR           146 query=neuroblastoma&age=under-18&status=completed # 2 2022-03-19 10:53:39          CTGOV           200        cond=neuroblastoma&recrs=e&age=0&intr=Drug"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"find-fields-variables-of-interest","dir":"Articles","previous_headings":"","what":"Find fields / variables of interest","title":"Summarise and analyse clinical trial information","text":"Specify part name variable interest; variables including deeply nested variable names searched. search fields cached thus accelerated R session, long new ctrLoadQueryIntoDb() executed.","code":"dbFindFields(namepart = \"date\", con = db) # Finding fields in database collection (may take some time) # Field names cached for this session. #                                                                    EUCTR #                                 \"n_date_of_competent_authority_decision\" #                                                                    EUCTR #                                  \"p_date_of_the_global_end_of_the_trial\" #                                                                    EUCTR #                                     \"trialInformation.analysisStageDate\" #                                                                    EUCTR #                                  \"trialInformation.globalEndOfTrialDate\" #                                                                    EUCTR #                                 \"trialInformation.primaryCompletionDate\" #                                                                    EUCTR #                                  \"trialInformation.recruitmentStartDate\" #                                                                    EUCTR # \"x6_date_on_which_this_record_was_first_entered_in_the_eudract_database\" #                                                                    EUCTR #                                     \"n_date_of_ethics_committee_opinion\" #                                                                    CTGOV #                                                        \"completion_date\" #                                                                    CTGOV #                                                     \"last_update_posted\" #                                                                    CTGOV #                                                  \"last_update_submitted\" #                                                                    CTGOV #                                               \"last_update_submitted_qc\" #                                                                    CTGOV #                                                \"primary_completion_date\" #                                                                    CTGOV #                                          \"required_header.download_date\" #                                                                    CTGOV #                                                             \"start_date\" #                                                                    CTGOV #                                                      \"verification_date\" #                                                                    CTGOV #              \"provided_document_section.provided_document.document_date\""},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"data-frame-from-database","dir":"Articles","previous_headings":"","what":"Data frame from database","title":"Summarise and analyse clinical trial information","text":"fields interest can obtained database represented R data.frame:","code":"result <- dbGetFieldsIntoDf(   c(\"f41_in_the_member_state\",     \"f422_in_the_whole_clinical_trial\",     \"a1_member_state_concerned\",     \"p_end_of_trial_status\",     \"n_date_of_competent_authority_decision\",     \"a2_eudract_number\",     \"overall_status\",     \"start_date\",     \"primary_completion_date\"),   con = db)"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"metadata-from-data-frame","dir":"Articles","previous_headings":"","what":"Metadata from data frame","title":"Summarise and analyse clinical trial information","text":"objects returned functions package include attributes metadata indicate database, table / collection query details. Metadata can reused R. database, variable “_id” unique index record. “_id” NCT number CTGOV records (e.g., “NCT00002560”), EudraCT number EUCTR records including postfix identifying EU Member State (e.g., “2008-001436-12-NL”). relevant de-duplicate records trial can registered CTGOV EUCTR, can records involved country EUCTR. De-duplication done analysis stage enables select trial record taken one register, one EU Member State. basis de-duplication recording additional trial identifiers supplementary fields (variables), checked reported using function dbFindIdsUniqueTrials(): unique ids can used like de-duplicate data.frame created :","code":"attributes(result) # [...] # $`ctrdata-dbname` # [1] \"my_database_name\"  # $`ctrdata-table` # [1] \"my_collection_name\"  # $`ctrdata-dbqueryhistory` #       query-timestamp query-register query-records                                        query-term # 1 2022-03-19 10:53:29          EUCTR           146 query=neuroblastoma&age=under-18&status=completed # 2 2022-03-19 10:53:39          CTGOV           200        cond=neuroblastoma&recrs=e&age=0&intr=Drug # Obtain de-duplicated trial record ids ids <- dbFindIdsUniqueTrials(   preferregister = \"EUCTR\",   con = db ) # Searching for duplicate trials... #  - Getting trial ids (may take some time), 346 found in collection #  - Finding duplicates among registers' and sponsor ids... #  - 106 EUCTR _id were not preferred EU Member State record for 42 trials #  - Keeping 187 / 40 records from CTGOV / EUCTR # = Returning keys (_id) of 227 records in collection \"my_collection_name\" # Eliminate duplicate trials records: result <- result[ result[[\"_id\"]] %in% ids, ] # nrow(result) # [1] 227"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"simple-analysis---dates","dir":"Articles","previous_headings":"","what":"Simple analysis - dates","title":"Summarise and analyse clinical trial information","text":"data.frame generated dbGetFieldsIntoDf(), fields typed dates, logical, character numbers. typing facilitates using respective type data analysis, example dates base R graphics: Histogram1","code":"str(result) # 'data.frame':   227 obs. of  10 variables: # $ _id                                   : chr  \"2004-004386-15-DE\" \"2005-000915-80-IT\" \"2005-001267-63-IT\" ... # $ f41_in_the_member_state               : int  NA NA 5 37 70 24 100 35 10 24 ... # $ f422_in_the_whole_clinical_trial      : int  230 NA 12 67 70 NA 100 156 2230 NA ... # $ a1_member_state_concerned             : chr  \"Germany - BfArM\" \"Italy - Italian Medicines Agency\" ... # $ p_end_of_trial_status                 : chr  \"Completed\" \"Completed\" \"Completed\" \"Completed\" ... # $ n_date_of_competent_authority_decision: Date, format: \"2005-07-08\" \"2005-04-21\" \"2005-07-08\" \"2006-05-26\" ... # $ a2_eudract_number                     : chr  \"2004-004386-15\" \"2005-000915-80\" \"2005-001267-63\" \"2005-002089-13\" ... # $ overall_status                        : chr  NA NA NA NA ... # $ start_date                            : Date, format: NA NA NA NA ... # $ primary_completion_date               : Date, format: NA NA NA NA ... # Open file for saving png(\"vignettes/nb1.png\") # Visualise trial start date hist(   result[[\"n_date_of_competent_authority_decision\"]],   breaks = \"years\") box() dev.off()"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"merge-corresponding-fields-from-registers","dir":"Articles","previous_headings":"","what":"Merge corresponding fields from registers","title":"Summarise and analyse clinical trial information","text":"field “n_date_of_competent_authority_decision” used exists EUCTR, yet corresponds field “start_date” CTGOV. Thus, give start trial, two fields can merged analysis, using convenience function dfMergeTwoVariablesRelevel() ctrdata package: Histogram2 sophisticated use dfMergeTwoVariablesRelevel(), values original variables can mapped new values merged variable, follows:","code":"# Merge two variables into a new variable: result$trialstart <- dfMergeTwoVariablesRelevel(   result,   colnames = c(     \"n_date_of_competent_authority_decision\",     \"start_date\")) # Unique values returned (first three): 2005-07-08, 2005-04-21, 2006-05-26  # Plot from both registers png(\"vignettes/nb2.png\") hist(   result[[\"trialstart\"]],   breaks = \"years\") box() dev.off() # First, define how values of the new, merged variable # (e.g., \"ongoing\") will result from values of the # original variable (e.g, \"Recruiting): mapped_values <- list(   \"ongoing\" = c(\"Recruiting\", \"Active\", \"Ongoing\",                 \"Active, not recruiting\",                 \"Enrolling by invitation\", \"Restarted\"),   \"completed\" = c(\"Completed\", \"Prematurely Ended\", \"Terminated\"),   \"other\"     = c(\"Withdrawn\", \"Suspended\", \"No longer available\",                   \"Not yet recruiting\", \"Temporarily Halted\",                   \"Unknown status\", \"GB - no longer in EU/EEA\"))  # Secondly, use the list of mapped # values when merging two variable: tmp <- dfMergeTwoVariablesRelevel(   result,   colnames = c(\"overall_status\",                \"p_end_of_trial_status\"),   levelslist = mapped_values) # Unique values returned: completed, ongoing, other  table(tmp) #   completed   ongoing     other #         223         3         1"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"annotations-made-by-user","dir":"Articles","previous_headings":"","what":"Annotations made by user","title":"Summarise and analyse clinical trial information","text":"using ctrLoadQueryIntoDb(), ctrdata adds record fields annotation record_last_import. annotation field single string user specifies retrieving trials (Retrieve clinical trial information). user can specify append, prefix replace existing annotations trial record loaded , see example . last date time trial record imported updated automatically using ctrLoadQueryIntoDb(). fields can also used analysis. example, string functions can used annotations, e.g. split components. Since annotations specified retrieving trials steps , far annotation fields stopifnodata set FALSE avoid function raises error alert users:","code":"ctrLoadQueryIntoDb(   queryterm = \"query=neuroblastoma&resultsstatus=trials-with-results\",   register = \"EUCTR\",   euctrresults = TRUE,   annotation.text = \"test annotation\",   annotation.mode = \"append\",   con = db )  dbFindFields(\"clinical_results.outcome_list.outcome\", db) result <- dbGetFieldsIntoDf(   fields = c(     \"annotation\",     \"record_last_import\"),   con = db)  str(result) # 'data.frame':   373 obs. of  3 variables: #  $ _id               : chr  \"2004-004386-15-DE\" \"2004-004386-15-ES\" \"2004-004386-15-GB\" ... #  $ annotation        : chr  \"test annotation\" \"test annotation\" \"test annotation\" ... #  $ record_last_import: Date, format: \"2022-03-20\" \"2022-03-20\" \"2022-03-20\" \"2022-03-20\""},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"analysing-nested-fields-such-as-trial-results","dir":"Articles","previous_headings":"","what":"Analysing nested fields such as trial results","title":"Summarise and analyse clinical trial information","text":"registers represent clinical trial information nesting fields (e.g., several reporting groups within several measures within one several endpoints). visualisation hierarchical representation CTGOV : CtgovNested analysis nested information highlighted duration response facilitated ctrdata follows. main steps : transform nested information long, name-value data frame identify measures interest (e.g. duration response, blue circles ) located information hierarchy specifying name value fields (wherename, wherevalue) finally obtain value specifying name(s) value field(s) (valuename, red circles figure ).","code":"# remotes::install_github(\"https://github.com/hrbrmstr/jsonview\") result <- dbGetFieldsIntoDf(\"clinical_results.outcome_list.outcome\", db) jsonview::json_tree_view(result[[\"clinical_results.outcome_list.outcome\"]][  result[[\"_id\"]] == \"NCT00520936\"]) # 1. Create data frame from results fields. # These are the key results fields from # CTGOV and from EUCTR: result <- dbGetFieldsIntoDf(   fields = c(     # CTGOV     \"clinical_results.baseline.analyzed_list.analyzed.count_list.count\",     \"clinical_results.baseline.group_list.group\",     \"clinical_results.baseline.analyzed_list.analyzed.units\",     \"clinical_results.outcome_list.outcome\",     \"study_design_info.allocation\",     # EUCTR     \"@attributes.eudractNumber\",     \"trialInformation.populationAgeGroup\",     \"subjectDisposition.recruitmentDetails\",     \"baselineCharacteristics.baselineReportingGroups.baselineReportingGroup\",     \"endPoints.endPoint\",     \"trialChanges.hasGlobalInterruptions\",     \"subjectAnalysisSets\",     \"adverseEvents.seriousAdverseEvents.seriousAdverseEvent\"   ),   con = db ) # Keep only unique trial records result <- result[ result[[\"_id\"]] %in% dbFindIdsUniqueTrials(con = db), ] # [...] #  - Keeping 184 / 50 records from CTGOV / EUCTR # = Returning keys (_id) of 234 records in collection \"my_collection_name\"  # 2. The columns of the results data frame # contain nested lists of fields, example: str(result[[\"endPoints.endPoint\"]][1])  # All nested data are transformed to a long, # name-value data.frame (resulting in several # hundred rows per trial record): long_result <- dfTrials2Long(df = result) # Total 99006 rows, 143 unique names of variables  # 3. Obtain values for fields of interest where # they related to measures of interest. The # parameters can be regular expressions. dor <- dfName2Value(   df = long_result,   wherename = paste0(     \"clinical_results.outcome_list.outcome.measure.title|\",     \"endPoints.endPoint.title\"),   wherevalue = \"duration of response\",   valuename = paste0(     \"clinical_results.*category_list.category.measurement_list.measurement.value|\",     \"endPoints.*armReportingGroup.tendencyValues.tendencyValue.value\"   ) )  # Duration of response has been reported variably in # months and days. Here, just select trials reporting # duration of response in months: dor <- dor[   grepl(\"months\",         dfName2Value(           df = long_result,           wherename = paste0(             \"clinical_results.*outcome.measure.title|\",             \"endPoints.endPoint.title\"),           wherevalue = \"duration of response\",           valuename = paste0(             \"clinical_results.*measure.units|\",             \"endPoints.endPoint.unit\")         )[[\"value\"]],         ignore.case = TRUE), ]  # the identifier is generated to identify repeated and # nested elements in a trial, so that it permits to # find the valuename that corresponds to the item # for which wherename has wherevalue) dor[, c(\"_id\", \"identifier\", \"value\")] #                 _id identifier value # 1 2010-019348-37-IT        8.2   7.0 # 2 2010-019348-37-IT        8.3   8.1 # 5 2013-003595-12-SK        6.2 999.0 # 6 2013-003595-12-SK        6.3 999.0 # 7 2013-003595-12-SK        6.4 999.0 # 8 2013-003595-12-SK        6.5 999.0 # 9 2013-003595-12-SK        6.6 999.0"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"analysing-primary-endpoints","dir":"Articles","previous_headings":"","what":"Analysing primary endpoints","title":"Summarise and analyse clinical trial information","text":"Text analysis used many fields trial information registers. example simply categorise type primary endpoint. addition, number subjects extracted compared type primary endpoint. BoxPEP","code":"# Several \"measure\" entries are in \"primary_outcome\". # They are concatenated into a list when specifying # the JSON path \"primary_outcome.measure\" result <- dbGetFieldsIntoDf(c(   # CTGOV   \"primary_outcome.measure\",   \"enrollment\",   # EUCTR   \"e51_primary_end_points\",   # \"f11_trial_has_subjects_under_18\"   \"f11_number_of_subjects_for_this_age_range\"),   con = db)  # De-duplicate result <- result[   result[[\"_id\"]] %in%     dbFindIdsUniqueTrials(con = db), ]  # Merge primary endpoint (pep) result$pep <- dfMergeTwoVariablesRelevel(   df = result,   colnames =     c(\"primary_outcome.measure\",       \"e51_primary_end_points\") )  # Merge number of subjects result$nsubj <- dfMergeTwoVariablesRelevel(   df = result,   colnames =     c(\"enrollment\",       \"f11_number_of_subjects_for_this_age_range\") )  # For primary endpoint of interest, # use regular expression on text: result$pep_is_efs <- grepl(   pattern = \"((progression|event|relapse|recurrence|disease)[- ]free)|pfs|dfs|efs)\",   x = result$pep,   ignore.case = TRUE)  # Tabulate table(result$pep_is_efs) # FALSE  TRUE #   184    21  # Plot library(ggplot2) ggplot(data = result,        aes(x = nsubj,            y = pep_is_efs)) +   geom_boxplot() +   scale_x_log10() ggsave(\"vignettes/boxpep.png\", width = 6, height = 4)"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"investigational-or-authorised-medicinal-product","dir":"Articles","previous_headings":"","what":"Investigational or authorised medicinal product?","title":"Summarise and analyse clinical trial information","text":"information status authorisation (licensing) medicine used trial recorded EUCTR field dimp.d21_imp_to_be_used_in_the_trial_has_a_marketing_authorisation. corresponding field CTGOV known. status tree starting dimp element. HistogramNBtrials","code":"# Get results result <- dbGetFieldsIntoDf(   fields =     c(\"a1_member_state_concerned\",       \"n_date_of_competent_authority_decision\",       \"dimp.d21_imp_to_be_used_in_the_trial_has_a_marketing_authorisation\",       \"x6_date_on_which_this_record_was_first_entered_in_the_eudract_database\",       \"f422_in_the_whole_clinical_trial\",       \"a2_eudract_number\"),   con = db)  # Find first date of authorisation in EU member state tmp <- aggregate(   result[[\"n_date_of_competent_authority_decision\"]],   by = list(result[[\"a2_eudract_number\"]]),   FUN = function(x) min(x)) result <- merge(   x = result,   y = tmp,   by.x = \"a2_eudract_number\",   by.y = \"Group.1\",   all.x = TRUE) result[[\"startdatefirst\"]] <- dfMergeTwoVariablesRelevel(   df = result,   colnames = c(     \"x\",     \"x6_date_on_which_this_record_was_first_entered_in_the_eudract_database\") )  # Now de-duplicate result <- result[   result[[\"_id\"]] %in%     dbFindIdsUniqueTrials(       include3rdcountrytrials = FALSE,       con = db), ]  # How many of the investigational medicinal product(s) # used in the trial are authorised? number_authorised <- sapply(   result[[\"dimp.d21_imp_to_be_used_in_the_trial_has_a_marketing_authorisation\"]],   function(i) length(i[i])) table(number_authorised, exclude = \"\") # number_authorised #  0  1  2  3  4  6  8 15  # 20 15  4  3  1  1  1  1  result[[\"any_authorised\"]] <- number_authorised > 0  # Plot library(ggplot2) library(scales) ggplot(   data = result,   aes(     x = startdatefirst,     fill = any_authorised)) +   scale_x_date(     breaks = breaks_width(width = \"2 years\"),     labels = date_format(\"%Y\")) +   geom_histogram(binwidth = 2 * 365.25) +   labs(     title = \"Neuroblastoma trials in EU\",     x = \"Year of trial authorisation (or entered in EUCTR)\",     y = \"Number of trials\",     fill = \"Medicine\\nauthorised?\") ggsave(\"vignettes/nbtrials.png\", width = 6, height = 4)"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"analyses-using-aggregation-pipeline-and-mapreduce","dir":"Articles","previous_headings":"","what":"Analyses using aggregation pipeline and mapreduce","title":"Summarise and analyse clinical trial information","text":"example analysis functions can run directly MongoDB server, fast consume R resources.","code":"# Load library for database access library(mongolite)  # Create R object m to access the # collection db created above: m <- mongo(url = paste0(db[[\"url\"]], \"/\", db[[\"db\"]]),            collection = db[[\"collection\"]])  # Number of records in  collection: m$count() # [1] 374  # Number of EUCTR records, using JSON for query: m$count(query = '{\"_id\": {\"$regex\": \"[0-9]{4}-[0-9]{6}-[0-9]{2}\",                  \"$options\": \"i\"}}') #[1] 173  # Alternative: m$count(query = '{\"ctrname\": \"EUCTR\"}') # [1] 173  # Number of CTGOV records: m$count(query = '{\"_id\": {\"$regex\": \"NCT[0-9]{8}\",                  \"$options\": \"i\"}}') # [1] 200  # Alternative: m$count(query = '{\"ctrname\": \"CTGOV\"}') # [1] 200  # To best define regular expressions for analyses, # inspect the field (here, primary_outcome.measure): # Regular expressions (\"$regex\") are case insensitive (\"i\") head(   m$distinct(key = \"primary_outcome.measure\",              query = '{\"_id\": {\"$regex\": \"NCT[0-9]{8}\", \"$options\": \"i\"}}')) # [1] \"- To demonstrate that 123I-mIBG planar scintigraphy is sensitive and ...\" # [2] \"1-year Progression-free Survival\" # [3] \"Ability of iodine I 131 metaiodobenzylguanidine to provide palliative therapy\" # [4] \"Acute and late toxicities\" # [5] \"Adverse events as a measure of safety/tolerability\" # [6] \"Adverse events as assessed by (CTCAE) version 4.0\""},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"aggregation","dir":"Articles","previous_headings":"Analyses using aggregation pipeline and mapreduce","what":"Aggregation","title":"Summarise and analyse clinical trial information","text":"following example uses aggregation pipeline MongoDB. See details mongo’s aggregation pipleline: https://docs.mongodb.org/manual/core/aggregation-pipeline/","code":"# Total count of PFS, EFS, RFS or DFS out <- m$aggregate(   # Count number of documents in collection that   # matches in primary_outcome.measure the   # regular expression,   pipeline =     '[{\"$match\": {\"primary_outcome.measure\":       {\"$regex\": \"(progression|event|relapse|recurrence|disease)[- ]free\",                  \"$options\": \"i\"}}},       {\"$group\": {\"_id\": \"null\", \"count\": {\"$sum\": 1}}}]') out #    _id count # 1 null    16  # List records of trials with overall survival  # as primary endpoint, and list start date out <- m$aggregate(   pipeline =     '[{\"$match\": {\"primary_outcome.measure\":       {\"$regex\": \"overall survival\", \"$options\": \"i\"}}},       {\"$project\": {\"_id\": 1, \"start_date\": 1}}]') head(out) #           _id      start_date # 1 NCT00499616 October 8, 2007 # 2 NCT00793845     August 2008 # 3 NCT00923351    June 2, 2007"},{"path":"https://rfhb.github.io/ctrdata/articles/ctrdata_summarise.html","id":"mapreduce","dir":"Articles","previous_headings":"Analyses using aggregation pipeline and mapreduce","what":"Mapreduce","title":"Summarise and analyse clinical trial information","text":"following examples uses map-reduce operation MongoDB. Note deprecated starting MongoDB 5. information: https://docs.mongodb.com/manual/core/map-reduce/","code":"# Count number of trials by number of study  # participants in bins of hundreds of participants: hist <- m$mapreduce(   map = \"function() {emit(Math.floor(this.f422_in_the_whole_clinical_trial/100)*100, 1)}\",   reduce = \"function(id, counts) {return Array.sum(counts)}\" ) # read as: 85 trials had 0 to less than 100 participants hist[order(hist[[\"_id\"]]),] #     _id value # 4     0    85 # 7   100    45 # 10  200    11 # 6   300     4 # 5   400     9 # 2   600     1 # 3  2200     4 # 9  2700     2 # 8  3300     4 # 1   NaN   209"},{"path":"https://rfhb.github.io/ctrdata/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Ralf Herold. Author, maintainer.","code":""},{"path":"https://rfhb.github.io/ctrdata/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Herold R (2022). ctrdata: Retrieve Analyze Clinical Trials Public Registers. R package version 1.10.1.9004, https://cran.r-project.org/package=ctrdata.","code":"@Manual{,   title = {ctrdata: Retrieve and Analyze Clinical Trials in Public Registers},   author = {Ralf Herold},   year = {2022},   note = {R package version 1.10.1.9004},   url = {https://cran.r-project.org/package=ctrdata}, }"},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"ctrdata-for-aggregating-and-analysing-clinical-trials","dir":"","previous_headings":"","what":"Retrieve and Analyze Clinical Trials in Public Registers","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"package ctrdata provides functions retrieving (downloading) information clinical trials public registers, aggregating analysing information; can used EU Clinical Trials Register (“EUCTR”, https://www.clinicaltrialsregister.eu/) ClinicalTrials.gov (“CTGOV”, https://clinicaltrials.gov/) ISRCTN (https://www.isrctn.com/) motivation understand trends design conduct trials, availability patients detailled results. ctrdata package R system, systems tools can used databases created . README reviewed 2022-08-08 version 1.10.0.9005 (see NEWS.md). Main features: Protocol-related trial information easily retrieved (downloaded): Users define query register’s web interface use ctrdata retrieve one step trials resulting query. Results-related trial information personal annotations can including retrieval. Synonyms active substance can also found. Retrieved (downloaded) trial information transformed stored document-centric database, fast offline access. Uses PostgreSQL (🔔new version 1.9.0), RSQLite MongoDB databases, via R package nodbi: see section Databases . Easily re-run previous query update database. Analysis can done R (using ctrdata convenience functions) others systems. Unique (de-duplicated) trial records identified across registers. ctrdata can merge recode information (fields) also provides easy access even deeply-nested fields (new version 1.4.0). Remember respect registers’ terms conditions (see ctrOpenSearchPagesInBrowser(copyright = TRUE)). Please cite package publication follows: “Ralf Herold (2021). ctrdata: Retrieve Analyze Clinical Trials Public Registers. R package version 1.10.0, https://cran.r-project.org/package=ctrdata” Package ctrdata used : Blogging Innovation coming paediatric research Report impact collaboration: value UK medical research EU science health","code":""},{"path":[]},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"id_1-install-package-ctrdata-in-r","dir":"","previous_headings":"Installation","what":"1. Install package ctrdata in R","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"Package ctrdata CRAN GitHub. Within R, use following commands install package ctrdata: commands also install package dependencies, nodbi, jsonlite, httr, curl, clipr, xml2, rvest stringi.","code":"# Install CRAN version: install.packages(\"ctrdata\")  # Alternatively, install development version: install.packages(\"devtools\") devtools::install_github(\"rfhb/ctrdata\", build_vignettes = TRUE)"},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"id_2-command-line-tools-perl-sed-and-php-52-or-higher","dir":"","previous_headings":"Installation","what":"2. Command line tools perl, sed and php (5.2 or higher)","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"required ctrLoadQueryIntoDb(), main function package ctrdata (see Example workflow); function also checks tools can used. MS Windows, install Cygwin: R, run ctrdata::installCygwinWindowsDoInstall() automated minimal installation. Alternatively, manually install Cygwin packages perl, php-jsonc php-simplexml c:\\cygwin. installation needs 160 MB disk space; administrator credentials needed. macOS including 11 Big Sur, already installed; alternative 🔔macOS 12 Monterey, homebrew can used: brew install php, seems include libraries required ctrdata. Linux, usually already installed; tools installation vary distribution (e.g., sudo apt install php-cli php-xml php-json).","code":""},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"vignettes","dir":"","previous_headings":"Installation","what":"Vignettes","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"Install R package ctrdata Retrieve clinical trial information Summarise analyse clinical trial information","code":""},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"overview-of-functions-in-ctrdata","dir":"","previous_headings":"","what":"Overview of functions in ctrdata","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"functions listed approximate order use user’s workflow (bold, main functions). package dplyr loaded, tibble returned instead data.frame.","code":""},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"databases-that-can-be-used-with-ctrdata","dir":"","previous_headings":"","what":"Databases that can be used with ctrdata","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"Package ctrdata retrieves trial information stores database collection, given connection object parameter con several ctrdata functions; connection object created slightly different ways three supported database backends can used ctrdata shown table. Besides ctrdata functions , connection object can equally used functions packages, nodbi (last row table) , case MongoDB database backend, mongolite (see vignettes).","code":""},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"example-workflow","dir":"","previous_headings":"","what":"Example workflow","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"aim download protocol-related trial information tabulate trials’ status conduct. Attach package ctrdata: See help get started ctrdata: Information trial registers can used ctrdata: Open registers’ advanced search pages browser: Adjust search parameters execute search browser trials interest listed browser, copy address browser’s address bar clipboard Search used example: https://www.clinicaltrialsregister.eu/ctr-search/search?query=cancer&age=-18&phase=phase-one&status=completed Get address clipboard: Retrieve protocol-related information, transform save database: database collection specified first, using nodbi (see specify PostgreSQL, RSQlite MongoDB backend); , trial information retrieved loaded collection: hood, scripts euctr2json.sh xml2json.php (ctrdata/exec) transform EUCTR plain text files CTGOV well ISRCTN XML files ndjson format, imported database collection. Analyse Tabulate status trials part agreed paediatric development program (paediatric investigation plan, PIP): Add records another register (CTGOV) collection Search used example: https://clinicaltrials.gov/ct2/results?cond=neuroblastoma&rslt=&recrs=e&age=0&intr=Drug Add records third register (ISRCTN) collection Search used example: https://www.isrctn.com/search?q=neuroblastoma Result-related trial information Analyse simple result details (see vignette examples): * Retrieve protocols, statistical analysis plans documents local folder ./files/","code":"library(ctrdata) help(\"ctrdata-package\") help(\"ctrdata-registers\") ctrOpenSearchPagesInBrowser()  # Please review and respect register copyrights: ctrOpenSearchPagesInBrowser(copyright = TRUE) q <- ctrGetQueryUrl() # * Using clipboard content as register query URL: https://www.clinicaltrialsregister.eu/ctr-search/search?query=cancer&age=under-18&phase=phase-one&status=completed # * Found search query from EUCTR: query=cancer&age=under-18&phase=phase-one&status=completed  q #                                                   query-term  query-register # 1 query=cancer&age=under-18&phase=phase-one&status=completed           EUCTR # Connect to (or newly create) an SQLite database # that is stored in a file on the local system: db <- nodbi::src_sqlite(   dbname = \"some_database_name.sqlite_file\",   collection = \"some_collection_name\")  # See section Databases below # for MongoDB as alternative  # Retrieve trials from public register: ctrLoadQueryIntoDb(   queryterm = q,   con = db) # * Found search query from EUCTR: query=cancer&age=under-18&phase=phase-one&status=completed # (1/3) Checking trials in EUCTR: # Retrieved overview, multiple records of 66 trial(s) from 4 page(s) to be downloaded # Checking helper binaries: done # Downloading trials (4 pages in parallel)... # Note: register server cannot compress data, transfer takes longer, about 0.4s per trial # Pages: 4 done, 0 ongoing # (2/3) Converting to JSON, 248 records converted # (3/3) Importing JSON records into database... # = Imported or updated 248 records on 66 trial(s) # * Updated history (\"meta-info\" in \"some_collection_name\") # Get all records that have values in the fields of interest: result <- dbGetFieldsIntoDf(   fields = c(     \"a7_trial_is_part_of_a_paediatric_investigation_plan\",     \"p_end_of_trial_status\",     \"a2_eudract_number\"),   con = db)  # Find unique trial identifiers for trials that have nore than # one record, for example for several EU Member States: uniqueids <- dbFindIdsUniqueTrials(con = db) # Searching for duplicate trials... #  - Getting trial ids, 279 found in collection #  - Finding duplicates among registers' and sponsor ids... #  - 208 EUCTR _id were not preferred EU Member State record for 71 trials #  - Keeping 71 records from EUCTR # = Returning keys (_id) of 71 records in collection \"some_collection_name\"  # Keep only unique / de-duplicated records: result <- subset(   result,   subset = `_id` %in% uniqueids )  # Tabulate the selected clinical trial information: with(result,      table(        p_end_of_trial_status,        a7_trial_is_part_of_a_paediatric_investigation_plan)) #                     a7_trial_is_part_of_a_paediatric_investigation_plan # p_end_of_trial_status      Information not present in EudraCT No Yes #   Completed                                                 6 32  16 #   GB - no longer in EU/EEA                                  0  7   5 #   Ongoing                                                   0  1   0 #   Prematurely Ended                                         1  2   0 #   Restarted                                                 0  1   0 # Retrieve trials from another register: ctrLoadQueryIntoDb(   queryterm = \"cond=neuroblastoma&rslt=With&recrs=e&age=0&intr=Drug\",   register = \"CTGOV\",   con = db) # * Found search query from CTGOV: cond=neuroblastoma&rslt=With&recrs=e&age=0&intr=Drug # (1/3) Checking trials in CTGOV: # Retrieved overview, records of 44 trial(s) are to be downloaded # Checking helper binaries: done # Downloading: 620 kB # (2/3) Converting to JSON, 44 records converted # (3/3) Importing JSON records into database... # = Imported or updated 43 trial(s) # * Updated history (\"meta-info\" in \"some_collection_name\") # Retrieve trials from another register: ctrLoadQueryIntoDb(   queryterm = \"https://www.isrctn.com/search?q=neuroblastoma\",   con = db) # * Found search query from ISRCTN: q=neuroblastoma # (1/3) Checking trials in ISRCTN: # Retrieved overview, records of 9 trial(s) are to be downloaded # Checking helper binaries: done # Downloading: 90 kB # (2/3) Converting to JSON, 9 records converted # (3/3) Importing JSON records into database... # = Imported or updated 9 trial(s) # * Updated history (\"meta-info\" in \"some_collection_name\") # Get all records that have values in any of the specified fields result <- dbGetFieldsIntoDf(   fields = c(     \"clinical_results.baseline.analyzed_list.analyzed.count_list.count\",     \"clinical_results.baseline.group_list.group\",     \"clinical_results.baseline.analyzed_list.analyzed.units\",     \"study_design_info.allocation\",     \"location\"),   con = db)  # Transform all fields into long name - value format result <- dfTrials2Long(df = result) # Total 6386 rows, 12 unique names of variables  # [1.] get counts of subjects for all arms into data frame # This count is in the group where either its title or its # description starts with \"Total\" nsubj <- dfName2Value(   df = result,   valuename = \"clinical_results.baseline.analyzed_list.analyzed.count_list.count.value\",   wherename = paste0(     \"clinical_results.baseline.group_list.group.title|\",     \"clinical_results.baseline.group_list.group.description\"),   wherevalue = \"^Total\" )  # [2.] count number of sites nsite <- dfName2Value(   df = result,   # some ctgov records use   # location.name, others use   # location.facility.name   valuename = \"^location.*name$\" ) # count nsite <- tapply(   X = nsite[[\"value\"]],   INDEX = nsite[[\"_id\"]],   FUN = length,   simplify = TRUE ) nsite <- data.frame(   \"_id\" = names(nsite),   nsite,   check.names = FALSE,   stringsAsFactors = FALSE,   row.names = NULL )  # [3.] randomised? ncon <- dfName2Value(   df = result,   valuename = \"study_design_info.allocation\" )  # merge sets nset <- merge(nsubj, nsite, by = \"_id\") nset <- merge(nset, ncon, by = \"_id\")  # Example plot library(ggplot2) ggplot(data = nset) +   labs(title = \"Neuroblastoma trials with results\",        subtitle = \"clinicaltrials.gov\") +   geom_point(     mapping = aes(       x = nsite,       y = value.x,       colour = value.y == \"Randomized\")) +   scale_x_log10() +   scale_y_log10() +   xlab(\"Number of sites\") +   ylab(\"Total number of subjects\") +   labs(colour = \"Randomised?\") ggsave(filename = \"man/figures/README-ctrdata_results_neuroblastoma.png\",        width = 5, height = 3, units = \"in\") # eudract files are downloaded as part of results ctrLoadQueryIntoDb(   queryterm = q,   euctrresults = TRUE,    euctrresultspdfpath = \"./files/\",   con = db)  # ctgov files can separately be downloaded sapply(   unlist(strsplit(     dbGetFieldsIntoDf(       fields = \"provided_document_section.provided_document.document_url\",       con = db)[[2]],      split = \" / \")),    function(f) download.file(     f, paste0(\"./files/\", gsub(\"[/:]\", \"-\", f))))"},{"path":[]},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"additional-features-under-consideration","dir":"","previous_headings":"Meta","what":"Additional features under consideration","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"Retrieve previous versions protocol- results-related information. challenge , apparently, initial versions queried historical versions can retrieved one--one structured format. Merge results-related fields retrieved different registers (e.g., corresponding endpoints). challenge incomplete congruency different structure fields.","code":""},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"acknowledgements","dir":"","previous_headings":"Meta","what":"Acknowledgements","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"Data providers curators clinical trial registers. Please review respect copyrights terms conditions, see ctrOpenSearchPagesInBrowser(copyright = TRUE). Package ctrdata made possible building work done R, curl, httr, xml2, rvest, mongolite, jsonlite, nodbi, RPostgres, RSQLite clipr.","code":""},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"issues-and-notes","dir":"","previous_headings":"Meta","what":"Issues and notes","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"Please file issues bugs . Also check handle closed issues, e.g. C stack usage close limit SSL certificate problem: unable get local issuer certificate Information trial registers may fully correct; see example publication CTGOV. attempts made harmonise field names registers (nevertheless, dfMergeTwoVariablesRelevel() can used merge map two variables / fields one).","code":""},{"path":[]},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"postgresql","dir":"","previous_headings":"Trial records’ JSON in databases","what":"PostgreSQL","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"Example JSON representation PostgreSQL","code":""},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"mongodb","dir":"","previous_headings":"Trial records’ JSON in databases","what":"MongoDB","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"Example JSON representation MongoDB","code":""},{"path":"https://rfhb.github.io/ctrdata/index.html","id":"sqlite","dir":"","previous_headings":"Trial records’ JSON in databases","what":"SQLite","title":"Retrieve and Analyze Clinical Trials in Public Registers","text":"Example JSON representation SQLite","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrDb.html","id":null,"dir":"Reference","previous_headings":"","what":"Check and prepare nodbi connection object for ctrdata — ctrDb","title":"Check and prepare nodbi connection object for ctrdata — ctrDb","text":"Check prepare nodbi connection object ctrdata","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrDb.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Check and prepare nodbi connection object for ctrdata — ctrDb","text":"","code":"ctrDb(con = nodbi::src_sqlite(collection = \"ctrdata_auto_generated\"))"},{"path":"https://rfhb.github.io/ctrdata/reference/ctrDb.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Check and prepare nodbi connection object for ctrdata — ctrDb","text":"con connection object, see section `Databases` ctrdata-package","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrDb.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Check and prepare nodbi connection object for ctrdata — ctrDb","text":"Connection object list, collection  element root","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrFindActiveSubstanceSynonyms.html","id":null,"dir":"Reference","previous_headings":"","what":"Find synonyms of an active substance — ctrFindActiveSubstanceSynonyms","title":"Find synonyms of an active substance — ctrFindActiveSubstanceSynonyms","text":"active substance can identified recommended international nonproprietary name (INN), trade product name, company code(s). Retrieves substances searched register 'ClinicalTrials.Gov' given active substance.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrFindActiveSubstanceSynonyms.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Find synonyms of an active substance — ctrFindActiveSubstanceSynonyms","text":"","code":"ctrFindActiveSubstanceSynonyms(activesubstance = \"\")"},{"path":"https://rfhb.github.io/ctrdata/reference/ctrFindActiveSubstanceSynonyms.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Find synonyms of an active substance — ctrFindActiveSubstanceSynonyms","text":"activesubstance active substance, atomic character vector","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrFindActiveSubstanceSynonyms.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Find synonyms of an active substance — ctrFindActiveSubstanceSynonyms","text":"character vector active substance (input parameter)  synonyms, NULL active substance found may invalid","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrFindActiveSubstanceSynonyms.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Find synonyms of an active substance — ctrFindActiveSubstanceSynonyms","text":"","code":"ctrFindActiveSubstanceSynonyms(activesubstance = \"imatinib\") #> [1] \"imatinib\"  \"gleevec\"   \"sti 571\"   \"glivec\"    \"CGP 57148\" \"st1571\"    # [1] \"imatinib\" \"gleevec\" \"sti 571\" \"glivec\" \"CGP 57148\" \"st1571\""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrGetQueryUrl.html","id":null,"dir":"Reference","previous_headings":"","what":"Get query details — ctrGetQueryUrl","title":"Get query details — ctrGetQueryUrl","text":"Extracts query parameters register name parameter `url` clipboard, URL register search copied.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrGetQueryUrl.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get query details — ctrGetQueryUrl","text":"","code":"ctrGetQueryUrl(url = \"\", register = \"\")"},{"path":"https://rfhb.github.io/ctrdata/reference/ctrGetQueryUrl.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get query details — ctrGetQueryUrl","text":"url URL browser address bar. specified, clipboard contents checked suitable URL. Can also contain query term dbQueryHistory()[\"query-term\"] register Optional name register (.e., \"EUCTR\" \"CTGOV\") case url query term","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrGetQueryUrl.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get query details — ctrGetQueryUrl","text":"data frame (tibble, dplyr loaded) column names `query-term` `query-register`. data frame (tibble) can passed parameter `query-term` ctrLoadQueryIntoDb parameter `url` ctrOpenSearchPagesInBrowser.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrGetQueryUrl.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get query details — ctrGetQueryUrl","text":"","code":"# user copied into the clipboard the URL from # the address bar of the browser that shows results # from a query in one of the trial registers try(ctrGetQueryUrl(), silent = TRUE) #> * Using clipboard content as register query URL: #' \\dontrun{ #> Warning: ctrGetQueryUrl(): no clinical trial register search URL found in parameter 'url' or in clipboard.  # extract query parameters from search result URL ctrGetQueryUrl(   url = \"https://clinicaltrials.gov/ct2/results?cond=&term=AREA%5BMaximumAge%5D+RANGE%5B0+days%2C+28+days%5D&type=Intr&rslt=&age_v=&gndr=&intr=Drugs%2C+Investigational&titles=&outc=&spons=&lead=&id=&cntry=&state=&city=&dist=&locn=&phase=2&rsub=&strd_s=01%2F01%2F2015&strd_e=01%2F01%2F2016&prcd_s=&prcd_e=&sfpd_s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort=\") #> * Found search query from CTGOV: term=AREA[MaximumAge]+RANGE[0+days,+28+days]&type=Intr&intr=Drugs,+Investigational&phase=2&strd_s=01/01/2015&strd_e=01/01/2016 #>                                                                                                                       query-term #> 1 term=AREA[MaximumAge]+RANGE[0+days,+28+days]&type=Intr&intr=Drugs,+Investigational&phase=2&strd_s=01/01/2015&strd_e=01/01/2016 #>   query-register #> 1          CTGOV"},{"path":"https://rfhb.github.io/ctrdata/reference/ctrLoadQueryIntoDb.html","id":null,"dir":"Reference","previous_headings":"","what":"Load and store register trial information — ctrLoadQueryIntoDb","title":"Load and store register trial information — ctrLoadQueryIntoDb","text":"Retrieves updates information clinical trials registers stores collection database. main function ctrdata-package accessing registers loading trial information database collection, even different queries different registers. query details stored database collection can accessed using dbQueryHistory. previous query can re-run, replaces adds trial records. However, user annotations trial records kept.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrLoadQueryIntoDb.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Load and store register trial information — ctrLoadQueryIntoDb","text":"","code":"ctrLoadQueryIntoDb(   queryterm = NULL,   register = \"\",   querytoupdate = NULL,   forcetoupdate = FALSE,   euctrresults = FALSE,   euctrresultshistory = FALSE,   euctrresultsfilespath = euctrresultspdfpath,   euctrresultspdfpath = NULL,   annotation.text = \"\",   annotation.mode = \"append\",   parallelretrievals = 10L,   only.count = FALSE,   con = NULL,   verbose = FALSE )"},{"path":"https://rfhb.github.io/ctrdata/reference/ctrLoadQueryIntoDb.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Load and store register trial information — ctrLoadQueryIntoDb","text":"queryterm Either string full URL search register, data frame returned ctrGetQueryUrl dbQueryHistory functions, , together parameter register, string query elements search URL. queryterm recorded collection later use update records. register String abbreviation register query, either \"EUCTR\", \"CTGOV\" \"ISRCTN\". needed queryterm provide information register query (see queryterm). querytoupdate Either word \"last\" number query (based dbQueryHistory) run retrieve trial records new updated since query run last time. parameter takes precedence queryterm. EUCTR, updates available last seven days; query run time passed since run last. forcetoupdate TRUE, run query given querytoupdate, irrespective run last (default FALSE). euctrresults TRUE, also download available results retrieving loading trials EUCTR. slows function. (CTGOV, available results always retrieved loaded.) euctrresultshistory TRUE, also download available history results publication EUCTR. quite time-consuming (default FALSE). euctrresultsfilespath relative absolute path  directory exists can created, save results files , e.g., PDF files result publications submitted EUCTR (default NULL). euctrresultspdfpath Deprecated, use euctrresultsfilespath annotation.text Text including records retrieved current query, field \"annotation\". annotation.mode One \"append\" (default), \"prepend\" \"replace\" new annotation.text respect existing annotation records retrieved current query. parallelretrievals Number parallel downloads information register, defaults 10. .count Set TRUE return number trial records found register query. load trial information database. Default FALSE. con connection object, see section `Databases` ctrdata-package verbose Printing additional information set TRUE; default FALSE.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrLoadQueryIntoDb.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Load and store register trial information — ctrLoadQueryIntoDb","text":"list elements `n` (number trial records newly imported updated), `success` (vector _id's successfully loaded records), `failed` (vector identifiers records failed load) `queryterm` (query term used). returned list several attributes (including database collection name, well query history database collection) facilitate documentation.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrLoadQueryIntoDb.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Load and store register trial information — ctrLoadQueryIntoDb","text":"","code":"if (FALSE) {  dbc <- nodbi::src_sqlite(collection = \"my_collection\")  # Retrieve protocol- and results-related information # on a single trial identified by its EU number ctrLoadQueryIntoDb(   queryterm = \"2013-001291-38\",   register = \"EUCTR\",   euctrresults = TRUE,   con = dbc )  # Retrieve all information on about 2,000 ongoing # interventional cancer trials involving children # into the same collection as used before ctrLoadQueryIntoDb(   queryterm = \"cancer&recr=Open&type=Intr&age=0\",   register = \"CTGOV\",   con = dbc )  # Retrieve all information on more than 40 trials # that are labelled as phase 3 and that mention # either neuroblastoma or lymphoma from ISRCTN, # into the same collection as used before ctrLoadQueryIntoDb(   queryterm = \"https://www.isrctn.com/search?q=neuroblastoma+OR+lymphoma&filters=phase%3APhase+III\",   con = dbc )  }"},{"path":"https://rfhb.github.io/ctrdata/reference/ctrOpenSearchPagesInBrowser.html","id":null,"dir":"Reference","previous_headings":"","what":"Open stored query or register search page — ctrOpenSearchPagesInBrowser","title":"Open stored query or register search page — ctrOpenSearchPagesInBrowser","text":"Open advanced search pages register(s), execute search browser","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrOpenSearchPagesInBrowser.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Open stored query or register search page — ctrOpenSearchPagesInBrowser","text":"","code":"ctrOpenSearchPagesInBrowser(url = \"\", register = \"\", copyright = FALSE, ...)"},{"path":"https://rfhb.github.io/ctrdata/reference/ctrOpenSearchPagesInBrowser.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Open stored query or register search page — ctrOpenSearchPagesInBrowser","text":"url search results page show browser. Can return value ctrGetQueryUrl dbQueryHistory. register Register(s) open. Either \"EUCTR\" \"CTGOV\" vector . Default open registers' advanced search pages. open browser previous search, output ctrGetQueryUrl one row dbQueryHistory can used. copyright (Optional) set TRUE, opens copyright pages register(s). ... May include deprecated input parameter.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrOpenSearchPagesInBrowser.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Open stored query or register search page — ctrOpenSearchPagesInBrowser","text":"Always TRUE, invisibly.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrOpenSearchPagesInBrowser.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Open stored query or register search page — ctrOpenSearchPagesInBrowser","text":"","code":"# Check copyrights before using registers ctrOpenSearchPagesInBrowser(copyright = TRUE)  # open last query loaded into the collection dbc <- nodbi::src_sqlite(    dbname = system.file(\"extdata\", \"demo.sqlite\", package = \"ctrdata\"),    collection = \"my_trials\")  ctrOpenSearchPagesInBrowser(   dbQueryHistory(con = dbc)) #> Warning: Using last query #> [1] \"https://www.isrctn.com/search?q=&filters=ageRange:Neonate,phase:Phase+III\""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrdata-package.html","id":null,"dir":"Reference","previous_headings":"","what":"ctrdata: get started, connect database and function overview — ctrdata-package","title":"ctrdata: get started, connect database and function overview — ctrdata-package","text":"package aggregating analysing information results clinical trials, retrieved public study registers","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrdata-package.html","id":"database-connection","dir":"Reference","previous_headings":"","what":"Database connection","title":"ctrdata: get started, connect database and function overview — ctrdata-package","text":"Package ctrdata retrieves trial information stores database collection, given connection object parameter con several ctrdata functions; connection object created slightly different ways three supported database backends: Example using ctrdata function connection object: ctrdata::dbQueryHistory(con = dbc). Besides ctrdata functions , connection object can equally used functions package nodbi, example nodbi::docdb_query(src = dbc, key = dbc$collection, fields = '{\"_id\": 1}', query = '{\"sponsors.lead_sponsor.agency_class\": \"Industry\"}')","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrdata-package.html","id":"operations-on-a-clinical-trial-register","dir":"Reference","previous_headings":"","what":"Operations on a clinical trial register","title":"ctrdata: get started, connect database and function overview — ctrdata-package","text":"ctrOpenSearchPagesInBrowser, ctrLoadQueryIntoDb (load trial records database collection), ctrFindActiveSubstanceSynonyms; see ctrdata-registers details registers search","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrdata-package.html","id":"get-a-data-frame-from-the-database-collection","dir":"Reference","previous_headings":"","what":"Get a data frame from the database collection","title":"ctrdata: get started, connect database and function overview — ctrdata-package","text":"dbFindFields (find names fields interest trial records collection), dbGetFieldsIntoDf (create data frame fields interest collection), dbFindIdsUniqueTrials (de-duplicated identifiers clinical trial records can used subset data frame)","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrdata-package.html","id":"operate-on-a-data-frame-with-trial-information","dir":"Reference","previous_headings":"","what":"Operate on a data frame with trial information","title":"ctrdata: get started, connect database and function overview — ctrdata-package","text":"dfTrials2Long (convert fields nested elements long format), dfName2Value (get values variable(s) interest). dfMergeTwoVariablesRelevel","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrdata-package.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"ctrdata: get started, connect database and function overview — ctrdata-package","text":"Ralf Herold ralf.herold@mailbox.org","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrdata-registers.html","id":null,"dir":"Reference","previous_headings":"","what":"ctrdata: detailed information on clinical trial registers — ctrdata-registers","title":"ctrdata: detailed information on clinical trial registers — ctrdata-registers","text":"Registers clinical trials can accessed package ctrdata-package end 2021","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrdata-registers.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"ctrdata: detailed information on clinical trial registers — ctrdata-registers","text":"EUCTR: European Union Clinical Trials Register contains 40,000 clinical trials (using one medicines investigational medicinal product, IMP; Europe beyond) CTGOV: ClinicalTrials.gov includes almost 400,000 interventional observational studies ISCRTN: ISRCTN Registry includes 21,000 interventional observational health studies *example expert search retrieves interventional trials neonates, investigating infectious conditions: EUCTR retrieves trials neonates, exclusively. CTGOV expert search retrieves trials exclusively neonates. ISRCTN retrieves small number studies. Thus, loading trials ctrLoadQueryIntoDb database collection, corresponding sets trials need defined, based values fields interest (e.g., eligibility.maximum_age CTGOV f115_children_211years EUCTR), can obtained collection using dbGetFieldsIntoDf.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/ctrdata-registers.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"ctrdata: detailed information on clinical trial registers — ctrdata-registers","text":"Ralf Herold ralf.herold@mailbox.org","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindFields.html","id":null,"dir":"Reference","previous_headings":"","what":"Find names of fields in the database collection — dbFindFields","title":"Find names of fields in the database collection — dbFindFields","text":"Given part name field interest user, function returns full field names used records previously loaded collection (using ctrLoadQueryIntoDb). field names can fed function dbGetFieldsIntoDf extract data collection data frame. addition full names leaf fields (e.g., clinical_results.outcome_list.outcome.measure.class_list.class.title) function also returns names node fields (e.g., clinical_results). Data node fields typically complex (multiply nested) can converted individual data elements function dfTrials2Long, possibly followed function dfName2Value.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindFields.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Find names of fields in the database collection — dbFindFields","text":"","code":"dbFindFields(namepart = \"\", con, verbose = FALSE)"},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindFields.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Find names of fields in the database collection — dbFindFields","text":"namepart plain string (can include regular expression, including Perl-style) searched among field names (keys) collection. Use `\".*` find fields. con connection object, see section `Databases` ctrdata-package verbose TRUE, prints additional information (default FALSE).","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindFields.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Find names of fields in the database collection — dbFindFields","text":"Vector strings full names field(s) found, alphabetical order register. named vector names vector register names respective fields.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindFields.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Find names of fields in the database collection — dbFindFields","text":"fields EUCTR (protocol- results-related information), https://eudract.ema.europa.eu/result.html. fields CTGOV (protocol-related information), see https://prsinfo.clinicaltrials.gov/definitions.html. fields ISRCTN (protocol-related information), see https://www.isrctn.com/page/definitions. Note: `dbFindFields` first called ctrLoadQueryIntoDb, take moment.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindFields.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Find names of fields in the database collection — dbFindFields","text":"","code":"dbc <- nodbi::src_sqlite(    dbname = system.file(\"extdata\", \"demo.sqlite\", package = \"ctrdata\"),    collection = \"my_trials\")  dbFindFields(namepart = \"date\", con = dbc) #> Finding fields in database collection (may take some time) #> Field names cached for this session. #>                                                                    EUCTR  #>                                 \"n_date_of_competent_authority_decision\"  #>                                                                    EUCTR  #>                                     \"n_date_of_ethics_committee_opinion\"  #>                                                                    EUCTR  #>                                  \"p_date_of_the_global_end_of_the_trial\"  #>                                                                    EUCTR  #>                     \"trialChanges.globalAmendments.globalAmendment.date\"  #>                                                                    EUCTR  #>                                     \"trialInformation.analysisStageDate\"  #>                                                                    EUCTR  #>                                  \"trialInformation.globalEndOfTrialDate\"  #>                                                                    EUCTR  #>                                  \"trialInformation.recruitmentStartDate\"  #>                                                                    EUCTR  #> \"x6_date_on_which_this_record_was_first_entered_in_the_eudract_database\"  #>                                                                    CTGOV  #>                                                        \"completion_date\"  #>                                                                    CTGOV  #>                                                     \"last_update_posted\"  #>                                                                    CTGOV  #>                                                  \"last_update_submitted\"  #>                                                                    CTGOV  #>                                               \"last_update_submitted_qc\"  #>                                                                    CTGOV  #>                                                \"primary_completion_date\"  #>                                                                    CTGOV  #>                                          \"required_header.download_date\"  #>                                                                    CTGOV  #>                                                             \"start_date\"  #>                                                                    CTGOV  #>                                                      \"verification_date\"  #>                                                                   ISRCTN  #>                                             \"trialDesign.overallEndDate\"  #>                                                                   ISRCTN  #>                                           \"trialDesign.overallStartDate\""},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindIdsUniqueTrials.html","id":null,"dir":"Reference","previous_headings":"","what":"Get identifiers of deduplicated trial records — dbFindIdsUniqueTrials","title":"Get identifiers of deduplicated trial records — dbFindIdsUniqueTrials","text":"Records clinical trial can loaded one register collection. function returns identifiers records collection loaded register(s) preferred user. registers recording identifiers also registers, used function provide vector identifiers deduplicated trials.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindIdsUniqueTrials.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get identifiers of deduplicated trial records — dbFindIdsUniqueTrials","text":"","code":"dbFindIdsUniqueTrials(   preferregister = c(\"EUCTR\", \"CTGOV\", \"ISRCTN\"),   prefermemberstate = \"DE\",   include3rdcountrytrials = TRUE,   con,   verbose = FALSE )"},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindIdsUniqueTrials.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get identifiers of deduplicated trial records — dbFindIdsUniqueTrials","text":"preferregister vector order preference registers generate unique _id's, default c(\"EUCTR\", \"CTGOV\", \"ISRCTN\") prefermemberstate Code single EU Member State records returned. available, record DE lacking , random Member State's record trial returned. list codes EU  Member States, please see vector countriesEUCTR. Specifying \"3RD\" return Third Country record trials, available. include3rdcountrytrials logical value trials retained conducted exclusively third countries, , outside European Union. Ignored prefermemberstate set \"3RD\". con connection object, see section `Databases` ctrdata-package verbose set TRUE, prints fields registers used find corresponding trial records","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindIdsUniqueTrials.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get identifiers of deduplicated trial records — dbFindIdsUniqueTrials","text":"vector strings keys (\"_id\") records collection represent unique trials.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindIdsUniqueTrials.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Get identifiers of deduplicated trial records — dbFindIdsUniqueTrials","text":"Note content records may differ registers (, EUCTR, records different Member States). differences considered function.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbFindIdsUniqueTrials.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get identifiers of deduplicated trial records — dbFindIdsUniqueTrials","text":"","code":"dbc <- nodbi::src_sqlite(    dbname = system.file(\"extdata\", \"demo.sqlite\", package = \"ctrdata\"),    collection = \"my_trials\")  dbFindIdsUniqueTrials(con = dbc) #> Searching for duplicate trials...  #>  - Getting all trial identifiers... #>  (may take some time)... #> , 157 found in collection #>  - Finding duplicates among registers' and sponsor ids... #>  - 69 EUCTR _id were not preferred EU Member State record for 22 trials #>  - Keeping 70 / 10 / 7 records from CTGOV / EUCTR / ISRCTN #> = Returning keys (_id) of 87 records in collection \"my_trials\" #>  [1] \"12949496\"           \"13281214\"           \"2007-004092-19-DE\"  #>  [4] \"2007-004277-26-DE\"  \"2011-001033-16-PT\"  \"2012-001916-41-NL\"  #>  [7] \"2013-003629-27-DE\"  \"2013-005512-10-DE\"  \"2014-003066-24-DE\"  #> [10] \"2014-003556-31-SE\"  \"2014-003582-24-DE\"  \"2014-004527-42-3RD\" #> [13] \"20343063\"           \"48721236\"           \"61070850\"           #> [16] \"76463425\"           \"88261002\"           \"NCT00004500\"        #> [19] \"NCT00005773\"        \"NCT00005774\"        \"NCT00005775\"        #> [22] \"NCT00005776\"        \"NCT00005777\"        \"NCT00009646\"        #> [25] \"NCT00016523\"        \"NCT00031447\"        \"NCT00031460\"        #> [28] \"NCT00099359\"        \"NCT00515281\"        \"NCT00623740\"        #> [31] \"NCT00640263\"        \"NCT00646399\"        \"NCT00682006\"        #> [34] \"NCT00713726\"        \"NCT00734539\"        \"NCT00908401\"        #> [37] \"NCT00922532\"        \"NCT00931632\"        \"NCT00977964\"        #> [40] \"NCT00994149\"        \"NCT01006668\"        \"NCT01035190\"        #> [43] \"NCT01183611\"        \"NCT01190995\"        \"NCT01243996\"        #> [46] \"NCT01265589\"        \"NCT01389856\"        \"NCT01490580\"        #> [49] \"NCT01517828\"        \"NCT01528852\"        \"NCT01536483\"        #> [52] \"NCT01555957\"        \"NCT01720524\"        \"NCT01723501\"        #> [55] \"NCT01783041\"        \"NCT01875757\"        \"NCT01899677\"        #> [58] \"NCT01954082\"        \"NCT02056223\"        \"NCT02305160\"        #> [61] \"NCT02374281\"        \"NCT02499393\"        \"NCT02510560\"        #> [64] \"NCT02620761\"        \"NCT02685137\"        \"NCT02700893\"        #> [67] \"NCT02802059\"        \"NCT02810782\"        \"NCT02954926\"        #> [70] \"NCT03022253\"        \"NCT03058666\"        \"NCT03079167\"        #> [73] \"NCT03082001\"        \"NCT03097484\"        \"NCT03110341\"        #> [76] \"NCT03163589\"        \"NCT03181646\"        \"NCT03208894\"        #> [79] \"NCT03268902\"        \"NCT03272594\"        \"NCT03280147\"        #> [82] \"NCT03325439\"        \"NCT03431558\"        \"NCT03876704\"        #> [85] \"NCT04001712\"        \"NCT04037514\"        \"NCT04041765\""},{"path":"https://rfhb.github.io/ctrdata/reference/dbGetFieldsIntoDf.html","id":null,"dir":"Reference","previous_headings":"","what":"Create data frame of specified fields from database collection — dbGetFieldsIntoDf","title":"Create data frame of specified fields from database collection — dbGetFieldsIntoDf","text":"Fields collection retrieved data frame (tibble). Note fields within record trial can hierarchical structured, , nested. Names fields can found dbFindFields. function uses field names appropriately type values returns, harmonising original values (e.g. \"Information present EudraCT\" becomes `NA`, \"Yes\" becomes `TRUE`, \"false\" becomes `FALSE`, date strings become class Date, number strings become numbers). function attempts simplify structure nested data may concatenate multiple strings field using \" / \" (see ); complex nested data, use function dfTrials2Long followed dfName2Value extract desired nested variable(s).","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbGetFieldsIntoDf.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Create data frame of specified fields from database collection — dbGetFieldsIntoDf","text":"","code":"dbGetFieldsIntoDf(fields = \"\", con, verbose = FALSE, stopifnodata = TRUE)"},{"path":"https://rfhb.github.io/ctrdata/reference/dbGetFieldsIntoDf.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Create data frame of specified fields from database collection — dbGetFieldsIntoDf","text":"fields Vector one strings, names sought fields. See function dbFindFields find names fields. \"item.subitem\" notation supported. con connection object, see section `Databases` ctrdata-package verbose Printing additional information set TRUE; (default FALSE). stopifnodata Stops error (detaul TRUE) warning (FALSE) sought field empty , available records database collection.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbGetFieldsIntoDf.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Create data frame of specified fields from database collection — dbGetFieldsIntoDf","text":"data frame (tibble, dplyr loaded) columns corresponding sought fields. column record `_id` always included. column can either simple data type (numeric, character, date) list. complicated lists, use function dfTrials2Long followed function dfName2Value extract values nested variables. maximum number rows returned data frame equal , less number records trials database collection.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbGetFieldsIntoDf.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Create data frame of specified fields from database collection — dbGetFieldsIntoDf","text":"","code":"dbc <- nodbi::src_sqlite(    dbname = system.file(\"extdata\", \"demo.sqlite\", package = \"ctrdata\"),    collection = \"my_trials\")  # get fields that are nested within another field # and can have multiple values with the nested field dbGetFieldsIntoDf(   fields = \"b1_sponsor.b31_and_b32_status_of_the_sponsor\",   con = dbc) #> b1_sponsor.b31_and_b32_status_of_the_sponsor...  #>      #> .  #>                    _id b1_sponsor.b31_and_b32_status_of_the_sponsor #> 158  2007-004092-19-AT                               Non-Commercial #> 210  2007-004092-19-CZ                               Non-Commercial #> 3    2007-004092-19-DE                               Non-Commercial #> 4    2007-004092-19-FR                               Non-Commercial #> 5    2007-004092-19-GB                               Non-Commercial #> 6    2007-004092-19-NL                               Non-Commercial #> 7   2007-004277-26-3RD                                   Commercial #> 8    2007-004277-26-AT                                   Commercial #> 9    2007-004277-26-BE                                   Commercial #> 10   2007-004277-26-DE                                   Commercial #> 11   2007-004277-26-DK                                   Commercial #> 12   2007-004277-26-ES                                   Commercial #> 13   2007-004277-26-FR                                   Commercial #> 14   2007-004277-26-GB                                   Commercial #> 15   2007-004277-26-IE                                   Commercial #> 16   2007-004277-26-IT                                   Commercial #> 17   2007-004277-26-NL                                   Commercial #> 18   2007-004277-26-PT                                   Commercial #> 19   2011-001033-16-AT                                   Commercial #> 20   2011-001033-16-DK                                   Commercial #> 21   2011-001033-16-ES                                   Commercial #> 22   2011-001033-16-GB                                   Commercial #> 23   2011-001033-16-GR                                   Commercial #> 24   2011-001033-16-HU                                   Commercial #> 25   2011-001033-16-LT                                   Commercial #> 26   2011-001033-16-PL                                   Commercial #> 27   2011-001033-16-PT                                   Commercial #> 28   2012-001916-41-BE                               Non-Commercial #> 29   2012-001916-41-ES                               Non-Commercial #> 30   2012-001916-41-IT                               Non-Commercial #> 31   2012-001916-41-NL                               Non-Commercial #> 32   2013-003629-27-BE                                   Commercial #> 33   2013-003629-27-DE                                   Commercial #> 34   2013-003629-27-DK                                   Commercial #> 35   2013-003629-27-ES                                   Commercial #> 36   2013-003629-27-FR                                   Commercial #> 37   2013-003629-27-GB                                   Commercial #> 38   2013-003629-27-IE                                   Commercial #> 39   2013-003629-27-IT                                   Commercial #> 40   2013-003629-27-NL                                   Commercial #> 41   2013-003629-27-PL                                   Commercial #> 42   2013-003629-27-SE                                   Commercial #> 43   2013-005512-10-DE                                   Commercial #> 44   2013-005512-10-DK                                   Commercial #> 45   2013-005512-10-ES                                   Commercial #> 46   2013-005512-10-FR                                   Commercial #> 47   2013-005512-10-GB                                   Commercial #> 48   2013-005512-10-IE                                   Commercial #> 49   2013-005512-10-IT                                   Commercial #> 50   2013-005512-10-NL                                   Commercial #> 51   2013-005512-10-PL                                   Commercial #> 52   2013-005512-10-SE                                   Commercial #> 53   2014-003066-24-AT                                   Commercial #> 54   2014-003066-24-BE                                   Commercial #> 55   2014-003066-24-BG                                   Commercial #> 56   2014-003066-24-CZ                                   Commercial #> 57   2014-003066-24-DE                                   Commercial #> 58   2014-003066-24-ES                                   Commercial #> 59   2014-003066-24-FR                                   Commercial #> 60   2014-003066-24-GB                                   Commercial #> 61   2014-003066-24-HU                                   Commercial #> 62   2014-003066-24-IT                                   Commercial #> 63   2014-003066-24-NL                                   Commercial #> 64   2014-003066-24-PL                                   Commercial #> 65   2014-003066-24-SE                                   Commercial #> 66   2014-003066-24-SK                                   Commercial #> 67   2014-003556-31-GB                                   Commercial #> 68   2014-003556-31-IT                                   Commercial #> 69   2014-003556-31-NL                                   Commercial #> 70   2014-003556-31-PL                                   Commercial #> 71   2014-003556-31-SE                                   Commercial #> 72   2014-003582-24-CZ                               Non-Commercial #> 73   2014-003582-24-DE                               Non-Commercial #> 74   2014-003582-24-EE                               Non-Commercial #> 75   2014-003582-24-ES                               Non-Commercial #> 76   2014-003582-24-IT                               Non-Commercial #> 77   2014-003582-24-NL                               Non-Commercial #> 78   2014-003582-24-SE                               Non-Commercial #> 79  2014-004527-42-3RD                                   Commercial  # fields that are lists of string values are # returned by concatenating values with a slash dbGetFieldsIntoDf(   fields = \"keyword\",   con = dbc) #> keyword...  #>      #>             _id #> 88  NCT00004500 #> 89  NCT00005773 #> 90  NCT00005774 #> 91  NCT00005775 #> 92  NCT00005776 #> 93  NCT00005777 #> 94  NCT00009646 #> 95  NCT00016523 #> 96  NCT00031447 #> 97  NCT00031460 #> 98  NCT00099359 #> 99  NCT00515281 #> 100 NCT00623740 #> 101 NCT00640263 #> 102 NCT00646399 #> 103 NCT00682006 #> 104 NCT00713726 #> 105 NCT00734539 #> 106 NCT00908401 #> 107 NCT00922532 #> 108 NCT00931632 #> 109 NCT00977964 #> 110 NCT00994149 #> 111 NCT01006668 #> 112 NCT01035190 #> 113 NCT01183611 #> 114 NCT01190995 #> 115 NCT01243996 #> 116 NCT01265589 #> 117 NCT01389856 #> 118 NCT01490580 #> 119 NCT01517828 #> 120 NCT01528852 #> 121 NCT01536483 #> 123 NCT01720524 #> 124 NCT01723501 #> 125 NCT01783041 #> 126 NCT01875757 #> 127 NCT01899677 #> 128 NCT01954082 #> 129 NCT02056223 #> 130 NCT02305160 #> 131 NCT02374281 #> 132 NCT02499393 #> 135 NCT02685137 #> 138 NCT02810782 #> 140 NCT03022253 #> 141 NCT03058666 #> 143 NCT03082001 #> 150 NCT03272594 #> 151 NCT03280147 #> 152 NCT03325439 #> 153 NCT03431558 #> 155 NCT04001712 #> 157 NCT04041765 #>                                                                                                                                                                                                                                                                                                                                   keyword #> 88                                                                                                                                                                                                                                                  cardiovascular and respiratory diseases / meconium aspiration syndrome / rare disease #> 89  NICHD Neonatal Research Network / Hypertension, pulmonary / Hypoxic respiratory failure / Meconium aspiration / Methemoglobinemia / Nitric oxide / Oxygen inhalation therapy / Persistent Fetal Circulation Syndrome / Pneumonia, aspiration / Respiratory distress syndrome / Respiratory insufficiency / Severe respiratory failure #> 90                                                                                                                                                        NICHD Neonatal Research Network / Pulmonary ventilation / Respiratory distress syndrome / Respiratory insufficiency / Surfactant, pulmonary / Mechanical Ventilation / Survanta #> 91                                                                                                                                                  NICHD Neonatal Research Network / Extremely Low Birth Weight (ELBW) infants / Prematurity / Glutamine / Total parenteral nutrition / Nutrition / Very low birth weight (VLBW) infants #> 92  NICHD Neonatal Research Network / Hypertension, pulmonary / Hypoxic respiratory failure / Meconium aspiration / Methemoglobinemia / Nitric oxide / Oxygen inhalation therapy / Persistent Fetal Circulation Syndrome / Pneumonia, aspiration / Respiratory distress syndrome / Respiratory insufficiency / Severe respiratory failure #> 93                                                                                                        NICHD Neonatal Research Network / Extremely Low Birth Weight (ELBW) / Prematurity / Chronic Lung Disease (CLD) / Dexamethasone / Glucocorticoids / Respiration, Artificial / Mechanical ventilation / Respiratory Insufficiency #> 94                                                                                                                                             Chronic lung disease / Indocin / Indomethacin / Infants, very low birth weight / Intraventricular hemorrhage / Necrotizing enterocolitis / Patent ductus arteriosus / Pulmonary hemorrhage #> 95                                                                                                               NICHD Neonatal Research Network / Extremely Low Birth Weight (ELBW) / Very Low Birth Weight (VLBW) / Prematurity / Inhaled nitric oxide / Aspiration syndrome / Idiopathic pulmonary hypertension / Pulmonary hypoplasia #> 96                                                                                                                                                                                                                                                                                                     Herpes Simplex, Acyclovir, Infants #> 97                                                                                                                                                                                                                                                                                acyclovir, central nervous system, Herpes Simplex Virus #> 98                                                                                                                                                       HIV / Perinatal / Prevention / Transmission / Nevirapine / Epivir / Zidovudine / Nelfinavir / ZDV / NVP / 3TC / NFV / Viracept / Viramune / HIV Seronegativity / Treatment Naive #> 99                                                                                                                                                                                                prematurity / nitric oxide / bronchopulmonary dysplasia / intraventricular hemorrhage / periventricular leukomalacia / neurodevelopment #> 100                                                                                                                                                                                                                                       Hydrocortisone / Very low birth weight / Bronchopulmonary dysplasia / Prevention Cerebral palsy #> 101                                                                                                                                                                                                                                                                 HIV-1 / Breastfeeding / Prevention / lamivudine / lopinavir/ritonavir #> 102                                                                                                                                                                                                              Staphylococcal / Coagulase Negative Staphylococcus / Monoclonal antibodies / Very Low Birth Weight Infants / Prophylaxis #> 103                                                                                                                                                                                                                                                                                              Omphalitis / 4% Chlorhexidine / Newborns #> 104                                                                                                                                                                                                                                           Pain / Analgesia / Newborn Infant / Opioids / Side-effects / Intensive care / Postoperative #> 105                                                                                                                                                                                                                                                             Candida / Neonate / Fluconazole / Prophylaxis / Colonization / Resistance #> 106                                                                                                                                                                                                                                                                   breastmilk / oral sucrose / analgesia / preterm neonates / Neonates #> 107                                                                                                                                                                                                                                                                             Hypoxic Respiratory Failure (HRF), Pulmonary Hypertension #> 108                                                                                                                                                                                                                                                                                                       Bronchopulmonary Dysplasia, BPD #> 109                                                                                                                                                                                                                                                                                                                                Infant #> 110                                                                                                                                                                                                                                                  Infants of Diabetic Mothers / Hypoglycemia / Diazoxide / Large for Gestation Infants #> 111                                                                                                                                                                                                                                                      Neonates / Intensive care / Endotracheal intubation / Neonates in intensive care #> 112                                                                                                                                                                                                                                                                Preterm Infants / Inhaled Corticosteroids / Bronchopulmonary Dysplasia #> 113                                                                                                                                                                                                                                                                        safety / immunogenicity / HBV vaccine / perinatal transmission #> 114                                                                                                                                                                                                                                                                                 Pain / Neonate / Procedure / Neurobehavioural outcome #> 115                                                                                                                                                                                                                                                                                  Patent ductus arteriosus, ibuprofen, preterm infants #> 116                                                                                                                                                                                                                                                                                        RDS / Infant, newborn / Vitamin A / Surfactant #> 117                                                                                                                                                                                                                                                                                     Persistent pulmonary hypertension, newborn / PPHN #> 118                                                                                                                                                                                                                                                  Pain / Newborn / Anaesthesia / opioids / propofol / neuromuscular blocker / atropine #> 119                                                                                                                                                                                                                                                                                     Intubation / Delivery room / Sedation / Analgesia #> 120                                                                                                                                                                                                                                   neonatal Mortality / chlorhexidine cord care / cord infections / african settings / clinical trials #> 121                                                                                                                                                                      Butyrate / Preterms / Very Low Birth Weight (<1250g) / Rectocolonic enemas / Digestive maturation / Parenteral nutrition weaning / ECUN / Whole gut transit time #> 123                                                                                                                                                                  persistent pulmonary hypertension / newborn / neonates / iv sildenafil / hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn #> 124                                                                                                                                                                                                                                                                         chlorhexidine / sepsis / neonatal / whole-body skin cleansing #> 125                                                                                                                                                      Prematurity / Carnitine supplementation / Neonatal Intensive Care / MRI / Amplitude-integrated EEG / NICU Network Neurobehavioral Scale / Bayley Scale of Infant Development III #> 126                                                                                                                                                                                                               Vitamin D / Acute bronchitis / Upper respiratory tract infection / Recurrent bronchitis / Acute bronchiolitis / Infants #> 127                                                                                                                                                                                                                                                                                        Symbiotic,cytokines, necrotising enterocolitis #> 128                                                                                                                                                                                                                                                                                 Retinopathy / Prematurity / Infant, Newborn, Diseases #> 129                                                                                                                                                                                                                                                                   Patent ductus arteriosus / Preterm infant / Paracetamol / Ibuprofen #> 130                                                                                                                                                                                                                                                        Respiratory distress syndrome / Pulmonary surfactant / Mortality / Prematurity #> 131                                                                                                                                                   Newborn / Neonatal Screening / Autonomic Nervous System / Pain / non-nutritive sucking / sucrose administration / nociceptive action / Electro acoustical characteristics of crying #> 132                                                                                                                                                                                                                                                                                newborn / therapeutic hypothermia / magnesium sulphate #> 135                                                                                                                                                                                                                                               Kernicterus / Neonatal Jaundice / Newborn Jaundice / Hyperbilirubinemia / Stannsoporfin #> 138                                                                                                                                                                                                                                                                                              opiate dependence / withdrawal / newborn #> 140                                                                                                                                                                                                                                                                                                                       PDA / Platelets #> 141                                                                                                                                                                                                                             Aerosol / surfactant / calfactant / Infasurf / Respiratory Distress Syndrome / RDS / Premature / Neonates #> 143                                                                                                                                                                                                                                                                                                                 Neonate / Pain / ELBW #> 150                                                                                                                                                               Neonatal pain / Pediatric pain / Pain assessment / Breastfeeding / Sucrose / Randomized controlled trial / Behavioural pain response / Neurophysiological pain response #> 151                                                                                                                                                                                                                                                                                             Neonate / Sepsis / Antibiotics / Duration #> 152                                                                                                                                                                                                                                Electroencephalographic neonatal seizures / Brivaracetam / Epilepsy / ENS / Newborns / Pharmacokinetic #> 153                                                                                                                                                                                                                                                                              Bovine Lactoferrin, Neonatal infection, Low Birth Weight #> 155                                                                                                                                                                                                                                                                                                                early caffeine preterm #> 157                                                                                                                                                                                                                                                                                               IgM-enriched Intravenous Immunoglobulin"},{"path":"https://rfhb.github.io/ctrdata/reference/dbQueryHistory.html","id":null,"dir":"Reference","previous_headings":"","what":"Show history of queries loaded into a database collection — dbQueryHistory","title":"Show history of queries loaded into a database collection — dbQueryHistory","text":"Show history queries loaded database collection","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbQueryHistory.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Show history of queries loaded into a database collection — dbQueryHistory","text":"","code":"dbQueryHistory(con, verbose = FALSE)"},{"path":"https://rfhb.github.io/ctrdata/reference/dbQueryHistory.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Show history of queries loaded into a database collection — dbQueryHistory","text":"con connection object, see section `Databases` ctrdata-package verbose TRUE, prints additional information (default FALSE).","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbQueryHistory.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Show history of queries loaded into a database collection — dbQueryHistory","text":"data frame (tibble, dplyr loaded)  columns: `query-timestamp`, `query-register`,  `query-records` (note: number records loaded last  executing ctrLoadQueryIntoDb, total record number)  `query-term`, one row time ctrLoadQueryIntoDb loaded trial records collection.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dbQueryHistory.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Show history of queries loaded into a database collection — dbQueryHistory","text":"","code":"dbc <- nodbi::src_sqlite(    dbname = system.file(\"extdata\", \"demo.sqlite\", package = \"ctrdata\"),    collection = \"my_trials\")  dbQueryHistory(con = dbc) #>       query-timestamp query-register query-records #> 1 2022-08-08 15:11:56          EUCTR            79 #> 2 2022-08-08 15:14:13          CTGOV            70 #> 3 2022-08-08 15:15:11         ISRCTN             8 #>                                                                                                                  query-term #> 1                                                query=&age=newborn&phase=phase-three&dateFrom=2015-01-01&dateTo=2015-03-01 #> 2 term=AREA[MaximumAge]+RANGE[0+days,+28+days]&intr=Drugs,+Investigational&strd_e=01/01/2020&type=Intr&phase=2&Search=Apply #> 3                                                                               q=&filters=ageRange:Neonate,phase:Phase+III"},{"path":"https://rfhb.github.io/ctrdata/reference/dfFindUniqueEuctrRecord.html","id":null,"dir":"Reference","previous_headings":"","what":"Select a single trial record from records of different EU Member States — dfFindUniqueEuctrRecord","title":"Select a single trial record from records of different EU Member States — dfFindUniqueEuctrRecord","text":"EUCTR provides one record per trial per EU Member State trial conducted. trials conducted one Member State, function returns one record per trial.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfFindUniqueEuctrRecord.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Select a single trial record from records of different EU Member States — dfFindUniqueEuctrRecord","text":"","code":"dfFindUniqueEuctrRecord(   df = NULL,   prefermemberstate = \"DE\",   include3rdcountrytrials = TRUE )"},{"path":"https://rfhb.github.io/ctrdata/reference/dfFindUniqueEuctrRecord.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Select a single trial record from records of different EU Member States — dfFindUniqueEuctrRecord","text":"df data frame created database collection includes columns \"_id\" \"a2_eudract_number\", example created function dbGetFieldsIntoDf(c(\"_id\", \"a2_eudract_number\")). prefermemberstate Code single EU Member State records returned. available, record DE lacking , random Member State's record trial returned. list codes EU  Member States, please see vector countriesEUCTR. Specifying \"3RD\" return Third Country record trials, available. include3rdcountrytrials logical value trials retained conducted exclusively third countries, , outside European Union. Ignored prefermemberstate set \"3RD\".","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfFindUniqueEuctrRecord.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Select a single trial record from records of different EU Member States — dfFindUniqueEuctrRecord","text":"data frame subset df corresponding sought   records.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfFindUniqueEuctrRecord.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Select a single trial record from records of different EU Member States — dfFindUniqueEuctrRecord","text":"Note: deduplicate trials different registers (EUCTR CTGOV), please first use function dbFindIdsUniqueTrials.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfListExtractKey.html","id":null,"dir":"Reference","previous_headings":"","what":"Extract named element(s) from list(s) into long-format\ndata frame — dfListExtractKey","title":"Extract named element(s) from list(s) into long-format\ndata frame — dfListExtractKey","text":"(Deprecated, use dfTrials2Long dfName2Value!) function uses name (key) extract element list data.frame obtained dbGetFieldsIntoDf. helps simplify working nested lists complex structures.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfListExtractKey.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Extract named element(s) from list(s) into long-format\ndata frame — dfListExtractKey","text":"","code":"dfListExtractKey(df, list.key = list(c(\"endPoints.endPoint\", \"^title\")))"},{"path":"https://rfhb.github.io/ctrdata/reference/dfListExtractKey.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Extract named element(s) from list(s) into long-format\ndata frame — dfListExtractKey","text":"df data frame (tibble) list.key list pairs list names key names, list name corresponds name column df holds list name key identifies element extracted. See example.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfListExtractKey.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Extract named element(s) from list(s) into long-format\ndata frame — dfListExtractKey","text":"data frame (tibble, dplyr loaded)  long format columns  name (identifying full path data frame,  \"<list>.<key>\"), _id (trial record), value  (name per _id), item (number value name  per _id).","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfListExtractKey.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Extract named element(s) from list(s) into long-format\ndata frame — dfListExtractKey","text":"","code":"dbc <- nodbi::src_sqlite(    dbname = system.file(\"extdata\", \"demo.sqlite\", package = \"ctrdata\"),    collection = \"my_trials\")  df <- dbGetFieldsIntoDf(   fields = c(     \"endPoints.endPoint\",     \"subjectDisposition.postAssignmentPeriods\"),   con = dbc) #> endPoints.endPoint...  #>      #> .  #>  #> subjectDisposition.postAssignmentPeriods...  #>      #> .   dfListExtractKey(   df = df,   list.key = list(       c(\"endPoints.endPoint\",         \"^title\"),       c(\"subjectDisposition.postAssignmentPeriods\",         \"arms.arm.type.value\") )) #> Warning: 'dfListExtractKey' is deprecated. #> Use 'dfName2Value' instead. #> See help(\"Deprecated\") #>                         name                _id #> 1   endPoints.endPoint.title 2007-004277-26-3RD #> 2   endPoints.endPoint.title 2007-004277-26-3RD #> 3   endPoints.endPoint.title 2007-004277-26-3RD #> 4   endPoints.endPoint.title 2007-004277-26-3RD #> 5   endPoints.endPoint.title 2007-004277-26-3RD #> 6   endPoints.endPoint.title 2007-004277-26-3RD #> 7   endPoints.endPoint.title  2007-004277-26-AT #> 8   endPoints.endPoint.title  2007-004277-26-AT #> 9   endPoints.endPoint.title  2007-004277-26-AT #> 10  endPoints.endPoint.title  2007-004277-26-AT #> 11  endPoints.endPoint.title  2007-004277-26-AT #> 12  endPoints.endPoint.title  2007-004277-26-AT #> 13  endPoints.endPoint.title  2007-004277-26-BE #> 14  endPoints.endPoint.title  2007-004277-26-BE #> 15  endPoints.endPoint.title  2007-004277-26-BE #> 16  endPoints.endPoint.title  2007-004277-26-BE #> 17  endPoints.endPoint.title  2007-004277-26-BE #> 18  endPoints.endPoint.title  2007-004277-26-BE #> 19  endPoints.endPoint.title  2007-004277-26-DE #> 20  endPoints.endPoint.title  2007-004277-26-DE #> 21  endPoints.endPoint.title  2007-004277-26-DE #> 22  endPoints.endPoint.title  2007-004277-26-DE #> 23  endPoints.endPoint.title  2007-004277-26-DE #> 24  endPoints.endPoint.title  2007-004277-26-DE #> 25  endPoints.endPoint.title  2007-004277-26-DK #> 26  endPoints.endPoint.title  2007-004277-26-DK #> 27  endPoints.endPoint.title  2007-004277-26-DK #> 28  endPoints.endPoint.title  2007-004277-26-DK #> 29  endPoints.endPoint.title  2007-004277-26-DK #> 30  endPoints.endPoint.title  2007-004277-26-DK #> 31  endPoints.endPoint.title  2007-004277-26-ES #> 32  endPoints.endPoint.title  2007-004277-26-ES #> 33  endPoints.endPoint.title  2007-004277-26-ES #> 34  endPoints.endPoint.title  2007-004277-26-ES #> 35  endPoints.endPoint.title  2007-004277-26-ES #> 36  endPoints.endPoint.title  2007-004277-26-ES #> 37  endPoints.endPoint.title  2007-004277-26-FR #> 38  endPoints.endPoint.title  2007-004277-26-FR #> 39  endPoints.endPoint.title  2007-004277-26-FR #> 40  endPoints.endPoint.title  2007-004277-26-FR #> 41  endPoints.endPoint.title  2007-004277-26-FR #> 42  endPoints.endPoint.title  2007-004277-26-FR #> 43  endPoints.endPoint.title  2007-004277-26-GB #> 44  endPoints.endPoint.title  2007-004277-26-GB #> 45  endPoints.endPoint.title  2007-004277-26-GB #> 46  endPoints.endPoint.title  2007-004277-26-GB #> 47  endPoints.endPoint.title  2007-004277-26-GB #> 48  endPoints.endPoint.title  2007-004277-26-GB #> 49  endPoints.endPoint.title  2007-004277-26-IE #> 50  endPoints.endPoint.title  2007-004277-26-IE #> 51  endPoints.endPoint.title  2007-004277-26-IE #> 52  endPoints.endPoint.title  2007-004277-26-IE #> 53  endPoints.endPoint.title  2007-004277-26-IE #> 54  endPoints.endPoint.title  2007-004277-26-IE #> 55  endPoints.endPoint.title  2007-004277-26-IT #> 56  endPoints.endPoint.title  2007-004277-26-IT #> 57  endPoints.endPoint.title  2007-004277-26-IT #> 58  endPoints.endPoint.title  2007-004277-26-IT #> 59  endPoints.endPoint.title  2007-004277-26-IT #> 60  endPoints.endPoint.title  2007-004277-26-IT #> 61  endPoints.endPoint.title  2007-004277-26-NL #> 62  endPoints.endPoint.title  2007-004277-26-NL #> 63  endPoints.endPoint.title  2007-004277-26-NL #> 64  endPoints.endPoint.title  2007-004277-26-NL #> 65  endPoints.endPoint.title  2007-004277-26-NL #> 66  endPoints.endPoint.title  2007-004277-26-NL #> 67  endPoints.endPoint.title  2007-004277-26-PT #> 68  endPoints.endPoint.title  2007-004277-26-PT #> 69  endPoints.endPoint.title  2007-004277-26-PT #> 70  endPoints.endPoint.title  2007-004277-26-PT #> 71  endPoints.endPoint.title  2007-004277-26-PT #> 72  endPoints.endPoint.title  2007-004277-26-PT #> 73  endPoints.endPoint.title  2011-001033-16-AT #> 74  endPoints.endPoint.title  2011-001033-16-AT #> 75  endPoints.endPoint.title  2011-001033-16-AT #> 76  endPoints.endPoint.title  2011-001033-16-AT #> 77  endPoints.endPoint.title  2011-001033-16-AT #> 78  endPoints.endPoint.title  2011-001033-16-AT #> 79  endPoints.endPoint.title  2011-001033-16-AT #> 80  endPoints.endPoint.title  2011-001033-16-AT #> 81  endPoints.endPoint.title  2011-001033-16-AT #> 82  endPoints.endPoint.title  2011-001033-16-DK #> 83  endPoints.endPoint.title  2011-001033-16-DK #> 84  endPoints.endPoint.title  2011-001033-16-DK #> 85  endPoints.endPoint.title  2011-001033-16-DK #> 86  endPoints.endPoint.title  2011-001033-16-DK #> 87  endPoints.endPoint.title  2011-001033-16-DK #> 88  endPoints.endPoint.title  2011-001033-16-DK #> 89  endPoints.endPoint.title  2011-001033-16-DK #> 90  endPoints.endPoint.title  2011-001033-16-DK #> 91  endPoints.endPoint.title  2011-001033-16-ES #> 92  endPoints.endPoint.title  2011-001033-16-ES #> 93  endPoints.endPoint.title  2011-001033-16-ES #> 94  endPoints.endPoint.title  2011-001033-16-ES #> 95  endPoints.endPoint.title  2011-001033-16-ES #> 96  endPoints.endPoint.title  2011-001033-16-ES #> 97  endPoints.endPoint.title  2011-001033-16-ES #> 98  endPoints.endPoint.title  2011-001033-16-ES #> 99  endPoints.endPoint.title  2011-001033-16-ES #> 100 endPoints.endPoint.title  2011-001033-16-GB #> 101 endPoints.endPoint.title  2011-001033-16-GB #> 102 endPoints.endPoint.title  2011-001033-16-GB #> 103 endPoints.endPoint.title  2011-001033-16-GB #> 104 endPoints.endPoint.title  2011-001033-16-GB #> 105 endPoints.endPoint.title  2011-001033-16-GB #> 106 endPoints.endPoint.title  2011-001033-16-GB #> 107 endPoints.endPoint.title  2011-001033-16-GB #> 108 endPoints.endPoint.title  2011-001033-16-GB #> 109 endPoints.endPoint.title  2011-001033-16-GR #> 110 endPoints.endPoint.title  2011-001033-16-GR #> 111 endPoints.endPoint.title  2011-001033-16-GR #> 112 endPoints.endPoint.title  2011-001033-16-GR #> 113 endPoints.endPoint.title  2011-001033-16-GR #> 114 endPoints.endPoint.title  2011-001033-16-GR #> 115 endPoints.endPoint.title  2011-001033-16-GR #> 116 endPoints.endPoint.title  2011-001033-16-GR #> 117 endPoints.endPoint.title  2011-001033-16-GR #> 118 endPoints.endPoint.title  2011-001033-16-HU #> 119 endPoints.endPoint.title  2011-001033-16-HU #> 120 endPoints.endPoint.title  2011-001033-16-HU #> 121 endPoints.endPoint.title  2011-001033-16-HU #> 122 endPoints.endPoint.title  2011-001033-16-HU #> 123 endPoints.endPoint.title  2011-001033-16-HU #> 124 endPoints.endPoint.title  2011-001033-16-HU #> 125 endPoints.endPoint.title  2011-001033-16-HU #> 126 endPoints.endPoint.title  2011-001033-16-HU #> 127 endPoints.endPoint.title  2011-001033-16-LT #> 128 endPoints.endPoint.title  2011-001033-16-LT #> 129 endPoints.endPoint.title  2011-001033-16-LT #> 130 endPoints.endPoint.title  2011-001033-16-LT #> 131 endPoints.endPoint.title  2011-001033-16-LT #> 132 endPoints.endPoint.title  2011-001033-16-LT #> 133 endPoints.endPoint.title  2011-001033-16-LT #> 134 endPoints.endPoint.title  2011-001033-16-LT #> 135 endPoints.endPoint.title  2011-001033-16-LT #> 136 endPoints.endPoint.title  2011-001033-16-PL #> 137 endPoints.endPoint.title  2011-001033-16-PL #> 138 endPoints.endPoint.title  2011-001033-16-PL #> 139 endPoints.endPoint.title  2011-001033-16-PL #> 140 endPoints.endPoint.title  2011-001033-16-PL #> 141 endPoints.endPoint.title  2011-001033-16-PL #> 142 endPoints.endPoint.title  2011-001033-16-PL #> 143 endPoints.endPoint.title  2011-001033-16-PL #> 144 endPoints.endPoint.title  2011-001033-16-PL #> 145 endPoints.endPoint.title  2011-001033-16-PT #> 146 endPoints.endPoint.title  2011-001033-16-PT #> 147 endPoints.endPoint.title  2011-001033-16-PT #> 148 endPoints.endPoint.title  2011-001033-16-PT #> 149 endPoints.endPoint.title  2011-001033-16-PT #> 150 endPoints.endPoint.title  2011-001033-16-PT #> 151 endPoints.endPoint.title  2011-001033-16-PT #> 152 endPoints.endPoint.title  2011-001033-16-PT #> 153 endPoints.endPoint.title  2011-001033-16-PT #> 154 endPoints.endPoint.title  2013-003629-27-BE #> 155 endPoints.endPoint.title  2013-003629-27-BE #> 156 endPoints.endPoint.title  2013-003629-27-BE #> 157 endPoints.endPoint.title  2013-003629-27-BE #> 158 endPoints.endPoint.title  2013-003629-27-BE #> 159 endPoints.endPoint.title  2013-003629-27-BE #> 160 endPoints.endPoint.title  2013-003629-27-BE #> 161 endPoints.endPoint.title  2013-003629-27-BE #> 162 endPoints.endPoint.title  2013-003629-27-BE #> 163 endPoints.endPoint.title  2013-003629-27-DE #> 164 endPoints.endPoint.title  2013-003629-27-DE #> 165 endPoints.endPoint.title  2013-003629-27-DE #> 166 endPoints.endPoint.title  2013-003629-27-DE #> 167 endPoints.endPoint.title  2013-003629-27-DE #> 168 endPoints.endPoint.title  2013-003629-27-DE #> 169 endPoints.endPoint.title  2013-003629-27-DE #> 170 endPoints.endPoint.title  2013-003629-27-DE #> 171 endPoints.endPoint.title  2013-003629-27-DE #> 172 endPoints.endPoint.title  2013-003629-27-DK #> 173 endPoints.endPoint.title  2013-003629-27-DK #> 174 endPoints.endPoint.title  2013-003629-27-DK #> 175 endPoints.endPoint.title  2013-003629-27-DK #> 176 endPoints.endPoint.title  2013-003629-27-DK #> 177 endPoints.endPoint.title  2013-003629-27-DK #> 178 endPoints.endPoint.title  2013-003629-27-DK #> 179 endPoints.endPoint.title  2013-003629-27-DK #> 180 endPoints.endPoint.title  2013-003629-27-DK #> 181 endPoints.endPoint.title  2013-003629-27-ES #> 182 endPoints.endPoint.title  2013-003629-27-ES #> 183 endPoints.endPoint.title  2013-003629-27-ES #> 184 endPoints.endPoint.title  2013-003629-27-ES #> 185 endPoints.endPoint.title  2013-003629-27-ES #> 186 endPoints.endPoint.title  2013-003629-27-ES #> 187 endPoints.endPoint.title  2013-003629-27-ES #> 188 endPoints.endPoint.title  2013-003629-27-ES #> 189 endPoints.endPoint.title  2013-003629-27-ES #> 190 endPoints.endPoint.title  2013-003629-27-FR #> 191 endPoints.endPoint.title  2013-003629-27-FR #> 192 endPoints.endPoint.title  2013-003629-27-FR #> 193 endPoints.endPoint.title  2013-003629-27-FR #> 194 endPoints.endPoint.title  2013-003629-27-FR #> 195 endPoints.endPoint.title  2013-003629-27-FR #> 196 endPoints.endPoint.title  2013-003629-27-FR #> 197 endPoints.endPoint.title  2013-003629-27-FR #> 198 endPoints.endPoint.title  2013-003629-27-FR #> 199 endPoints.endPoint.title  2013-003629-27-GB #> 200 endPoints.endPoint.title  2013-003629-27-GB #> 201 endPoints.endPoint.title  2013-003629-27-GB #> 202 endPoints.endPoint.title  2013-003629-27-GB #> 203 endPoints.endPoint.title  2013-003629-27-GB #> 204 endPoints.endPoint.title  2013-003629-27-GB #> 205 endPoints.endPoint.title  2013-003629-27-GB #> 206 endPoints.endPoint.title  2013-003629-27-GB #> 207 endPoints.endPoint.title  2013-003629-27-GB #> 208 endPoints.endPoint.title  2013-003629-27-IE #> 209 endPoints.endPoint.title  2013-003629-27-IE #> 210 endPoints.endPoint.title  2013-003629-27-IE #> 211 endPoints.endPoint.title  2013-003629-27-IE #> 212 endPoints.endPoint.title  2013-003629-27-IE #> 213 endPoints.endPoint.title  2013-003629-27-IE #> 214 endPoints.endPoint.title  2013-003629-27-IE #> 215 endPoints.endPoint.title  2013-003629-27-IE #> 216 endPoints.endPoint.title  2013-003629-27-IE #> 217 endPoints.endPoint.title  2013-003629-27-IT #> 218 endPoints.endPoint.title  2013-003629-27-IT #> 219 endPoints.endPoint.title  2013-003629-27-IT #> 220 endPoints.endPoint.title  2013-003629-27-IT #> 221 endPoints.endPoint.title  2013-003629-27-IT #> 222 endPoints.endPoint.title  2013-003629-27-IT #> 223 endPoints.endPoint.title  2013-003629-27-IT #> 224 endPoints.endPoint.title  2013-003629-27-IT #> 225 endPoints.endPoint.title  2013-003629-27-IT #> 226 endPoints.endPoint.title  2013-003629-27-NL #> 227 endPoints.endPoint.title  2013-003629-27-NL #> 228 endPoints.endPoint.title  2013-003629-27-NL #> 229 endPoints.endPoint.title  2013-003629-27-NL #> 230 endPoints.endPoint.title  2013-003629-27-NL #> 231 endPoints.endPoint.title  2013-003629-27-NL #> 232 endPoints.endPoint.title  2013-003629-27-NL #> 233 endPoints.endPoint.title  2013-003629-27-NL #> 234 endPoints.endPoint.title  2013-003629-27-NL #> 235 endPoints.endPoint.title  2013-003629-27-PL #> 236 endPoints.endPoint.title  2013-003629-27-PL #> 237 endPoints.endPoint.title  2013-003629-27-PL #> 238 endPoints.endPoint.title  2013-003629-27-PL #> 239 endPoints.endPoint.title  2013-003629-27-PL #> 240 endPoints.endPoint.title  2013-003629-27-PL #> 241 endPoints.endPoint.title  2013-003629-27-PL #> 242 endPoints.endPoint.title  2013-003629-27-PL #> 243 endPoints.endPoint.title  2013-003629-27-PL #> 244 endPoints.endPoint.title  2013-003629-27-SE #> 245 endPoints.endPoint.title  2013-003629-27-SE #> 246 endPoints.endPoint.title  2013-003629-27-SE #> 247 endPoints.endPoint.title  2013-003629-27-SE #> 248 endPoints.endPoint.title  2013-003629-27-SE #> 249 endPoints.endPoint.title  2013-003629-27-SE #> 250 endPoints.endPoint.title  2013-003629-27-SE #>                                                                                                                                                                                       value #> 1                                                                                  Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 2                                                                                                     Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 3                       Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 4   Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 5                                                                                                      Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 6                                                                                                                                                 Time to first respiratory hospitalization #> 7                                                                                  Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 8                                                                                                     Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 9                       Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 10  Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 11                                                                                                     Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 12                                                                                                                                                Time to first respiratory hospitalization #> 13                                                                                 Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 14                                                                                                    Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 15                      Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 16  Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 17                                                                                                     Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 18                                                                                                                                                Time to first respiratory hospitalization #> 19                                                                                 Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 20                                                                                                    Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 21                      Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 22  Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 23                                                                                                     Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 24                                                                                                                                                Time to first respiratory hospitalization #> 25                                                                                 Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 26                                                                                                    Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 27                      Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 28  Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 29                                                                                                     Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 30                                                                                                                                                Time to first respiratory hospitalization #> 31                                                                                 Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 32                                                                                                    Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 33                      Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 34  Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 35                                                                                                     Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 36                                                                                                                                                Time to first respiratory hospitalization #> 37                                                                                 Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 38                                                                                                    Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 39                      Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 40  Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 41                                                                                                     Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 42                                                                                                                                                Time to first respiratory hospitalization #> 43                                                                                 Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 44                                                                                                    Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 45                      Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 46  Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 47                                                                                                     Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 48                                                                                                                                                Time to first respiratory hospitalization #> 49                                                                                 Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 50                                                                                                    Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 51                      Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 52  Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 53                                                                                                     Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 54                                                                                                                                                Time to first respiratory hospitalization #> 55                                                                                 Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 56                                                                                                    Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 57                      Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 58  Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 59                                                                                                     Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 60                                                                                                                                                Time to first respiratory hospitalization #> 61                                                                                 Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 62                                                                                                    Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 63                      Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 64  Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 65                                                                                                     Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 66                                                                                                                                                Time to first respiratory hospitalization #> 67                                                                                 Relative Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28 #> 68                                                                                                    Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses #> 69                      Relative change from baseline in FEV1 percent predicted at Day 28 in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 70  Mean Actual change from baseline in FEV1 percent predicted across 3 treatment courses in subjects who received inhaled tobramycin for ≥ 84 days in the 12 months prior to randomization #> 71                                                                                                     Time to need for intravenous (IV) antipseudomonal antibiotics for respiratory events #> 72                                                                                                                                                Time to first respiratory hospitalization #> 73                                                                                                                                             Incidence rate of FVIII inhibitors (≥0.6 BU) #> 74                                   Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Main phase #> 75                              Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Extension phase #> 76           Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: excellent, good, moderate and none: Combined main and extension phases #> 77                                                                                                                                                     Annualised bleeding rate: Main phase #> 78                                                                                                                                                Annualised bleeding rate: Extension phase #> 79                                                                                                                             Annualised bleeding rate: Combined main and extension phases #> 80                                                                                                                            Incidence rate of FVIII inhibitors (≥0.6 BU): Extension phase #> 81                                                                                                         Incidence rate of FVIII inhibitors (≥0.6 BU): Combined main and extension phases #> 82                                                                                                                                             Incidence rate of FVIII inhibitors (≥0.6 BU) #> 83                                   Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Main phase #> 84                              Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Extension phase #> 85           Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: excellent, good, moderate and none: Combined main and extension phases #> 86                                                                                                                                                     Annualised bleeding rate: Main phase #> 87                                                                                                                                                Annualised bleeding rate: Extension phase #> 88                                                                                                                             Annualised bleeding rate: Combined main and extension phases #> 89                                                                                                                            Incidence rate of FVIII inhibitors (≥0.6 BU): Extension phase #> 90                                                                                                         Incidence rate of FVIII inhibitors (≥0.6 BU): Combined main and extension phases #> 91                                                                                                                                             Incidence rate of FVIII inhibitors (≥0.6 BU) #> 92                                   Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Main phase #> 93                              Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Extension phase #> 94           Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: excellent, good, moderate and none: Combined main and extension phases #> 95                                                                                                                                                     Annualised bleeding rate: Main phase #> 96                                                                                                                                                Annualised bleeding rate: Extension phase #> 97                                                                                                                             Annualised bleeding rate: Combined main and extension phases #> 98                                                                                                                            Incidence rate of FVIII inhibitors (≥0.6 BU): Extension phase #> 99                                                                                                         Incidence rate of FVIII inhibitors (≥0.6 BU): Combined main and extension phases #> 100                                                                                                                                            Incidence rate of FVIII inhibitors (≥0.6 BU) #> 101                                  Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Main phase #> 102                             Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Extension phase #> 103          Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: excellent, good, moderate and none: Combined main and extension phases #> 104                                                                                                                                                    Annualised bleeding rate: Main phase #> 105                                                                                                                                               Annualised bleeding rate: Extension phase #> 106                                                                                                                            Annualised bleeding rate: Combined main and extension phases #> 107                                                                                                                           Incidence rate of FVIII inhibitors (≥0.6 BU): Extension phase #> 108                                                                                                        Incidence rate of FVIII inhibitors (≥0.6 BU): Combined main and extension phases #> 109                                                                                                                                            Incidence rate of FVIII inhibitors (≥0.6 BU) #> 110                                  Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Main phase #> 111                             Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Extension phase #> 112          Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: excellent, good, moderate and none: Combined main and extension phases #> 113                                                                                                                                                    Annualised bleeding rate: Main phase #> 114                                                                                                                                               Annualised bleeding rate: Extension phase #> 115                                                                                                                            Annualised bleeding rate: Combined main and extension phases #> 116                                                                                                                           Incidence rate of FVIII inhibitors (≥0.6 BU): Extension phase #> 117                                                                                                        Incidence rate of FVIII inhibitors (≥0.6 BU): Combined main and extension phases #> 118                                                                                                                                            Incidence rate of FVIII inhibitors (≥0.6 BU) #> 119                                  Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Main phase #> 120                             Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Extension phase #> 121          Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: excellent, good, moderate and none: Combined main and extension phases #> 122                                                                                                                                                    Annualised bleeding rate: Main phase #> 123                                                                                                                                               Annualised bleeding rate: Extension phase #> 124                                                                                                                            Annualised bleeding rate: Combined main and extension phases #> 125                                                                                                                           Incidence rate of FVIII inhibitors (≥0.6 BU): Extension phase #> 126                                                                                                        Incidence rate of FVIII inhibitors (≥0.6 BU): Combined main and extension phases #> 127                                                                                                                                            Incidence rate of FVIII inhibitors (≥0.6 BU) #> 128                                  Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Main phase #> 129                             Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Extension phase #> 130          Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: excellent, good, moderate and none: Combined main and extension phases #> 131                                                                                                                                                    Annualised bleeding rate: Main phase #> 132                                                                                                                                               Annualised bleeding rate: Extension phase #> 133                                                                                                                            Annualised bleeding rate: Combined main and extension phases #> 134                                                                                                                           Incidence rate of FVIII inhibitors (≥0.6 BU): Extension phase #> 135                                                                                                        Incidence rate of FVIII inhibitors (≥0.6 BU): Combined main and extension phases #> 136                                                                                                                                            Incidence rate of FVIII inhibitors (≥0.6 BU) #> 137                                  Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Main phase #> 138                             Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Extension phase #> 139          Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: excellent, good, moderate and none: Combined main and extension phases #> 140                                                                                                                                                    Annualised bleeding rate: Main phase #> 141                                                                                                                                               Annualised bleeding rate: Extension phase #> 142                                                                                                                            Annualised bleeding rate: Combined main and extension phases #> 143                                                                                                                           Incidence rate of FVIII inhibitors (≥0.6 BU): Extension phase #> 144                                                                                                        Incidence rate of FVIII inhibitors (≥0.6 BU): Combined main and extension phases #> 145                                                                                                                                            Incidence rate of FVIII inhibitors (≥0.6 BU) #> 146                                  Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Main phase #> 147                             Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: Excellent, Good, Moderate and None: Extension phase #> 148          Haemostatic effect of turoctocog alfa on treatment of bleeds assessed on a predefined four point scale: excellent, good, moderate and none: Combined main and extension phases #> 149                                                                                                                                                    Annualised bleeding rate: Main phase #> 150                                                                                                                                               Annualised bleeding rate: Extension phase #> 151                                                                                                                            Annualised bleeding rate: Combined main and extension phases #> 152                                                                                                                           Incidence rate of FVIII inhibitors (≥0.6 BU): Extension phase #> 153                                                                                                        Incidence rate of FVIII inhibitors (≥0.6 BU): Combined main and extension phases #> 154                                                                         Percentage of Subjects With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay #> 155                                                                         Annualized Number of Bleeding Episodes (Spontaneous and Traumatic) per Subject (Annualized Bleeding Rate [ABR]) #> 156                                                                                                                                Annualized Number of Spontaneous Joint Bleeding Episodes #> 157                                                                  Number of rFIXFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale #> 158                                                                                                                                                     Total Number of Exposure Days (EDs) #> 159                                                                                   Total Annualized rFIXFc Consumption per Subject for the Prevention and Treatment of Bleeding Episodes #> 160                                                                                                                   Number of Injections of rFIXFc Required to Resolve a Bleeding Episode #> 161                                                                                                             Average dose per Injection of rFIXFc Required to Resolve a Bleeding Episode #> 162                                                                                                                                Change From Baseline in rFIXFc Incremental Recovery (IR) #> 163                                                                         Percentage of Subjects With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay #> 164                                                                         Annualized Number of Bleeding Episodes (Spontaneous and Traumatic) per Subject (Annualized Bleeding Rate [ABR]) #> 165                                                                                                                                Annualized Number of Spontaneous Joint Bleeding Episodes #> 166                                                                  Number of rFIXFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale #> 167                                                                                                                                                     Total Number of Exposure Days (EDs) #> 168                                                                                   Total Annualized rFIXFc Consumption per Subject for the Prevention and Treatment of Bleeding Episodes #> 169                                                                                                                   Number of Injections of rFIXFc Required to Resolve a Bleeding Episode #> 170                                                                                                             Average dose per Injection of rFIXFc Required to Resolve a Bleeding Episode #> 171                                                                                                                                Change From Baseline in rFIXFc Incremental Recovery (IR) #> 172                                                                         Percentage of Subjects With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay #> 173                                                                         Annualized Number of Bleeding Episodes (Spontaneous and Traumatic) per Subject (Annualized Bleeding Rate [ABR]) #> 174                                                                                                                                Annualized Number of Spontaneous Joint Bleeding Episodes #> 175                                                                  Number of rFIXFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale #> 176                                                                                                                                                     Total Number of Exposure Days (EDs) #> 177                                                                                   Total Annualized rFIXFc Consumption per Subject for the Prevention and Treatment of Bleeding Episodes #> 178                                                                                                                   Number of Injections of rFIXFc Required to Resolve a Bleeding Episode #> 179                                                                                                             Average dose per Injection of rFIXFc Required to Resolve a Bleeding Episode #> 180                                                                                                                                Change From Baseline in rFIXFc Incremental Recovery (IR) #> 181                                                                         Percentage of Subjects With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay #> 182                                                                         Annualized Number of Bleeding Episodes (Spontaneous and Traumatic) per Subject (Annualized Bleeding Rate [ABR]) #> 183                                                                                                                                Annualized Number of Spontaneous Joint Bleeding Episodes #> 184                                                                  Number of rFIXFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale #> 185                                                                                                                                                     Total Number of Exposure Days (EDs) #> 186                                                                                   Total Annualized rFIXFc Consumption per Subject for the Prevention and Treatment of Bleeding Episodes #> 187                                                                                                                   Number of Injections of rFIXFc Required to Resolve a Bleeding Episode #> 188                                                                                                             Average dose per Injection of rFIXFc Required to Resolve a Bleeding Episode #> 189                                                                                                                                Change From Baseline in rFIXFc Incremental Recovery (IR) #> 190                                                                         Percentage of Subjects With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay #> 191                                                                         Annualized Number of Bleeding Episodes (Spontaneous and Traumatic) per Subject (Annualized Bleeding Rate [ABR]) #> 192                                                                                                                                Annualized Number of Spontaneous Joint Bleeding Episodes #> 193                                                                  Number of rFIXFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale #> 194                                                                                                                                                     Total Number of Exposure Days (EDs) #> 195                                                                                   Total Annualized rFIXFc Consumption per Subject for the Prevention and Treatment of Bleeding Episodes #> 196                                                                                                                   Number of Injections of rFIXFc Required to Resolve a Bleeding Episode #> 197                                                                                                             Average dose per Injection of rFIXFc Required to Resolve a Bleeding Episode #> 198                                                                                                                                Change From Baseline in rFIXFc Incremental Recovery (IR) #> 199                                                                         Percentage of Subjects With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay #> 200                                                                         Annualized Number of Bleeding Episodes (Spontaneous and Traumatic) per Subject (Annualized Bleeding Rate [ABR]) #> 201                                                                                                                                Annualized Number of Spontaneous Joint Bleeding Episodes #> 202                                                                  Number of rFIXFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale #> 203                                                                                                                                                     Total Number of Exposure Days (EDs) #> 204                                                                                   Total Annualized rFIXFc Consumption per Subject for the Prevention and Treatment of Bleeding Episodes #> 205                                                                                                                   Number of Injections of rFIXFc Required to Resolve a Bleeding Episode #> 206                                                                                                             Average dose per Injection of rFIXFc Required to Resolve a Bleeding Episode #> 207                                                                                                                                Change From Baseline in rFIXFc Incremental Recovery (IR) #> 208                                                                         Percentage of Subjects With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay #> 209                                                                         Annualized Number of Bleeding Episodes (Spontaneous and Traumatic) per Subject (Annualized Bleeding Rate [ABR]) #> 210                                                                                                                                Annualized Number of Spontaneous Joint Bleeding Episodes #> 211                                                                  Number of rFIXFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale #> 212                                                                                                                                                     Total Number of Exposure Days (EDs) #> 213                                                                                   Total Annualized rFIXFc Consumption per Subject for the Prevention and Treatment of Bleeding Episodes #> 214                                                                                                                   Number of Injections of rFIXFc Required to Resolve a Bleeding Episode #> 215                                                                                                             Average dose per Injection of rFIXFc Required to Resolve a Bleeding Episode #> 216                                                                                                                                Change From Baseline in rFIXFc Incremental Recovery (IR) #> 217                                                                         Percentage of Subjects With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay #> 218                                                                         Annualized Number of Bleeding Episodes (Spontaneous and Traumatic) per Subject (Annualized Bleeding Rate [ABR]) #> 219                                                                                                                                Annualized Number of Spontaneous Joint Bleeding Episodes #> 220                                                                  Number of rFIXFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale #> 221                                                                                                                                                     Total Number of Exposure Days (EDs) #> 222                                                                                   Total Annualized rFIXFc Consumption per Subject for the Prevention and Treatment of Bleeding Episodes #> 223                                                                                                                   Number of Injections of rFIXFc Required to Resolve a Bleeding Episode #> 224                                                                                                             Average dose per Injection of rFIXFc Required to Resolve a Bleeding Episode #> 225                                                                                                                                Change From Baseline in rFIXFc Incremental Recovery (IR) #> 226                                                                         Percentage of Subjects With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay #> 227                                                                         Annualized Number of Bleeding Episodes (Spontaneous and Traumatic) per Subject (Annualized Bleeding Rate [ABR]) #> 228                                                                                                                                Annualized Number of Spontaneous Joint Bleeding Episodes #> 229                                                                  Number of rFIXFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale #> 230                                                                                                                                                     Total Number of Exposure Days (EDs) #> 231                                                                                   Total Annualized rFIXFc Consumption per Subject for the Prevention and Treatment of Bleeding Episodes #> 232                                                                                                                   Number of Injections of rFIXFc Required to Resolve a Bleeding Episode #> 233                                                                                                             Average dose per Injection of rFIXFc Required to Resolve a Bleeding Episode #> 234                                                                                                                                Change From Baseline in rFIXFc Incremental Recovery (IR) #> 235                                                                         Percentage of Subjects With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay #> 236                                                                         Annualized Number of Bleeding Episodes (Spontaneous and Traumatic) per Subject (Annualized Bleeding Rate [ABR]) #> 237                                                                                                                                Annualized Number of Spontaneous Joint Bleeding Episodes #> 238                                                                  Number of rFIXFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale #> 239                                                                                                                                                     Total Number of Exposure Days (EDs) #> 240                                                                                   Total Annualized rFIXFc Consumption per Subject for the Prevention and Treatment of Bleeding Episodes #> 241                                                                                                                   Number of Injections of rFIXFc Required to Resolve a Bleeding Episode #> 242                                                                                                             Average dose per Injection of rFIXFc Required to Resolve a Bleeding Episode #> 243                                                                                                                                Change From Baseline in rFIXFc Incremental Recovery (IR) #> 244                                                                         Percentage of Subjects With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay #> 245                                                                         Annualized Number of Bleeding Episodes (Spontaneous and Traumatic) per Subject (Annualized Bleeding Rate [ABR]) #> 246                                                                                                                                Annualized Number of Spontaneous Joint Bleeding Episodes #> 247                                                                  Number of rFIXFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale #> 248                                                                                                                                                     Total Number of Exposure Days (EDs) #> 249                                                                                   Total Annualized rFIXFc Consumption per Subject for the Prevention and Treatment of Bleeding Episodes #> 250                                                                                                                   Number of Injections of rFIXFc Required to Resolve a Bleeding Episode #>     item #> 1      1 #> 2      2 #> 3      3 #> 4      4 #> 5      5 #> 6      6 #> 7      1 #> 8      2 #> 9      3 #> 10     4 #> 11     5 #> 12     6 #> 13     1 #> 14     2 #> 15     3 #> 16     4 #> 17     5 #> 18     6 #> 19     1 #> 20     2 #> 21     3 #> 22     4 #> 23     5 #> 24     6 #> 25     1 #> 26     2 #> 27     3 #> 28     4 #> 29     5 #> 30     6 #> 31     1 #> 32     2 #> 33     3 #> 34     4 #> 35     5 #> 36     6 #> 37     1 #> 38     2 #> 39     3 #> 40     4 #> 41     5 #> 42     6 #> 43     1 #> 44     2 #> 45     3 #> 46     4 #> 47     5 #> 48     6 #> 49     1 #> 50     2 #> 51     3 #> 52     4 #> 53     5 #> 54     6 #> 55     1 #> 56     2 #> 57     3 #> 58     4 #> 59     5 #> 60     6 #> 61     1 #> 62     2 #> 63     3 #> 64     4 #> 65     5 #> 66     6 #> 67     1 #> 68     2 #> 69     3 #> 70     4 #> 71     5 #> 72     6 #> 73     1 #> 74     2 #> 75     3 #> 76     4 #> 77     5 #> 78     6 #> 79     7 #> 80     8 #> 81     9 #> 82     1 #> 83     2 #> 84     3 #> 85     4 #> 86     5 #> 87     6 #> 88     7 #> 89     8 #> 90     9 #> 91     1 #> 92     2 #> 93     3 #> 94     4 #> 95     5 #> 96     6 #> 97     7 #> 98     8 #> 99     9 #> 100    1 #> 101    2 #> 102    3 #> 103    4 #> 104    5 #> 105    6 #> 106    7 #> 107    8 #> 108    9 #> 109    1 #> 110    2 #> 111    3 #> 112    4 #> 113    5 #> 114    6 #> 115    7 #> 116    8 #> 117    9 #> 118    1 #> 119    2 #> 120    3 #> 121    4 #> 122    5 #> 123    6 #> 124    7 #> 125    8 #> 126    9 #> 127    1 #> 128    2 #> 129    3 #> 130    4 #> 131    5 #> 132    6 #> 133    7 #> 134    8 #> 135    9 #> 136    1 #> 137    2 #> 138    3 #> 139    4 #> 140    5 #> 141    6 #> 142    7 #> 143    8 #> 144    9 #> 145    1 #> 146    2 #> 147    3 #> 148    4 #> 149    5 #> 150    6 #> 151    7 #> 152    8 #> 153    9 #> 154    1 #> 155    2 #> 156    3 #> 157    4 #> 158    5 #> 159    6 #> 160    7 #> 161    8 #> 162    9 #> 163    1 #> 164    2 #> 165    3 #> 166    4 #> 167    5 #> 168    6 #> 169    7 #> 170    8 #> 171    9 #> 172    1 #> 173    2 #> 174    3 #> 175    4 #> 176    5 #> 177    6 #> 178    7 #> 179    8 #> 180    9 #> 181    1 #> 182    2 #> 183    3 #> 184    4 #> 185    5 #> 186    6 #> 187    7 #> 188    8 #> 189    9 #> 190    1 #> 191    2 #> 192    3 #> 193    4 #> 194    5 #> 195    6 #> 196    7 #> 197    8 #> 198    9 #> 199    1 #> 200    2 #> 201    3 #> 202    4 #> 203    5 #> 204    6 #> 205    7 #> 206    8 #> 207    9 #> 208    1 #> 209    2 #> 210    3 #> 211    4 #> 212    5 #> 213    6 #> 214    7 #> 215    8 #> 216    9 #> 217    1 #> 218    2 #> 219    3 #> 220    4 #> 221    5 #> 222    6 #> 223    7 #> 224    8 #> 225    9 #> 226    1 #> 227    2 #> 228    3 #> 229    4 #> 230    5 #> 231    6 #> 232    7 #> 233    8 #> 234    9 #> 235    1 #> 236    2 #> 237    3 #> 238    4 #> 239    5 #> 240    6 #> 241    7 #> 242    8 #> 243    9 #> 244    1 #> 245    2 #> 246    3 #> 247    4 #> 248    5 #> 249    6 #> 250    7 #>  [ reached 'max' / getOption(\"max.print\") -- omitted 418 rows ]"},{"path":"https://rfhb.github.io/ctrdata/reference/dfMergeTwoVariablesRelevel.html","id":null,"dir":"Reference","previous_headings":"","what":"Merge two variables — dfMergeTwoVariablesRelevel","title":"Merge two variables — dfMergeTwoVariablesRelevel","text":"Merge two variables data frame returned dbGetFieldsIntoDf new variable, optionally also map values new levels.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfMergeTwoVariablesRelevel.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Merge two variables — dfMergeTwoVariablesRelevel","text":"","code":"dfMergeTwoVariablesRelevel(df = NULL, colnames = \"\", levelslist = NULL, ...)"},{"path":"https://rfhb.github.io/ctrdata/reference/dfMergeTwoVariablesRelevel.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Merge two variables — dfMergeTwoVariablesRelevel","text":"df data.frame two variables (columns) merged one. colnames vector length two names two columns hold variables merged. See colnames obtain names columns data frame. levelslist list one slice new value used vector old values (optional). ... deprecated varnames parameter (removed)","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfMergeTwoVariablesRelevel.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Merge two variables — dfMergeTwoVariablesRelevel","text":"vector strings","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfMergeTwoVariablesRelevel.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Merge two variables — dfMergeTwoVariablesRelevel","text":"","code":"vars2merge <- c(\"overall_status\", \"x5_trial_status\")  dbc <- nodbi::src_sqlite(    dbname = system.file(\"extdata\", \"demo.sqlite\", package = \"ctrdata\"),    collection = \"my_trials\")  df <- dbGetFieldsIntoDf(   fields = vars2merge,   con = dbc) #> overall_status...  #>      #>  #> x5_trial_status...  #>       statusvalues <- list(   \"ongoing\" = c(\"Recruiting\", \"Active\", \"Ongoing\",                 \"Active, not recruiting\", \"Enrolling by invitation\"),   \"completed\" = c(\"Completed\", \"Prematurely Ended\", \"Terminated\"),   \"other\" = c(\"Withdrawn\", \"Suspended\",               \"No longer available\", \"Not yet recruiting\"))  dfMergeTwoVariablesRelevel(   df = df,   colnames = vars2merge,   levelslist = statusvalues) #> Unique values returned (first three): ongoing, GB - no longer in EU/EEA, completed #>   [1] \"ongoing\"                  \"ongoing\"                  #>   [3] \"ongoing\"                  \"GB - no longer in EU/EEA\" #>   [5] \"completed\"                \"completed\"                #>   [7] \"completed\"                \"completed\"                #>   [9] \"completed\"                \"completed\"                #>  [11] \"completed\"                \"completed\"                #>  [13] \"completed\"                \"completed\"                #>  [15] \"completed\"                \"completed\"                #>  [17] \"completed\"                \"completed\"                #>  [19] \"completed\"                \"completed\"                #>  [21] \"completed\"                \"completed\"                #>  [23] \"completed\"                \"completed\"                #>  [25] \"completed\"                \"completed\"                #>  [27] \"completed\"                \"completed\"                #>  [29] \"completed\"                \"completed\"                #>  [31] \"completed\"                \"completed\"                #>  [33] \"completed\"                \"completed\"                #>  [35] \"completed\"                \"completed\"                #>  [37] \"completed\"                \"completed\"                #>  [39] \"completed\"                \"completed\"                #>  [41] \"completed\"                \"completed\"                #>  [43] \"completed\"                \"completed\"                #>  [45] \"completed\"                \"completed\"                #>  [47] \"completed\"                \"completed\"                #>  [49] \"completed\"                \"completed\"                #>  [51] \"completed\"                \"completed\"                #>  [53] \"ongoing\"                  \"ongoing\"                  #>  [55] \"ongoing\"                  \"completed\"                #>  [57] \"ongoing\"                  \"completed\"                #>  [59] \"completed\"                \"completed\"                #>  [61] \"completed\"                \"completed\"                #>  [63] \"completed\"                \"completed\"                #>  [65] \"completed\"                \"completed\"                #>  [67] \"completed\"                \"completed\"                #>  [69] \"completed\"                \"completed\"                #>  [71] \"completed\"                \"completed\"                #>  [73] \"completed\"                \"completed\"                #>  [75] \"completed\"                \"completed\"                #>  [77] \"completed\"                \"completed\"                #>  [79] \"completed\"                \"completed\"                #>  [81] \"ongoing\"                  \"completed\"                #>  [83] \"completed\"                \"completed\"                #>  [85] \"completed\"                \"completed\"                #>  [87] \"completed\"                \"Unknown status\"           #>  [89] \"other\"                    \"completed\"                #>  [91] \"completed\"                \"Unknown status\"           #>  [93] \"Unknown status\"           \"completed\"                #>  [95] \"completed\"                \"completed\"                #>  [97] \"completed\"                \"Unknown status\"           #>  [99] \"completed\"                \"completed\"                #> [101] \"Unknown status\"           \"Unknown status\"           #> [103] \"completed\"                \"completed\"                #> [105] \"completed\"                \"other\"                    #> [107] \"completed\"                \"completed\"                #> [109] \"completed\"                \"completed\"                #> [111] \"other\"                    \"completed\"                #> [113] \"completed\"                \"completed\"                #> [115] \"Unknown status\"           \"ongoing\"                  #> [117] \"completed\"                \"completed\"                #> [119] \"completed\"                \"completed\"                #> [121] \"completed\"                \"completed\"                #> [123] \"completed\"                \"ongoing\"                  #> [125] \"completed\"                \"completed\"                #> [127] \"Unknown status\"           \"Unknown status\"           #> [129] \"Unknown status\"           \"completed\"                #> [131] \"completed\"                \"completed\"                #> [133] \"ongoing\"                  \"completed\"                #> [135] \"Unknown status\"           \"Unknown status\"           #> [137] \"completed\"                \"Unknown status\"           #> [139] \"Unknown status\""},{"path":"https://rfhb.github.io/ctrdata/reference/dfName2Value.html","id":null,"dir":"Reference","previous_headings":"","what":"Get value for variable of interest — dfName2Value","title":"Get value for variable of interest — dfName2Value","text":"Get information interest (e.g., endpoint) long data frame protocol- result-related trial information returned dfTrials2Long. Parameters `valuename`, `wherename` `wherevalue` matched using Perl regular expressions ignoring case.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfName2Value.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get value for variable of interest — dfName2Value","text":"","code":"dfName2Value(df, valuename = \"\", wherename = \"\", wherevalue = \"\")"},{"path":"https://rfhb.github.io/ctrdata/reference/dfName2Value.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get value for variable of interest — dfName2Value","text":"df data frame (tibble) four columns (`_id`, `identifier`, `name`, `value`) returned dfTrials2Long valuename character string name field holds value variable interest (e.g., summary measure \"endPoints.*tendencyValue.value\") wherename character string identify variable interest (e.g., \"endPoints.endPoint.title\") wherevalue character string value interest variable interest (e.g., \"duration response\")","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfName2Value.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get value for variable of interest — dfName2Value","text":"data frame (tibble, dplyr loaded)  columns `_id`, `identifier`,  `name`, `value` includes values interest,  values strings unless value elements  numbers. `ìdentifier` generated function  dfTrials2Long identify matching elements, e.g.  endpoint descriptions measurements.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfName2Value.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get value for variable of interest — dfName2Value","text":"","code":"dbc <- nodbi::src_sqlite(    dbname = system.file(\"extdata\", \"demo.sqlite\", package = \"ctrdata\"),    collection = \"my_trials\")  df <- dbGetFieldsIntoDf( fields = c(   # ctgov - typical results fields   \"clinical_results.baseline.analyzed_list.analyzed.count_list.count\",   \"clinical_results.baseline.group_list.group\",   \"clinical_results.baseline.analyzed_list.analyzed.units\",   \"clinical_results.outcome_list.outcome\",   \"study_design_info.allocation\",   # euctr - typical results fields   \"trialInformation.fullTitle\",   \"subjectDisposition.recruitmentDetails\",   \"baselineCharacteristics.baselineReportingGroups.baselineReportingGroup\",   \"endPoints.endPoint\",   \"trialChanges.hasGlobalInterruptions\",   \"subjectAnalysisSets\",   \"adverseEvents.seriousAdverseEvents.seriousAdverseEvent\"   ), con = dbc) #> clinical_results.baseline.analyzed_list.analyzed.count_list.count...  #>      #> .  #> .  #> .  #> .  #> .  #>  #> clinical_results.baseline.group_list.group...  #>      #> .  #> .  #> .  #>  #> clinical_results.baseline.analyzed_list.analyzed.units...  #>      #> .  #> .  #> .  #> .  #>  #> clinical_results.outcome_list.outcome...  #>      #> .  #> .  #>  #> study_design_info.allocation...  #>      #> .  #>  #> trialInformation.fullTitle...  #>      #> .  #>  #> subjectDisposition.recruitmentDetails...  #>      #> .  #>  #> baselineCharacteristics.baselineReportingGroups.baselineReportingGroup...  #>      #> .  #> .  #>  #> endPoints.endPoint...  #>      #> .  #>  #> trialChanges.hasGlobalInterruptions...  #>      #> .  #>  #> subjectAnalysisSets...  #>      #>  #> adverseEvents.seriousAdverseEvents.seriousAdverseEvent...  #>      #> .  #> .   # convert to long reslong <- dfTrials2Long(df = df) #> clinical_results.baseline.analyzed_list.analyzed.count_list.count                                                                                                                                        #> clinical_results.baseline.group_list.group                                                                                                                                                               #> clinical_results.baseline.analyzed_list.analyzed.units                                                                                                                                                   #> clinical_results.outcome_list.outcome                                                                                                                                                                    #> study_design_info.allocation                                                                                                                                                                             #> trialInformation.fullTitle                                                                                                                                                                               #> subjectDisposition.recruitmentDetails                                                                                                                                                                    #> baselineCharacteristics.baselineReportingGroups.baselineReportingGroup                                                                                                                                   #> endPoints.endPoint                                                                                                                                                                                       #> trialChanges.hasGlobalInterruptions                                                                                                                                                                      #> subjectAnalysisSets.subjectAnalysisSet                                                                                                                                                                   #> adverseEvents.seriousAdverseEvents.seriousAdverseEvent                                                                                                                                                   #>                                                                                                                                                                                                          #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #>  #> Total 71832 rows, 128 unique names of variables  # get values for endpoint of interest, e.g. 'response' dfName2Value(   df = reslong,   valuename = paste0(     \"endPoints.endPoint.*armReportingGroup.tendencyValues.tendencyValue.value|\",     \"clinical_results.*category.measurement_list.measurement.value|\",     \"clinical_results.*outcome.measure.units|endPoints.endPoint.unit\"   ),   wherename = paste0(     \"clinical_results.*outcome.measure.title|\",     \"endPoints.endPoint.title\"),   wherevalue = \"response\") #> Returning values for 21 out of 124 trials #>                   _id identifier #> 1   2013-003629-27-BE        1.4 #> 2   2013-003629-27-DE        1.4 #> 3   2013-003629-27-DK        1.4 #> 4   2013-003629-27-ES        1.4 #> 5   2013-003629-27-FR        1.4 #> 6   2013-003629-27-GB        1.4 #> 7   2013-003629-27-IE        1.4 #> 8   2013-003629-27-IT        1.4 #> 9   2013-003629-27-NL        1.4 #> 10  2013-003629-27-PL        1.4 #> 11  2013-003629-27-SE        1.4 #> 12  2013-005512-10-DE        1.4 #> 13  2013-005512-10-DE      1.4.1 #> 14  2013-005512-10-DE      1.4.2 #> 15  2013-005512-10-DE      1.4.3 #> 16  2013-005512-10-DE      1.4.4 #> 17  2013-005512-10-DE      1.4.5 #> 18  2013-005512-10-DE      1.4.6 #> 19  2013-005512-10-DE      1.4.7 #> 20  2013-005512-10-DE      1.4.8 #> 21  2013-005512-10-DE      1.4.9 #> 22  2013-005512-10-DE     1.4.10 #> 23  2013-005512-10-DE     1.4.11 #> 24  2013-005512-10-DE     1.4.12 #> 25  2013-005512-10-DE       1.10 #> 26  2013-005512-10-DK        1.4 #> 27  2013-005512-10-DK      1.4.1 #> 28  2013-005512-10-DK      1.4.2 #> 29  2013-005512-10-DK      1.4.3 #> 30  2013-005512-10-DK      1.4.4 #> 31  2013-005512-10-DK      1.4.5 #> 32  2013-005512-10-DK      1.4.6 #> 33  2013-005512-10-DK      1.4.7 #> 34  2013-005512-10-DK      1.4.8 #> 35  2013-005512-10-DK      1.4.9 #> 36  2013-005512-10-DK     1.4.10 #> 37  2013-005512-10-DK     1.4.11 #> 38  2013-005512-10-DK     1.4.12 #> 39  2013-005512-10-DK       1.10 #> 40  2013-005512-10-ES        1.4 #> 41  2013-005512-10-ES      1.4.1 #> 42  2013-005512-10-ES      1.4.2 #> 43  2013-005512-10-ES      1.4.3 #> 44  2013-005512-10-ES      1.4.4 #> 45  2013-005512-10-ES      1.4.5 #> 46  2013-005512-10-ES      1.4.6 #> 47  2013-005512-10-ES      1.4.7 #> 48  2013-005512-10-ES      1.4.8 #> 49  2013-005512-10-ES      1.4.9 #> 50  2013-005512-10-ES     1.4.10 #> 51  2013-005512-10-ES     1.4.11 #> 52  2013-005512-10-ES     1.4.12 #> 53  2013-005512-10-ES       1.10 #> 54  2013-005512-10-FR        1.4 #> 55  2013-005512-10-FR      1.4.1 #> 56  2013-005512-10-FR      1.4.2 #> 57  2013-005512-10-FR      1.4.3 #> 58  2013-005512-10-FR      1.4.4 #> 59  2013-005512-10-FR      1.4.5 #> 60  2013-005512-10-FR      1.4.6 #> 61  2013-005512-10-FR      1.4.7 #> 62  2013-005512-10-FR      1.4.8 #> 63  2013-005512-10-FR      1.4.9 #> 64  2013-005512-10-FR     1.4.10 #> 65  2013-005512-10-FR     1.4.11 #> 66  2013-005512-10-FR     1.4.12 #> 67  2013-005512-10-FR       1.10 #> 68  2013-005512-10-GB        1.4 #> 69  2013-005512-10-GB      1.4.1 #> 70  2013-005512-10-GB      1.4.2 #> 71  2013-005512-10-GB      1.4.3 #> 72  2013-005512-10-GB      1.4.4 #> 73  2013-005512-10-GB      1.4.5 #> 74  2013-005512-10-GB      1.4.6 #> 75  2013-005512-10-GB      1.4.7 #> 76  2013-005512-10-GB      1.4.8 #> 77  2013-005512-10-GB      1.4.9 #> 78  2013-005512-10-GB     1.4.10 #> 79  2013-005512-10-GB     1.4.11 #> 80  2013-005512-10-GB     1.4.12 #> 81  2013-005512-10-GB       1.10 #> 82  2013-005512-10-IE        1.4 #> 83  2013-005512-10-IE      1.4.1 #> 84  2013-005512-10-IE      1.4.2 #> 85  2013-005512-10-IE      1.4.3 #> 86  2013-005512-10-IE      1.4.4 #> 87  2013-005512-10-IE      1.4.5 #> 88  2013-005512-10-IE      1.4.6 #> 89  2013-005512-10-IE      1.4.7 #> 90  2013-005512-10-IE      1.4.8 #> 91  2013-005512-10-IE      1.4.9 #> 92  2013-005512-10-IE     1.4.10 #> 93  2013-005512-10-IE     1.4.11 #> 94  2013-005512-10-IE     1.4.12 #> 95  2013-005512-10-IE       1.10 #> 96  2013-005512-10-IT        1.4 #> 97  2013-005512-10-IT      1.4.1 #> 98  2013-005512-10-IT      1.4.2 #> 99  2013-005512-10-IT      1.4.3 #> 100 2013-005512-10-IT      1.4.4 #> 101 2013-005512-10-IT      1.4.5 #> 102 2013-005512-10-IT      1.4.6 #> 103 2013-005512-10-IT      1.4.7 #> 104 2013-005512-10-IT      1.4.8 #> 105 2013-005512-10-IT      1.4.9 #> 106 2013-005512-10-IT     1.4.10 #> 107 2013-005512-10-IT     1.4.11 #> 108 2013-005512-10-IT     1.4.12 #> 109 2013-005512-10-IT       1.10 #> 110 2013-005512-10-NL        1.4 #> 111 2013-005512-10-NL      1.4.1 #> 112 2013-005512-10-NL      1.4.2 #> 113 2013-005512-10-NL      1.4.3 #> 114 2013-005512-10-NL      1.4.4 #> 115 2013-005512-10-NL      1.4.5 #> 116 2013-005512-10-NL      1.4.6 #> 117 2013-005512-10-NL      1.4.7 #> 118 2013-005512-10-NL      1.4.8 #> 119 2013-005512-10-NL      1.4.9 #> 120 2013-005512-10-NL     1.4.10 #> 121 2013-005512-10-NL     1.4.11 #> 122 2013-005512-10-NL     1.4.12 #> 123 2013-005512-10-NL       1.10 #> 124 2013-005512-10-PL        1.4 #> 125 2013-005512-10-PL      1.4.1 #> 126 2013-005512-10-PL      1.4.2 #> 127 2013-005512-10-PL      1.4.3 #> 128 2013-005512-10-PL      1.4.4 #> 129 2013-005512-10-PL      1.4.5 #> 130 2013-005512-10-PL      1.4.6 #> 131 2013-005512-10-PL      1.4.7 #> 132 2013-005512-10-PL      1.4.8 #> 133 2013-005512-10-PL      1.4.9 #> 134 2013-005512-10-PL     1.4.10 #> 135 2013-005512-10-PL     1.4.11 #> 136 2013-005512-10-PL     1.4.12 #> 137 2013-005512-10-PL       1.10 #> 138 2013-005512-10-SE        1.4 #> 139 2013-005512-10-SE      1.4.1 #> 140 2013-005512-10-SE      1.4.2 #> 141 2013-005512-10-SE      1.4.3 #> 142 2013-005512-10-SE      1.4.4 #> 143 2013-005512-10-SE      1.4.5 #> 144 2013-005512-10-SE      1.4.6 #> 145 2013-005512-10-SE      1.4.7 #> 146 2013-005512-10-SE      1.4.8 #> 147 2013-005512-10-SE      1.4.9 #> 148 2013-005512-10-SE     1.4.10 #> 149 2013-005512-10-SE     1.4.11 #> 150 2013-005512-10-SE     1.4.12 #> 151 2013-005512-10-SE       1.10 #>                                                                                           name #> 1                                                                      endPoints.endPoint.unit #> 2                                                                      endPoints.endPoint.unit #> 3                                                                      endPoints.endPoint.unit #> 4                                                                      endPoints.endPoint.unit #> 5                                                                      endPoints.endPoint.unit #> 6                                                                      endPoints.endPoint.unit #> 7                                                                      endPoints.endPoint.unit #> 8                                                                      endPoints.endPoint.unit #> 9                                                                      endPoints.endPoint.unit #> 10                                                                     endPoints.endPoint.unit #> 11                                                                     endPoints.endPoint.unit #> 12                                                                     endPoints.endPoint.unit #> 13  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 14  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 15  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 16  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 17  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 18  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 19  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 20  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 21  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 22  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 23  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 24  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 25                                                                     endPoints.endPoint.unit #> 26                                                                     endPoints.endPoint.unit #> 27  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 28  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 29  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 30  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 31  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 32  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 33  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 34  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 35  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 36  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 37  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 38  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 39                                                                     endPoints.endPoint.unit #> 40                                                                     endPoints.endPoint.unit #> 41  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 42  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 43  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 44  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 45  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 46  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 47  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 48  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 49  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 50  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 51  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 52  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 53                                                                     endPoints.endPoint.unit #> 54                                                                     endPoints.endPoint.unit #> 55  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 56  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 57  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 58  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 59  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 60  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 61  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 62  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 63  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 64  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 65  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 66  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 67                                                                     endPoints.endPoint.unit #> 68                                                                     endPoints.endPoint.unit #> 69  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 70  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 71  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 72  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 73  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 74  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 75  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 76  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 77  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 78  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 79  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 80  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 81                                                                     endPoints.endPoint.unit #> 82                                                                     endPoints.endPoint.unit #> 83  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 84  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 85  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 86  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 87  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 88  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 89  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 90  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 91  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 92  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 93  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 94  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 95                                                                     endPoints.endPoint.unit #> 96                                                                     endPoints.endPoint.unit #> 97  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 98  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 99  endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 100 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 101 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 102 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 103 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 104 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 105 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 106 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 107 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 108 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 109                                                                    endPoints.endPoint.unit #> 110                                                                    endPoints.endPoint.unit #> 111 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 112 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 113 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 114 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 115 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 116 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 117 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 118 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 119 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 120 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 121 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 122 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 123                                                                    endPoints.endPoint.unit #> 124                                                                    endPoints.endPoint.unit #> 125 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 126 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 127 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 128 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 129 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 130 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 131 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 132 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 133 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 134 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 135 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 136 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 137                                                                    endPoints.endPoint.unit #> 138                                                                    endPoints.endPoint.unit #> 139 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 140 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 141 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 142 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 143 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 144 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 145 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 146 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 147 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 148 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 149 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 150 endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value #> 151                                                                    endPoints.endPoint.unit #>                       value #> 1   responses to injections #> 2   responses to injections #> 3   responses to injections #> 4   responses to injections #> 5   responses to injections #> 6   responses to injections #> 7   responses to injections #> 8   responses to injections #> 9   responses to injections #> 10  responses to injections #> 11  responses to injections #> 12  responses to injections #> 13                      102 #> 14                       16 #> 15                        2 #> 16                      118 #> 17                      163 #> 18                       27 #> 19                       14 #> 20                       89 #> 21                       20 #> 22                       14 #> 23                        3 #> 24                       11 #> 25                 subjects #> 26  responses to injections #> 27                      102 #> 28                       16 #> 29                        2 #> 30                      118 #> 31                      163 #> 32                       27 #> 33                       14 #> 34                       89 #> 35                       20 #> 36                       14 #> 37                        3 #> 38                       11 #> 39                 subjects #> 40  responses to injections #> 41                      102 #> 42                       16 #> 43                        2 #> 44                      118 #> 45                      163 #> 46                       27 #> 47                       14 #> 48                       89 #> 49                       20 #> 50                       14 #> 51                        3 #> 52                       11 #> 53                 subjects #> 54  responses to injections #> 55                      102 #> 56                       16 #> 57                        2 #> 58                      118 #> 59                      163 #> 60                       27 #> 61                       14 #> 62                       89 #> 63                       20 #> 64                       14 #> 65                        3 #> 66                       11 #> 67                 subjects #> 68  responses to injections #> 69                      102 #> 70                       16 #> 71                        2 #> 72                      118 #> 73                      163 #> 74                       27 #> 75                       14 #> 76                       89 #> 77                       20 #> 78                       14 #> 79                        3 #> 80                       11 #> 81                 subjects #> 82  responses to injections #> 83                      102 #> 84                       16 #> 85                        2 #> 86                      118 #> 87                      163 #> 88                       27 #> 89                       14 #> 90                       89 #> 91                       20 #> 92                       14 #> 93                        3 #> 94                       11 #> 95                 subjects #> 96  responses to injections #> 97                      102 #> 98                       16 #> 99                        2 #> 100                     118 #> 101                     163 #> 102                      27 #> 103                      14 #> 104                      89 #> 105                      20 #> 106                      14 #> 107                       3 #> 108                      11 #> 109                subjects #> 110 responses to injections #> 111                     102 #> 112                      16 #> 113                       2 #> 114                     118 #> 115                     163 #> 116                      27 #> 117                      14 #> 118                      89 #> 119                      20 #> 120                      14 #> 121                       3 #> 122                      11 #> 123                subjects #> 124 responses to injections #> 125                     102 #> 126                      16 #> 127                       2 #> 128                     118 #> 129                     163 #> 130                      27 #> 131                      14 #> 132                      89 #> 133                      20 #> 134                      14 #> 135                       3 #> 136                      11 #> 137                subjects #> 138 responses to injections #> 139                     102 #> 140                      16 #> 141                       2 #> 142                     118 #> 143                     163 #> 144                      27 #> 145                      14 #> 146                      89 #> 147                      20 #> 148                      14 #> 149                       3 #> 150                      11 #> 151                subjects"},{"path":"https://rfhb.github.io/ctrdata/reference/dfTrials2Long.html","id":null,"dir":"Reference","previous_headings":"","what":"Convert data frame with trial records into long format — dfTrials2Long","title":"Convert data frame with trial records into long format — dfTrials2Long","text":"function works procotol- results- related information. converts lists values data frame returned dbGetFieldsIntoDf individual rows long data frame. resulting data frame, values interest can selected using dfName2Value. function intended fields complex content, node field \"clinical_results\" EUCTR, dbGetFieldsIntoDf returns multiply nested list function converts every observation every (leaf) field row .","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfTrials2Long.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Convert data frame with trial records into long format — dfTrials2Long","text":"","code":"dfTrials2Long(df)"},{"path":"https://rfhb.github.io/ctrdata/reference/dfTrials2Long.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Convert data frame with trial records into long format — dfTrials2Long","text":"df Data frame (tibble) columns including trial identifier (_id) one variables obtained dbGetFieldsIntoDf","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfTrials2Long.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Convert data frame with trial records into long format — dfTrials2Long","text":"data frame  (tibble, dplyr loaded) four columns: `_id`, `identifier`, `name`, `value`","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/dfTrials2Long.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Convert data frame with trial records into long format — dfTrials2Long","text":"","code":"dbc <- nodbi::src_sqlite(    dbname = system.file(\"extdata\", \"demo.sqlite\", package = \"ctrdata\"),    collection = \"my_trials\")  df <- dbGetFieldsIntoDf(   fields = \"clinical_results\",   con = dbc) #> clinical_results...  #>      #> .  #> .  #> .  #> .  #> .  #> .  #> .   dfTrials2Long(df = df) #> clinical_results.participant_flow                                                                                                                                                                        #> clinical_results.baseline                                                                                                                                                                                #> clinical_results.outcome_list.outcome                                                                                                                                                                    #> clinical_results.reported_events                                                                                                                                                                         #> clinical_results.certain_agreements                                                                                                                                                                      #> clinical_results.limitations_and_caveats                                                                                                                                                                 #> clinical_results.point_of_contact                                                                                                                                                                        #>                                                                                                                                                                                                          #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #> .  #>  #> Total 177020 rows, 102 unique names of variables #>             _id identifier #> 1   NCT00004500          0 #> 2   NCT00004500          0 #> 3   NCT00004500          0 #> 4   NCT00004500          0 #> 5   NCT00004500          0 #> 6   NCT00004500          0 #> 7   NCT00004500          0 #> 8   NCT00004500          0 #> 9   NCT00004500          0 #> 10  NCT00004500          0 #> 11  NCT00005773        1.1 #> 12  NCT00005773        1.2 #> 13  NCT00005773        1.1 #> 14  NCT00005773        1.2 #> 15  NCT00005773        1.1 #> 16  NCT00005773        1.2 #> 17  NCT00005773        9.1 #> 18  NCT00005773        9.2 #> 19  NCT00005773        9.1 #> 20  NCT00005773        9.2 #> 21  NCT00005773        9.1 #> 22  NCT00005773        9.2 #> 23  NCT00005773       10.1 #> 24  NCT00005773       10.2 #> 25  NCT00005773       10.1 #> 26  NCT00005773       10.2 #> 27  NCT00005773       10.1 #> 28  NCT00005773       10.2 #> 29  NCT00005773       11.1 #> 30  NCT00005773       11.2 #> 31  NCT00005773       11.3 #> 32  NCT00005773       11.1 #> 33  NCT00005773       11.2 #> 34  NCT00005773       11.3 #> 35  NCT00005773       11.1 #> 36  NCT00005773       11.2 #> 37  NCT00005773       11.3 #> 38  NCT00005773       15.1 #> 39  NCT00005773       15.2 #> 40  NCT00005773       15.1 #> 41  NCT00005773       15.2 #> 42  NCT00005773       18.1 #> 43  NCT00005773       18.2 #> 44  NCT00005773       18.1 #> 45  NCT00005773       18.2 #> 46  NCT00005773       18.1 #> 47  NCT00005773       18.2 #> 48  NCT00005773       21.1 #> 49  NCT00005773       21.2 #> 50  NCT00005773       21.1 #> 51  NCT00005773       21.2 #> 52  NCT00005773       21.1 #> 53  NCT00005773       21.2 #> 54  NCT00005773       30.1 #> 55  NCT00005773       30.2 #> 56  NCT00005773       30.1 #> 57  NCT00005773       30.2 #> 58  NCT00005773       30.1 #> 59  NCT00005773       30.2 #> 60  NCT00005773       31.1 #> 61  NCT00005773       31.2 #> 62  NCT00005773       31.1 #> 63  NCT00005773       31.2 #> 64  NCT00005773       31.1 #> 65  NCT00005773       31.2 #> 66  NCT00005773       35.1 #> 67  NCT00005773       35.2 #> 68  NCT00005773       35.1 #> 69  NCT00005773       35.2 #> 70  NCT00005773       35.1 #> 71  NCT00005773       35.2 #> 72  NCT00005773       36.1 #> 73  NCT00005773       36.2 #> 74  NCT00005773       36.1 #> 75  NCT00005773       36.2 #> 76  NCT00005773       36.1 #> 77  NCT00005773       36.2 #> 78  NCT00005773       38.1 #> 79  NCT00005773       38.2 #> 80  NCT00005773       38.1 #> 81  NCT00005773       38.2 #> 82  NCT00005773       38.1 #> 83  NCT00005773       38.2 #> 84  NCT00005773       40.1 #> 85  NCT00005773       40.2 #> 86  NCT00005773       40.1 #> 87  NCT00005773       40.2 #> 88  NCT00005773       40.1 #> 89  NCT00005773       40.2 #> 90  NCT00005773       41.1 #> 91  NCT00005773       41.2 #> 92  NCT00005773       41.1 #> 93  NCT00005773       41.2 #> 94  NCT00005773       41.1 #> 95  NCT00005773       41.2 #> 96  NCT00005773       57.1 #> 97  NCT00005773       57.2 #> 98  NCT00005773       57.1 #> 99  NCT00005773       57.2 #> 100 NCT00005773       57.1 #> 101 NCT00005773       57.2 #> 102 NCT00005774          1 #> 103 NCT00005774        1.1 #> 104 NCT00005774        1.2 #> 105 NCT00005774        1.3 #> 106 NCT00005774        1.4 #> 107 NCT00005774      1.1.1 #> 108 NCT00005774      1.1.2 #> 109 NCT00005774      1.1.1 #> 110 NCT00005774      1.1.2 #> 111 NCT00005774      1.2.1 #> 112 NCT00005774      1.2.2 #> 113 NCT00005774      1.2.1 #> 114 NCT00005774      1.2.2 #> 115 NCT00005774      1.3.1 #> 116 NCT00005774      1.3.2 #> 117 NCT00005774      1.3.1 #> 118 NCT00005774      1.3.2 #> 119 NCT00005774      1.4.1 #> 120 NCT00005774      1.4.2 #> 121 NCT00005774      1.4.1 #> 122 NCT00005774      1.4.2 #> 123 NCT00005774          9 #> 124 NCT00005774        9.1 #> 125 NCT00005774        9.2 #> 126 NCT00005774        9.3 #> 127 NCT00005774      9.1.1 #> 128 NCT00005774      9.1.2 #> 129 NCT00005774      9.1.1 #> 130 NCT00005774      9.1.2 #> 131 NCT00005774      9.2.1 #> 132 NCT00005774      9.2.2 #> 133 NCT00005774      9.2.1 #> 134 NCT00005774      9.2.2 #> 135 NCT00005774      9.3.1 #> 136 NCT00005774      9.3.2 #> 137 NCT00005774      9.3.1 #> 138 NCT00005774      9.3.2 #> 139 NCT00005774        9.1 #> 140 NCT00005774        9.2 #> 141 NCT00005774        9.3 #> 142 NCT00005774        9.4 #> 143 NCT00005774      9.1.1 #> 144 NCT00005774      9.1.2 #> 145 NCT00005774      9.1.1 #> 146 NCT00005774      9.1.2 #> 147 NCT00005774      9.2.1 #> 148 NCT00005774      9.2.2 #> 149 NCT00005774      9.2.1 #> 150 NCT00005774      9.2.2 #> 151 NCT00005774      9.3.1 #> 152 NCT00005774      9.3.2 #> 153 NCT00005774      9.3.1 #> 154 NCT00005774      9.3.2 #> 155 NCT00005774      9.4.1 #> 156 NCT00005774      9.4.2 #> 157 NCT00005774      9.4.1 #> 158 NCT00005774      9.4.2 #> 159 NCT00005774         10 #> 160 NCT00005774       10.1 #> 161 NCT00005774       10.2 #> 162 NCT00005774       10.3 #> 163 NCT00005774     10.1.1 #> 164 NCT00005774     10.1.2 #> 165 NCT00005774     10.1.1 #> 166 NCT00005774     10.1.2 #> 167 NCT00005774     10.2.1 #> 168 NCT00005774     10.2.2 #> 169 NCT00005774     10.2.1 #> 170 NCT00005774     10.2.2 #> 171 NCT00005774     10.3.1 #> 172 NCT00005774     10.3.2 #> 173 NCT00005774     10.3.1 #> 174 NCT00005774     10.3.2 #> 175 NCT00005774       10.1 #> 176 NCT00005774       10.2 #> 177 NCT00005774       10.3 #> 178 NCT00005774       10.4 #> 179 NCT00005774       10.5 #> 180 NCT00005774       10.6 #> 181 NCT00005774       10.7 #> 182 NCT00005774     10.1.1 #> 183 NCT00005774     10.1.2 #> 184 NCT00005774     10.1.1 #> 185 NCT00005774     10.1.2 #> 186 NCT00005774     10.2.1 #> 187 NCT00005774     10.2.2 #> 188 NCT00005774     10.2.1 #> 189 NCT00005774     10.2.2 #> 190 NCT00005774     10.3.1 #> 191 NCT00005774     10.3.2 #> 192 NCT00005774     10.3.1 #> 193 NCT00005774     10.3.2 #> 194 NCT00005774     10.4.1 #> 195 NCT00005774     10.4.2 #> 196 NCT00005774     10.4.1 #> 197 NCT00005774     10.4.2 #> 198 NCT00005774     10.5.1 #> 199 NCT00005774     10.5.2 #> 200 NCT00005774     10.5.1 #> 201 NCT00005774     10.5.2 #> 202 NCT00005774     10.6.1 #> 203 NCT00005774     10.6.2 #> 204 NCT00005774     10.6.1 #> 205 NCT00005774     10.6.2 #> 206 NCT00005774     10.7.1 #> 207 NCT00005774     10.7.2 #> 208 NCT00005774     10.7.1 #> 209 NCT00005774     10.7.2 #> 210 NCT00005774         11 #> 211 NCT00005774       11.1 #> 212 NCT00005774       11.2 #> 213 NCT00005774       11.3 #> 214 NCT00005774     11.1.1 #> 215 NCT00005774     11.1.2 #> 216 NCT00005774     11.1.3 #> 217 NCT00005774     11.1.1 #> 218 NCT00005774     11.1.2 #> 219 NCT00005774     11.1.3 #> 220 NCT00005774     11.2.1 #> 221 NCT00005774     11.2.2 #> 222 NCT00005774     11.2.3 #> 223 NCT00005774     11.2.1 #> 224 NCT00005774     11.2.2 #> 225 NCT00005774     11.2.3 #> 226 NCT00005774     11.3.1 #> 227 NCT00005774     11.3.2 #> 228 NCT00005774     11.3.3 #> 229 NCT00005774     11.3.1 #> 230 NCT00005774     11.3.2 #> 231 NCT00005774     11.3.3 #> 232 NCT00005774       11.1 #> 233 NCT00005774       11.2 #> 234 NCT00005774       11.3 #> 235 NCT00005774       11.4 #> 236 NCT00005774     11.1.1 #> 237 NCT00005774     11.1.2 #> 238 NCT00005774     11.1.3 #> 239 NCT00005774     11.1.1 #> 240 NCT00005774     11.1.2 #> 241 NCT00005774     11.1.3 #> 242 NCT00005774     11.2.1 #> 243 NCT00005774     11.2.2 #> 244 NCT00005774     11.2.3 #> 245 NCT00005774     11.2.1 #> 246 NCT00005774     11.2.2 #> 247 NCT00005774     11.2.3 #> 248 NCT00005774     11.3.1 #> 249 NCT00005774     11.3.2 #> 250 NCT00005774     11.3.3 #>                                                                                                                                name #> 1                                                                                                 clinical_results.participant_flow #> 2                                                                                                 clinical_results.participant_flow #> 3                                                                                                 clinical_results.participant_flow #> 4                                                                                                 clinical_results.participant_flow #> 5                                                                                                 clinical_results.participant_flow #> 6                                                                                                 clinical_results.participant_flow #> 7                                                                                                 clinical_results.participant_flow #> 8                                                                                                 clinical_results.participant_flow #> 9                                                                                                 clinical_results.participant_flow #> 10                                                                                                clinical_results.participant_flow #> 11                                                                                 clinical_results.participant_flow.group.group_id #> 12                                                                                 clinical_results.participant_flow.group.group_id #> 13                                                                                    clinical_results.participant_flow.group.title #> 14                                                                                    clinical_results.participant_flow.group.title #> 15                                                                              clinical_results.participant_flow.group.description #> 16                                                                              clinical_results.participant_flow.group.description #> 17                                                                                 clinical_results.participant_flow.group.group_id #> 18                                                                                 clinical_results.participant_flow.group.group_id #> 19                                                                                    clinical_results.participant_flow.group.title #> 20                                                                                    clinical_results.participant_flow.group.title #> 21                                                                              clinical_results.participant_flow.group.description #> 22                                                                              clinical_results.participant_flow.group.description #> 23                                                                                 clinical_results.participant_flow.group.group_id #> 24                                                                                 clinical_results.participant_flow.group.group_id #> 25                                                                                    clinical_results.participant_flow.group.title #> 26                                                                                    clinical_results.participant_flow.group.title #> 27                                                                              clinical_results.participant_flow.group.description #> 28                                                                              clinical_results.participant_flow.group.description #> 29                                                                                 clinical_results.participant_flow.group.group_id #> 30                                                                                 clinical_results.participant_flow.group.group_id #> 31                                                                                 clinical_results.participant_flow.group.group_id #> 32                                                                                    clinical_results.participant_flow.group.title #> 33                                                                                    clinical_results.participant_flow.group.title #> 34                                                                                    clinical_results.participant_flow.group.title #> 35                                                                              clinical_results.participant_flow.group.description #> 36                                                                              clinical_results.participant_flow.group.description #> 37                                                                              clinical_results.participant_flow.group.description #> 38                                                                                 clinical_results.participant_flow.group.group_id #> 39                                                                                 clinical_results.participant_flow.group.group_id #> 40                                                                                    clinical_results.participant_flow.group.title #> 41                                                                                    clinical_results.participant_flow.group.title #> 42                                                                                 clinical_results.participant_flow.group.group_id #> 43                                                                                 clinical_results.participant_flow.group.group_id #> 44                                                                                    clinical_results.participant_flow.group.title #> 45                                                                                    clinical_results.participant_flow.group.title #> 46                                                                              clinical_results.participant_flow.group.description #> 47                                                                              clinical_results.participant_flow.group.description #> 48                                                                                 clinical_results.participant_flow.group.group_id #> 49                                                                                 clinical_results.participant_flow.group.group_id #> 50                                                                                    clinical_results.participant_flow.group.title #> 51                                                                                    clinical_results.participant_flow.group.title #> 52                                                                              clinical_results.participant_flow.group.description #> 53                                                                              clinical_results.participant_flow.group.description #> 54                                                                                 clinical_results.participant_flow.group.group_id #> 55                                                                                 clinical_results.participant_flow.group.group_id #> 56                                                                                    clinical_results.participant_flow.group.title #> 57                                                                                    clinical_results.participant_flow.group.title #> 58                                                                              clinical_results.participant_flow.group.description #> 59                                                                              clinical_results.participant_flow.group.description #> 60                                                                                 clinical_results.participant_flow.group.group_id #> 61                                                                                 clinical_results.participant_flow.group.group_id #> 62                                                                                    clinical_results.participant_flow.group.title #> 63                                                                                    clinical_results.participant_flow.group.title #> 64                                                                              clinical_results.participant_flow.group.description #> 65                                                                              clinical_results.participant_flow.group.description #> 66                                                                                 clinical_results.participant_flow.group.group_id #> 67                                                                                 clinical_results.participant_flow.group.group_id #> 68                                                                                    clinical_results.participant_flow.group.title #> 69                                                                                    clinical_results.participant_flow.group.title #> 70                                                                              clinical_results.participant_flow.group.description #> 71                                                                              clinical_results.participant_flow.group.description #> 72                                                                                 clinical_results.participant_flow.group.group_id #> 73                                                                                 clinical_results.participant_flow.group.group_id #> 74                                                                                    clinical_results.participant_flow.group.title #> 75                                                                                    clinical_results.participant_flow.group.title #> 76                                                                              clinical_results.participant_flow.group.description #> 77                                                                              clinical_results.participant_flow.group.description #> 78                                                                                 clinical_results.participant_flow.group.group_id #> 79                                                                                 clinical_results.participant_flow.group.group_id #> 80                                                                                    clinical_results.participant_flow.group.title #> 81                                                                                    clinical_results.participant_flow.group.title #> 82                                                                              clinical_results.participant_flow.group.description #> 83                                                                              clinical_results.participant_flow.group.description #> 84                                                                                 clinical_results.participant_flow.group.group_id #> 85                                                                                 clinical_results.participant_flow.group.group_id #> 86                                                                                    clinical_results.participant_flow.group.title #> 87                                                                                    clinical_results.participant_flow.group.title #> 88                                                                              clinical_results.participant_flow.group.description #> 89                                                                              clinical_results.participant_flow.group.description #> 90                                                                                 clinical_results.participant_flow.group.group_id #> 91                                                                                 clinical_results.participant_flow.group.group_id #> 92                                                                                    clinical_results.participant_flow.group.title #> 93                                                                                    clinical_results.participant_flow.group.title #> 94                                                                              clinical_results.participant_flow.group.description #> 95                                                                              clinical_results.participant_flow.group.description #> 96                                                                                 clinical_results.participant_flow.group.group_id #> 97                                                                                 clinical_results.participant_flow.group.group_id #> 98                                                                                    clinical_results.participant_flow.group.title #> 99                                                                                    clinical_results.participant_flow.group.title #> 100                                                                             clinical_results.participant_flow.group.description #> 101                                                                             clinical_results.participant_flow.group.description #> 102                                                                                  clinical_results.participant_flow.period.title #> 103                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 104                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 105                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 106                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 107                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 108                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 109                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 110                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 111                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 112                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 113                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 114                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 115                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 116                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 117                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 118                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 119                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 120                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 121                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 122                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 123                                                                                  clinical_results.participant_flow.period.title #> 124                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 125                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 126                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 127                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 128                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 129                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 130                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 131                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 132                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 133                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 134                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 135                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 136                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 137                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 138                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 139                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 140                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 141                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 142                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 143 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 144 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 145    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 146    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 147 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 148 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 149    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 150    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 151 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 152 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 153    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 154    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 155 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 156 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 157    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 158    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 159                                                                                  clinical_results.participant_flow.period.title #> 160                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 161                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 162                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 163                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 164                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 165                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 166                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 167                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 168                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 169                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 170                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 171                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 172                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 173                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 174                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 175                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 176                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 177                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 178                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 179                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 180                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 181                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 182 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 183 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 184    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 185    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 186 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 187 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 188    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 189    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 190 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 191 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 192    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 193    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 194 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 195 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 196    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 197    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 198 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 199 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 200    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 201    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 202 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 203 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 204    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 205    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 206 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 207 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 208    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 209    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 210                                                                                  clinical_results.participant_flow.period.title #> 211                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 212                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 213                                                         clinical_results.participant_flow.period.milestone_list.milestone.title #> 214                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 215                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 216                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 217                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 218                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 219                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 220                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 221                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 222                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 223                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 224                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 225                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 226                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 227                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 228                       clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.group_id #> 229                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 230                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 231                          clinical_results.participant_flow.period.milestone_list.milestone.participants_list.participants.count #> 232                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 233                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 234                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 235                                   clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.title #> 236 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 237 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 238 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 239    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 240    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 241    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 242 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 243 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 244 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 245    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 246    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 247    clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.count #> 248 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 249 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #> 250 clinical_results.participant_flow.period.drop_withdraw_reason_list.drop_withdraw_reason.participants_list.participants.group_id #>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   value #> 1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Recruitment occurred between March 2000 and October 2002. Infants were enrolled from neonatal intensive care units and were randomized to open-label study treatment. #> 2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Neonates diagnosed with HSV-1 or HSV-2 at least than or equal to 28 days of age as evidenced by infections limited to the skin, eye and mouth with normal CNS and treated with intravenous acyclovir therapy. #> 3                                                                                                                                                                                                                                                                                                                                                                                                                                                           Neonates diagnosed with HSV-1 or HSV-2 <= 28 days of age with evidence of CNS HSV disease (with or without evidence of viral dissemination to other organs, such as the skin, liver, and lungs) then treated with intravenous acyclovir therapy. Subject has negative CSF PCR results within 48 hours prior to completion of intravenous acyclovir therapy. #> 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           The first subject was enrolled on 02/27/2004 and the study ended 02/28/2011. A total of 17 sites in Brazil, South Africa, Argentina and the U.S. participated in the study. #> 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The first subject was enrolled on 29 Mar 2009 and the last randomized subject completed the trial on 20 Jan 2011. The trial was conducted in the neonatal intensive care unit. #> 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      First patient, first visit was 8 December 2011 and last patient, last visit was 5 December 2013. The investigational sites were tertiary care centers with neonatal intensive care unit facilities at which inhaled nitric oxide (iNO) was used as standard of care for persistent pulmonary hypertension of the newborn (PPHN). #> 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      The trial was prematurely interrupted for logistic reasons in July 2016: a fourth drug manufacturing run was necessary because the intralipids had passed their expiration date and funding had run out. During the study period, 755 patients were screened for eligibility, and 173 randomized #> 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       This study was planned in two parts Part A (double-blind phase) and Part B (long-term, non-intervention phase). #> 9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Infants born at <32 weeks gestation admitted to the Neonatal Intensive Care Unit (NICU) at Weiler and Wakefield Divisions of Montefiore Medical Center were enrolled in this study. #> 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                From April 2014 to September 2015, infants born before 28 weeks gestation and surviving >12 hours were screened when admitted to one of the 18 NICHD NRN Centers (approximately 44 sites) in the United States and enrolled in the study if they met the eligibility criteria and consent was obtained before 72 hours postnatal age. #> 11                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 12                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Lucinactant #> 14                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Standard Care #> 15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Lucinactant via bronchoaveolar lavage #> 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Standard Care included the use of oxygen, CMV, sedation, paralysis, vasopressors, and/or alkalinization #> 17                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 18                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Placebo #> 20                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Acyclovir #> 21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Identical to oral acyclovir suspension in appearance and taste. Volume is identical to the administration of active drug. #> 22                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Oral suspension 300 mg/m^2/dose TID for 6 months. #> 23                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 24                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 25                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Acyclovir #> 26                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Placebo #> 27                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Oral suspension 300 mg/m^2/dose TID for 6 months. #> 28                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Identical volume as acyclovir. #> 29                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 30                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 31                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P3 #> 32                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Arm A (ZDV Only) #> 33                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    ARM B (ZDV + NVP) #> 34                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              ARM C (ZDV + 3TC + NFV) #> 35                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Standard of care ( Zidovudine only). 12 mg PO BID if BW>2000 grams ; 8 mg PO BID if BW<\/= 2000 grams #> 36                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Standard of care (Zidovudine) plus Nevirapine (NVP)\\rNVP, first dose initiated within 48 hrs of birth, second dose 48 hrs (+ 4 hours) after the first dose, and third dose 96 hours (+ 4 hours) after the second dose :\\r12 mg PO per dose if BW > 2000 grams, 8 mg PO per dose if BW < 2000 grams #> 37                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Standard of Care (Zidovudine) plus 2 weeks of Epivir (3TC) and Nelfinavir (NFV) 3TC, given for 2 weeks: 6 mg po bid if BW > 2000 grams 4 mg po bid if BW < 2000 grams AND\\rNFV, given for 2 weeks:\\r200 mg po bid if BW > 3000 grams 150 mg po bid if BW > 2,000 - 3000 grams 100 mg PO BID if BW < 2000 grams #> 38                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 39                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 40                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Pagibaximab #> 41                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Placebo #> 42                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 43                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 44                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Fluconazole #> 45                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Placebo #> 46                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             fluconazole 6mg/kg IV or PO twice weekly for 6 weeks\\rfluconazole: 6 mg/kg PO/IV twice weekly x 14 doses #> 47                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Placebo IV or PO twice weekly for 6 weeks\\rplacebo: placebo: normal saline (IV) or 3 parts Ora Plus oral suspension vehicle and 1 part simethicone suspension (PO): will be given twice weekly PO/IV for 14 doses #> 48                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 49                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 50                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Inhaled Nitric Oxide #> 51                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Placebo #> 52                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Inhaled Nitric Oxide\\rInhaled Nitric Oxide: Inhaled Nitric Oxide will be administered continuously starting at 20ppm into the inspiratory limb of the ventilator circuit in mechanically ventilated subject using an INOvent delivery system of by nasal cannula as needed for 24 days of therapy. #> 53                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Nitrogen Placebo\\rPlacebo: Nitrogen gas will be administered in the same manner as the experimental drug. #> 54                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 55                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 56                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Bosentan #> 57                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Placebo #> 58                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Bosentan\\rBosentan: 2 mg/kg of weight at birth twice daily (b.i.d); quadrisectable 32 mg tablet of bosentan dispersed in sterile water and administered by nasogastric or orogastric tube. #> 59                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Matching placebo\\rMatching placebo: twice daily (b.i.d); quadrisectable 32 mg tablet of matching placebo dispersed in sterile water and administered by nasogastric or orogastric tube. #> 60                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 61                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 62                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Atropine Atracurium Sufentanil #> 63                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Atropine Propofol #> 64                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           n=82 allocated to atropine+atracurium+sufentanil\\rn=80 received allocated intervention\\rn=2 did not receive allocated intervention\\rn=1 never intubated\\rn=1 received another premedication\\r82 included in final analysis #> 65                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     n=91 allocated to atropine+propofol\\rn= 2 excluded for lack of consent\\rn=83 received allocated intervention\\rn=6 did not receive allocated intervention\\rn=2 never intubated\\rn=4 received another premedication\\r89 included in final analysis #> 66                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 67                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 68                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Low Dose Intravenous Lipids #> 69                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      High Dose of Intravenous Lipids #> 70                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               intravenous lipid: intravenous given daily for 6 weeks #> 71                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               intravenous lipid: intravenous given daily for 6 weeks #> 72                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 73                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 74                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        IV Sildenafil #> 75                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Placebo #> 76                                                                                                                                                                                                                                                Part A: Participants received sildenafil intravenously based on their body weight at a loading dose of 0.1 milligrams per kg (mg/kg) for 30 minutes on Day 1 followed by a maintenance dose of 0.03 milligrams per kg per hour (mg/kg/hr), for a minimum of 2 days and maximum of 14 days. Infusion continuation was upon investigator discretion in view of participants' safety and well-being. Part B: Participants who started Part A (not necessarily completed Part A) and who were eligible and consented, continued to be followed up in part B of the study. #> 77                                                                                                                                                                                                                                                                                                                               Participants received placebo (0.9 % normal saline or dextrose 10%) at a rate matched to sildenafil infusion, intravenously, based on participant's weight, for a minimum of 2 days and maximum of 14 days. Infusion continuation was upon investigator discretion in view of participants' safety and well-being. Part B: Participants who started Part A (not necessarily completed Part A) and who were eligible and consented, continued to be followed up in part B of the study. #> 78                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 79                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 80                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          5% Dextrose #> 81                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          L-carnitine #> 82                                                                                                                                    Infants randomized to the placebo group will receive 5% dextrose intravenously. If infant is receiving 100 cc/kg/day of enteral feeds before the supplementation endpoint, an equivalent volume of placebo (5% Dextrose) will be given to the study patients.\\r5% Dextrose: Infants will receive 5% dextrose (placebo) three times a day (volume equivalent to the experimental drug) intravenously for a minimum of 2 weeks or until they achieve enteral feeding volume of 100 cc/kg/day. If infant is receiving 100 cc/kg/day of enteral feeds before the supplementation endpoint, an equivalent volume of enteral placebo (5% Dextrose) will be given to the study patients. #> 83                                                                                                                                                                               Infants randomized to the study group will receive L-carnitine intravenously. If infant is receiving 100 cc/kg/day of enteral feeds before the supplementation endpoint, an equivalent dose of enteral L-carnitine will be given to the study patients.\\rL-carnitine: Infants will receive L-carnitine 50 micromoles/kg/day, divided into three doses, intravenously for a minimum of 2 weeks or until they achieve enteral feeding volume of 100 cc/kg/day. If infant is receiving 100 cc/kg/day of enteral feeds before the supplementation endpoint, an equivalent dose of enteral L-carnitine will be given to the study patients. #> 84                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 85                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 86                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Symbiotic #> 87                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Distilled Water #> 88                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  symbiotic preparation 1/2 sachet twice daily during 30 days\\rsymbiotic: Symbiotic 1/2 sachet twice daily will be added to the breast milk or formula during 30 days #> 89                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              2 x 0.5 cc distilled water will be given during 30 days\\rdistilled water: 0.5 cc distilled water twice daily will be added to the breast milk or formula during 30 days #> 90                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 91                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 92                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Myo-Inositol 5% Injection #> 93                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 5% Glucose(Dextrose) #> 94  Inositol (i.e myo-Inositol) 5% Injection is an isotonic, preservative-free, sterile 5% solution of myo-inositol in water containing 0.5 gm sodium chloride per liter (8.55mM), pH 6.5-7.5. The medication is administered twice per day at 12-hour intervals at a dose of 80 mg inositol/kg/day (40 mg inositol/kg/dose), which is equivalent to 1.6 mL/kg/day (0.80 mL/kg/dose) begining within 12-72 hours of birth and continuing until the earliest of 34 weeks postmenstrual age (PMA), 10 weeks chronologic age, or the time of discharge. The doses are administered intravenously (IV) using syringe pump over 15-30 minutes until enteral feeds reach 120ml/kg/day (or sooner if the infant is no longer receiving IV fluids), at which time the same dose and formulation will be administered enterally. #> 95                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The placebo is 5% dextrose (5% glucose) in sterile water (D5W pyrogen and preservative free) United States Pharmacopoeia (USP) for IV infusion. The placebo is administered in the same dose (80 mg glucose/kg/day divided in 2 doses administered every 12 hours) and dispensed in the same manner (intravenously or enterally) as the inositol. #> 96                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P1 #> 97                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   P2 #> 98                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Standard Therapy ALONE #> 99                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Standard Therapy Plus Aromatherapy #> 100                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   These infants receive standard care ONLY, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy. #> 101                                                                                                                                    These infants will receive aromatherapy, consisting of Lavender and Chamomile essential oils, in addition to standard care, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.\\rlavender and chamomile essential oils: Our patches are obtained from BioEsse Technologies™. Each patch contains a 50:50 mixture of Lavender and Chamomile essential oils in a 55 microliter standard dose patch. The patches release the aromatherapy over a 2-8 hours period and the diffusion rate of each patch is identical. The back of the patch is layered with a hypoallergenic medical grade adhesive, similar to the material found on ECG leads. #> 102                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Overall Study #> 103                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             STARTED #> 104                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1 Year Follow-Up #> 105                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           COMPLETED #> 106                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       NOT COMPLETED #> 107                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 108                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 109                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  38 #> 110                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  31 #> 111                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 112                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 113                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  24 #> 114                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  24 #> 115                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 116                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 117                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  38 #> 118                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  31 #> 119                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 120                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 121                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   0 #> 122                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   0 #> 123                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Overall Study #> 124                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             STARTED #> 125                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           COMPLETED #> 126                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       NOT COMPLETED #> 127                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 128                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 129                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  14 #> 130                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  15 #> 131                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 132                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 133                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   4 #> 134                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   8 #> 135                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 136                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  10 #> 138                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   7 #> 139                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Lost to Follow-up #> 140                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Non-compliant #> 141                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Re-activation of Disease #> 142                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Disruption of blinded study drug supply #> 143                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 144                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 145                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   0 #> 146                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 #> 147                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 148                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 149                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 #> 150                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 #> 151                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 152                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 153                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   2 #> 154                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 #> 155                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 156                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 157                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   7 #> 158                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   4 #> 159                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Overall Study #> 160                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             STARTED #> 161                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           COMPLETED #> 162                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       NOT COMPLETED #> 163                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 164                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 165                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  24 #> 166                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  22 #> 167                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 168                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 169                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  15 #> 170                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   8 #> 171                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 172                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 173                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   9 #> 174                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  14 #> 175                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Lost to Follow-up #> 176                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Withdrawal by Subject #> 177                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Non-Compliant #> 178                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Death #> 179                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Reactivation of Disease #> 180                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Disruption of blinded drug supply #> 181                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Confirmed unevaluable #> 182                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 183                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 184                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   0 #> 185                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 #> 186                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 187                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 188                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 #> 189                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 #> 190                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 191                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 192                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 #> 193                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 #> 194                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 195                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 196                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   0 #> 197                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 #> 198                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 199                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 200                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   5 #> 201                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   9 #> 202                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 203                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 204                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   2 #> 205                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   0 #> 206                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 207                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 208                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   0 #> 209                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 #> 210                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Overall Study #> 211                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             STARTED #> 212                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           COMPLETED #> 213                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       NOT COMPLETED #> 214                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 215                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 216                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P3 #> 217                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 581 #> 218                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 580 #> 219                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 574 #> 220                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 221                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 222                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P3 #> 223                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 527 #> 224                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 515 #> 225                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 506 #> 226                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 227                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 228                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P3 #> 229                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  54 #> 230                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  65 #> 231                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  68 #> 232                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Death #> 233                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Withdrawal by Subject #> 234                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Lost to Follow-up #> 235                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   moved out of area #> 236                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 237                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 238                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P3 #> 239                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  11 #> 240                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  15 #> 241                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  17 #> 242                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 243                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 244                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P3 #> 245                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  19 #> 246                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  19 #> 247                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  23 #> 248                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P1 #> 249                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P2 #> 250                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P3 #>  [ reached 'max' / getOption(\"max.print\") -- omitted 176770 rows ]"},{"path":"https://rfhb.github.io/ctrdata/reference/installCygwinWindowsDoInstall.html","id":null,"dir":"Reference","previous_headings":"","what":"Install necessary helper apps (Windows only) — installCygwinWindowsDoInstall","title":"Install necessary helper apps (Windows only) — installCygwinWindowsDoInstall","text":"Convenience function install minimal Cygwin environment MS Windows, including perl, sed php. Alternatively case difficulties, download run cygwin setup follows: cygwinsetup.exe ---admin --quiet-mode --verbose --upgrade-also --root c:/cygwin --site https://www.mirrorservice.org/sites/sourceware.org/pub/cygwin/ --packages perl,php-jsonc,php-simplexml. binaries required function ctrLoadQueryIntoDb function package.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/installCygwinWindowsDoInstall.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Install necessary helper apps (Windows only) — installCygwinWindowsDoInstall","text":"","code":"installCygwinWindowsDoInstall(force = FALSE, proxy = Sys.getenv(\"https_proxy\"))"},{"path":"https://rfhb.github.io/ctrdata/reference/installCygwinWindowsDoInstall.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Install necessary helper apps (Windows only) — installCygwinWindowsDoInstall","text":"force Set TRUE update Cygwin environment previously installed function, overwrite existing installation c:\\cygwin proxy Specify proxy used downloading via http, e.g. `host_or_ip:port`; defaults environment variable `https_proxy`. Set `\"\"` specify unset proxy.","code":""},{"path":"https://rfhb.github.io/ctrdata/reference/installCygwinWindowsDoInstall.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Install necessary helper apps (Windows only) — installCygwinWindowsDoInstall","text":"","code":"try(installCygwinWindowsDoInstall(), silent = TRUE)"},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-11019005-2022-08-08","dir":"Changelog","previous_headings":"","what":"ctrdata 1.10.1.9005 (2022-08-08)","title":"ctrdata 1.10.1.9005 (2022-08-08)","text":"new development version handle tibble internal function fix handling certain ISRCTN queries fix dbGetFieldsIntoDf() missing data changing timeouts methods testing fix slow speed dfName2Value() add demo database run examples","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-1101-2022-07-24","dir":"Changelog","previous_headings":"","what":"ctrdata 1.10.1 (2022-07-24)","title":"ctrdata 1.10.1 (2022-07-24)","text":"CRAN release: 2022-07-24 fix documentation issues (https://stat.ethz.ch/pipermail/r-package-devel/2022q3/008240.html) fix unit test unused missing argument fix GitHub actions tests","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-1100-2022-07-01","dir":"Changelog","previous_headings":"","what":"ctrdata 1.10.0 (2022-07-01)","title":"ctrdata 1.10.0 (2022-07-01)","text":"CRAN release: 2022-07-06 ctrLoadQueryIntoDb new parameter euctrresultsfilespath, deprecating euctrresultspdfpath ctrLoadQueryIntoDb now also extracts saves results files PDF files ctrFindActiveSubstanceSynonyms() returns NULL non-existing active substance","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-191-2022-04-24","dir":"Changelog","previous_headings":"","what":"ctrdata 1.9.1 (2022-04-24)","title":"ctrdata 1.9.1 (2022-04-24)","text":"CRAN release: 2022-04-24 type e811… variables bugfix dbGetFieldsIntoDf bugfix annotations mix backends editorial update vignettes","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-190-2022-03-13","dir":"Changelog","previous_headings":"","what":"ctrdata 1.9.0 (2022-03-13)","title":"ctrdata 1.9.0 (2022-03-13)","text":"CRAN release: 2022-03-13 chunked trial batches ndjson files accelerated database import package dplyr loaded, functions return tibble instead data frame update correct documentation dbFindFields() returns vector fields now names register field occurs accelerated binary checks (cygwin / Windows) remove internet proxy mangling order use system configuration (e.g., transparent proxies used, environment variable https_proxy specified user) refactored internal caching correct dbGetFieldsIntoDf() specific nested data structures correct dfTrials2Long() specific fields correct dbFindIdsUniqueTrials() single trial register modify field typing decode HTML entities type fields difftime, e.g. min_age CTGOV speed parts dbGetFieldsIntoDf() simplify fields dbFindFields() returns names leaf node fields improve update documentation changed EU Member State default DE dbFindIdsUniqueTrials() corrected installCygwinWindowsDoInstall() properly update installation (remove –prune-install) test binaries installCygwinWindowsDoInstall() cache successful binary testing correct typing required_header.download_date improve numbering dfTrials2Long, covering nested items","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-1809001-2021-12-11","dir":"Changelog","previous_headings":"","what":"ctrdata 1.8.0.9001 (2021-12-11)","title":"ctrdata 1.8.0.9001 (2021-12-11)","text":"thorough documentation improvement simplified dbFindFields cleaned testing binaries cleaned heper scripts removed ctrGetQueryUrlFromBrowser(), long deprecated","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-1809000-2021-11-22","dir":"Changelog","previous_headings":"","what":"ctrdata 1.8.0.9000 (2021-11-22)","title":"ctrdata 1.8.0.9000 (2021-11-22)","text":"uses nodbi 0.6.0 can use PostgreSQL backend include PostgreSQL Github Actions","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-180-2021-11-18","dir":"Changelog","previous_headings":"","what":"ctrdata 1.8.0 (2021-11-18)","title":"ctrdata 1.8.0 (2021-11-18)","text":"CRAN release: 2021-11-21 changes match nodbi 0.5.0 simplifying database operations (user-visible functions: ctrLoadQueryIntoDb, dbFindIdsUniqueTrials, dbGetFieldsIntoDf), without changes API","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-1719000-2021-08-23","dir":"Changelog","previous_headings":"","what":"ctrdata 1.7.1.9000 (2021-08-23)","title":"ctrdata 1.7.1.9000 (2021-08-23)","text":"new development version","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-171-2021-08-22","dir":"Changelog","previous_headings":"","what":"ctrdata 1.7.1 (2021-08-22)","title":"ctrdata 1.7.1 (2021-08-22)","text":"CRAN release: 2021-08-22 fix DBI needed Imports anymore (CRAN Note) fix potential file name issue conversion script fix dbFindFields() never return _id (previously depended database backend) changed tests (CRAN detection, register availability, additional tests)","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-170-2021-07-24","dir":"Changelog","previous_headings":"","what":"ctrdata 1.7.0 (2021-07-24)","title":"ctrdata 1.7.0 (2021-07-24)","text":"CRAN release: 2021-07-25 much reduced database backend-specific code, using nodbi 0.4.3 (released 2021-07-23) also introduces transactions sqlite using RSQLite >=2.2.4 (released 2021-03-12) temporary directory creation needed, automated deletion changes detecting non-functioning register servers streamlined unit testing","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-160-2021-05-09","dir":"Changelog","previous_headings":"","what":"ctrdata 1.6.0 (2021-05-09)","title":"ctrdata 1.6.0 (2021-05-09)","text":"CRAN release: 2021-05-09 added support ISRCTN refactored checking binaries caching info updated EUCTR download parameters refactored ctrGetQueryUrl ctrOpenSearchPagesInBrowser harmonised error checking avoid errors external scripts refactored url / query mangling, added detailed testing refactored storing JSON database (handle big files, reduce memory) improved dbFindIdsUniqueTrials (speed, memory, register coverage) factored conversion JSON accelerated EUCTR results history download storage external scripts now create multiple chunks records use identifier fields dbFindIdsUniqueTrials","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-1539000-2021-04-29","dir":"Changelog","previous_headings":"","what":"ctrdata 1.5.3.9000 (2021-04-29)","title":"ctrdata 1.5.3.9000 (2021-04-29)","text":"adding user info field entries typed","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-153-2021-04-19","dir":"Changelog","previous_headings":"","what":"ctrdata 1.5.3 (2021-04-19)","title":"ctrdata 1.5.3 (2021-04-19)","text":"CRAN release: 2021-04-19 include message handle server certificate issues, propagating user settings httr curl operations ensure identical return structures new trials found dfTrials2Long: harmonise identifier level assignment, address cases field occurs input df dfMergeTwoVariablesRelevel: corrected improved user info dfName2Value: remove duplicate rows, e.g. duplicated criteria","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-152-2021-04-05","dir":"Changelog","previous_headings":"","what":"ctrdata 1.5.2 (2021-04-05)","title":"ctrdata 1.5.2 (2021-04-05)","text":"CRAN release: 2021-04-06 bugfix EOL converting EUCTR files","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-151-2021-03-21","dir":"Changelog","previous_headings":"","what":"ctrdata 1.5.1 (2021-03-21)","title":"ctrdata 1.5.1 (2021-03-21)","text":"CRAN release: 2021-03-21 bugfix non-matching euctr protocol result ids: trials EUCTR results downloaded version 1.5.0 downloaded (ctrLoadQueryIntoDb) dfTrials2Long refactored accelerated API change: dfTrials2Long return value (identifier replaces main_id sub_id) new option save EUCTR results PDF files user-specified directory","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-150-2021-03-14","dir":"Changelog","previous_headings":"","what":"ctrdata 1.5.0 (2021-03-14)","title":"ctrdata 1.5.0 (2021-03-14)","text":"CRAN release: 2021-03-16 return values dbGetFieldsIntoDf now mostly identical whether using src_mongo src_sqlite, best ensure portability analysis code permit dots queries / URLs improved handling queryterm renamed ctrGetQueryUrlFromBrowser ctrGetQueryUrl soft deprecated ctrGetQueryUrlFromBrowser ensure parallel retrievals EUCTR speed routines dbGetFieldsIntoDf make dfTrials2Long handle NA better improved documentation, clarified examples simplified internals typing fields, start typing results fields","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-141-2020-11-03","dir":"Changelog","previous_headings":"","what":"ctrdata 1.4.1 (2020-11-03)","title":"ctrdata 1.4.1 (2020-11-03)","text":"CRAN release: 2020-11-03 reset row names data frames returned functions update curl parameters accessing EUCTR","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-14-2020-10-17","dir":"Changelog","previous_headings":"","what":"ctrdata 1.4 (2020-10-17)","title":"ctrdata 1.4 (2020-10-17)","text":"new: easy access variables dfTrials2Long() + dfName2Value() improved dfMergeTwoVariablesRelevel() maintain type data revised simplified vignettes deprecated: dfListExtractKey() refactored parts euctr retrieval notify user euctr register server permit compression long retrieval take","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-1329000-2020-10-08","dir":"Changelog","previous_headings":"","what":"ctrdata 1.3.2.9000 (2020-10-08)","title":"ctrdata 1.3.2.9000 (2020-10-08)","text":"fixed identifying unique ids","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-132-2020-10-03","dir":"Changelog","previous_headings":"","what":"ctrdata 1.3.2 (2020-10-03)","title":"ctrdata 1.3.2 (2020-10-03)","text":"CRAN release: 2020-10-05 quote system file paths","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-131-2020-08-01","dir":"Changelog","previous_headings":"","what":"ctrdata 1.3.1 (2020-08-01)","title":"ctrdata 1.3.1 (2020-08-01)","text":"CRAN release: 2020-08-02 fix error CI tests","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-130-2020-07-27","dir":"Changelog","previous_headings":"","what":"ctrdata 1.3.0 (2020-07-27)","title":"ctrdata 1.3.0 (2020-07-27)","text":"CRAN release: 2020-07-27 workaround EUCTR certificate issue streamline ctrGetQueryUrlFromBrowser() better handling complex fields include tests query string handling, checking parameters return values better clean-testing ctrLoadQueryIntoDb(querytorerun = …) now looks date querytorerun last run, often use euctr update options switching travis github action upped coverage code tested","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-121-2020-05-18","dir":"Changelog","previous_headings":"","what":"ctrdata 1.2.1 (2020-05-18)","title":"ctrdata 1.2.1 (2020-05-18)","text":"CRAN release: 2020-05-18 tinytest >= 1.2.1 avoid regression error correct testing detail","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-12-2019-12-07","dir":"Changelog","previous_headings":"","what":"ctrdata 1.2 (2019-12-07)","title":"ctrdata 1.2 (2019-12-07)","text":"CRAN release: 2019-12-08 correct cygwin install detail","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-11-2019-11-12","dir":"Changelog","previous_headings":"","what":"ctrdata 1.1 (2019-11-12)","title":"ctrdata 1.1 (2019-11-12)","text":"CRAN release: 2019-11-12 release nodbi 0.4 available","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-1019005-2019-11-09","dir":"Changelog","previous_headings":"","what":"ctrdata 1.0.1.9005 (2019-11-09)","title":"ctrdata 1.0.1.9005 (2019-11-09)","text":"update description installation github","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-1019004-2019-11-04","dir":"Changelog","previous_headings":"","what":"ctrdata 1.0.1.9004 (2019-11-04)","title":"ctrdata 1.0.1.9004 (2019-11-04)","text":"handled mixed arrays text values key ctgov trial records user information importing","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-1019003-2019-11-04","dir":"Changelog","previous_headings":"","what":"ctrdata 1.0.1.9003 (2019-11-04)","title":"ctrdata 1.0.1.9003 (2019-11-04)","text":"nesting added euctr trial records user verbose information extended record importing","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-1019002-2019-11-03","dir":"Changelog","previous_headings":"","what":"ctrdata 1.0.1.9002 (2019-11-03)","title":"ctrdata 1.0.1.9002 (2019-11-03)","text":"improved parsing euctr trial records correct re-opening sqlite connection","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-101-2019-10-22","dir":"Changelog","previous_headings":"","what":"ctrdata 1.0.1 (2019-10-22)","title":"ctrdata 1.0.1 (2019-10-22)","text":"CRAN release: 2019-10-23 correction testing","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-10-2019-10-16","dir":"Changelog","previous_headings":"","what":"ctrdata 1.0 (2019-10-16)","title":"ctrdata 1.0 (2019-10-16)","text":"CRAN release: 2019-10-16 switch nodbi::scr_{mongo,sqlite}() re-implementation functions switch testthat tinytest, users can check tinytest::test_package(“ctrdata”) improvements euctr trial import new function dfListExtractKey","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0189005-2019-05-02","dir":"Changelog","previous_headings":"","what":"ctrdata 0.18.9005 (2019-05-02)","title":"ctrdata 0.18.9005 (2019-05-02)","text":"speed testing bash commands windows","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0182-2019-04-30","dir":"Changelog","previous_headings":"","what":"ctrdata 0.18.2 (2019-04-30)","title":"ctrdata 0.18.2 (2019-04-30)","text":"CRAN release: 2019-05-01 new release extended compatibility cygwin Windows","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0189004-2019-04-28","dir":"Changelog","previous_headings":"","what":"ctrdata 0.18.9004 (2019-04-28)","title":"ctrdata 0.18.9004 (2019-04-28)","text":"find use cygw* windows refactored escaping bash command called windows","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0189002-2019-04-21","dir":"Changelog","previous_headings":"","what":"ctrdata 0.18.9002 (2019-04-21)","title":"ctrdata 0.18.9002 (2019-04-21)","text":"corrected typing date fields","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0181-2019-04-14","dir":"Changelog","previous_headings":"","what":"ctrdata 0.18.1 (2019-04-14)","title":"ctrdata 0.18.1 (2019-04-14)","text":"simplified cygwin install updated documentation corrected inconsistent handling query terms","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0189001-2019-04-12","dir":"Changelog","previous_headings":"","what":"ctrdata 0.18.9001 (2019-04-12)","title":"ctrdata 0.18.9001 (2019-04-12)","text":"added automated proxy handling","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-018-2019-04-11","dir":"Changelog","previous_headings":"","what":"ctrdata 0.18 (2019-04-11)","title":"ctrdata 0.18 (2019-04-11)","text":"CRAN release: 2019-04-11 release version bug fixes field typing move use remote mongodb server updated vignettes","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-017-2019-03-27","dir":"Changelog","previous_headings":"","what":"ctrdata 0.17 (2019-03-27)","title":"ctrdata 0.17 (2019-03-27)","text":"release version","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0169002-2019-03-26","dir":"Changelog","previous_headings":"","what":"ctrdata 0.16.9002 (2019-03-26)","title":"ctrdata 0.16.9002 (2019-03-26)","text":"improve dbFindFields() formatting added parameter force running query ","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0169001-2019-03-26","dir":"Changelog","previous_headings":"","what":"ctrdata 0.16.9001 (2019-03-26","title":"ctrdata 0.16.9001 (2019-03-26","text":"added typing (numeric fields) improve cygwin install attempts information","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0169000-2019-03-24","dir":"Changelog","previous_headings":"","what":"ctrdata 0.16.9000 (2019-03-24)","title":"ctrdata 0.16.9000 (2019-03-24)","text":"removed dependency local mongodb installation (major rewrite) improved support remote mongodb servers (note changes host / db / uri parameters)","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0159007-2019-03-15","dir":"Changelog","previous_headings":"","what":"ctrdata 0.15.9007 (2019-03-15)","title":"ctrdata 0.15.9007 (2019-03-15)","text":"Important: Added checking SSL certificates EUCTR EUCTR server sending required intermediate root certificates, thus failing curl httr, see https://www.digicert.com/help/?host=www.clinicaltrialsregister.eu","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0150-2019-03-13","dir":"Changelog","previous_headings":"","what":"ctrdata 0.15.0 (2019-03-13)","title":"ctrdata 0.15.0 (2019-03-13)","text":"fixed EUCTR results retrieval (curl return value order predictable) removed second time adding metadata one function streamlined user information progress feedback","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0143-2019-03-12","dir":"Changelog","previous_headings":"","what":"ctrdata 0.14.3 (2019-03-12)","title":"ctrdata 0.14.3 (2019-03-12)","text":"turned error message new trials found prevent failing tests new trials found rss feed","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0142-2019-03-07","dir":"Changelog","previous_headings":"","what":"ctrdata 0.14.2 (2019-03-07)","title":"ctrdata 0.14.2 (2019-03-07)","text":"harmonise user information","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0141-2019-03-07","dir":"Changelog","previous_headings":"","what":"ctrdata 0.14.1 (2019-03-07)","title":"ctrdata 0.14.1 (2019-03-07)","text":"CRAN release: 2019-03-12 replaced RCurl (failed register servers) httr curl create README.md README.Rmd","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-014-2019-03-06","dir":"Changelog","previous_headings":"","what":"ctrdata 0.14 (2019-03-06)","title":"ctrdata 0.14 (2019-03-06)","text":"intention submit CRAN, therefore changing several warnings messages, improve testing tool chain applications","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0133-2019-03-03","dir":"Changelog","previous_headings":"","what":"ctrdata 0.13.3 (2019-03-03)","title":"ctrdata 0.13.3 (2019-03-03)","text":"prettified dbFindFields() removing count symbols (XX.) paths improve converting invalid XML EUCTR result files JSON","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0132-2019-02-28","dir":"Changelog","previous_headings":"","what":"ctrdata 0.13.2 (2019-02-28)","title":"ctrdata 0.13.2 (2019-02-28)","text":"made EUCTR retrieval robust added marginal case url single trial EUCTR extended timeout checking online status EUCTR","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0131-2019-02-24","dir":"Changelog","previous_headings":"","what":"ctrdata 0.13.1 (2019-02-24)","title":"ctrdata 0.13.1 (2019-02-24)","text":"added typing dates logical fields using dbGetFieldsIntoDf()","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-013-2019-01-06","dir":"Changelog","previous_headings":"","what":"ctrdata 0.13 (2019-01-06)","title":"ctrdata 0.13 (2019-01-06)","text":"dbGetVariablesIntoDf() deprecated, use dbGetFieldsIntoDf() instead dbFindVariable() deprecated, use dbFindFields() instead dbMergeTwoVariablesRelevel() parameter varnames deprecated, use colnames instead","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0121-2018-12-15","dir":"Changelog","previous_headings":"","what":"ctrdata 0.12.1 (2018-12-15)","title":"ctrdata 0.12.1 (2018-12-15)","text":"added function ctrFindActiveSubstanceSynonyms() obtain synonyms active substance added user information number trials CTGOV downloaded, limit 5000 per query corrected import EUCTR details = FALSE","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-012-2018-05-19","dir":"Changelog","previous_headings":"","what":"ctrdata 0.12 (2018-05-19)","title":"ctrdata 0.12 (2018-05-19)","text":"added possibility add user’s annotations records retrieved query (new option annotate.text)","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0112-2018-04-22","dir":"Changelog","previous_headings":"","what":"ctrdata 0.11.2 (2018-04-22)","title":"ctrdata 0.11.2 (2018-04-22)","text":"changed queryterm processing","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0111-2018-04-07","dir":"Changelog","previous_headings":"","what":"ctrdata 0.11.1 (2018-04-07)","title":"ctrdata 0.11.1 (2018-04-07)","text":"improved installFindMongoBinaries(), now better detect mongo binary locations use example cron scripts, may access user’s path information","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-011-2018-01-28","dir":"Changelog","previous_headings":"","what":"ctrdata 0.11 (2018-01-28)","title":"ctrdata 0.11 (2018-01-28)","text":"newly retrieved: EUCTR results history, new fields “firstreceived_results_date” “version_results_history” adding feature per issue #8","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0104-2017-12-28","dir":"Changelog","previous_headings":"","what":"ctrdata 0.10.4 (2017-12-28)","title":"ctrdata 0.10.4 (2017-12-28)","text":"note compatibility mongoDB versions fixing issue #8 simplified license","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0-10-4","dir":"Changelog","previous_headings":"","what":"ctrdata 0.10.3 (2017-11-24)","title":"ctrdata 0.10.4 (2017-12-28)","text":"changed custom-built “x5_trial_status” “p_end_of_trial_status” provided EUCTR","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0102-2017-11-22","dir":"Changelog","previous_headings":"","what":"ctrdata 0.10.2 (2017-11-22)","title":"ctrdata 0.10.2 (2017-11-22)","text":"editorial project updates","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0101-2017-07-30","dir":"Changelog","previous_headings":"","what":"ctrdata 0.10.1 (2017-07-30)","title":"ctrdata 0.10.1 (2017-07-30)","text":"now loading results euctr available xml","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0100-2017-07-25","dir":"Changelog","previous_headings":"","what":"ctrdata 0.10.0 (2017-07-25)","title":"ctrdata 0.10.0 (2017-07-25)","text":"fully load results ctgov prepare loading results euctr","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0914-2017-06-28","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.14 (2017-06-28)","title":"ctrdata 0.9.14 (2017-06-28)","text":"refactored system calls windows now part continuous integration","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0913-2017-06-23","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.13 (2017-06-23)","title":"ctrdata 0.9.13 (2017-06-23)","text":"refactored ctrLoadQueryIntoDb","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0912-2017-06-18","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.12 (2017-06-18)","title":"ctrdata 0.9.12 (2017-06-18)","text":"Preparing new CTGOV interface Improved documentation Corrected ctrGetQueryUrlFromBrowser return value","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-09111-2017-02-04","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.11.1 (2017-02-04)","title":"ctrdata 0.9.11.1 (2017-02-04)","text":"Improved documentation","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0911-2017-01-15","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.11 (2017-01-15)","title":"ctrdata 0.9.11 (2017-01-15)","text":"Added functionality: EUCTR fallback import mechanism large JSON file fails import mongoDB (splitting importing one JSON file trial, tested several thousand trials)","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-09101-2017-01-12","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.10.1 (2017-01-12)","title":"ctrdata 0.9.10.1 (2017-01-12)","text":"Fixes issues conversion EUCTR records details. Fixes issue placebo information converted IMP fields.","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-09100-2016-12-28","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.10.0 (2016-12-28)","title":"ctrdata 0.9.10.0 (2016-12-28)","text":"Added metadata attributes returned objects indicate database, query, timestamp etc.","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0995-2016-12-14","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.9.5 (2016-12-14)","title":"ctrdata 0.9.9.5 (2016-12-14)","text":"Added option ctrLoadQueryIntoDb(querytoupdate = “last”) re-download last query collection","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0994-2016-11-18","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.9.4 (2016-11-18)","title":"ctrdata 0.9.9.4 (2016-11-18)","text":"Added progress indicator ctrLoadQueryIntoDb() indicate network download traffic","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0993-2016-11-17","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.9.3 (2016-11-17)","title":"ctrdata 0.9.9.3 (2016-11-17)","text":"deduplication dbFindIdsUniqueTrials() optimised speed memory, added check ISRCTN","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0992-2016-11-13","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.9.2 (2016-11-13)","title":"ctrdata 0.9.9.2 (2016-11-13)","text":"corrected deduplication dbFindIdsUniqueTrials()","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-0991-2016-11-12","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9.9.1 (2016-11-12)","title":"ctrdata 0.9.9.1 (2016-11-12)","text":"renamed ctrQueryHistoryInDb() dbQueryHistory() note: change json format query history, breaking compatibility refactored concerned functions use mongolite rmongodb supported","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-09-2016-10-17","dir":"Changelog","previous_headings":"","what":"ctrdata 0.9 (2016-10-17)","title":"ctrdata 0.9 (2016-10-17)","text":"changed implementation dbFindIdsUniqueTrials() editorial changes examples","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-081-2016-09-07","dir":"Changelog","previous_headings":"","what":"ctrdata 0.8.1 (2016-09-07)","title":"ctrdata 0.8.1 (2016-09-07)","text":"added field indicate source register improved ctrLoadQueryIntoDb() details = FALSE added example map plotting","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-08-2016-09-04","dir":"Changelog","previous_headings":"","what":"ctrdata 0.8 (2016-09-04)","title":"ctrdata 0.8 (2016-09-04)","text":"dbFindIdsUniqueTrials now encapsulates dfFindIdsUniqueEuctrRecord dfFindIdsUniqueEuctrRecords removed installation instructions updated recently rmongodb removed CRAN","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-07-2016-05-29","dir":"Changelog","previous_headings":"","what":"ctrdata 0.7 (2016-05-29)","title":"ctrdata 0.7 (2016-05-29)","text":"dbGetVariablesIntoDf changed concatenate values array objects completed test adaptation travis improving perl regex checking helper applications","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-062-2016-04-20","dir":"Changelog","previous_headings":"","what":"ctrdata 0.6.2 (2016-04-20)","title":"ctrdata 0.6.2 (2016-04-20)","text":"add / update field “record_last_import” every imported / updated record","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-061-2016-04-02","dir":"Changelog","previous_headings":"","what":"ctrdata 0.6.1 (2016-04-02)","title":"ctrdata 0.6.1 (2016-04-02)","text":"changed provide vignettes","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-06-2016-02-25","dir":"Changelog","previous_headings":"","what":"ctrdata 0.6 (2016-02-25)","title":"ctrdata 0.6 (2016-02-25)","text":"different update mechanism EUCTR implemented corrected function name db… dfFindUniqueEuctrRecord()","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-059-2016-01-23","dir":"Changelog","previous_headings":"","what":"ctrdata 0.5.9 (2016-01-23)","title":"ctrdata 0.5.9 (2016-01-23)","text":"Corrected bugs Started preparation submission CRAN Preparing include package unit tests","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-05-2015-11-29","dir":"Changelog","previous_headings":"","what":"ctrdata 0.5 (2015-11-29)","title":"ctrdata 0.5 (2015-11-29)","text":"Published github Improved documentation","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-04-2015-10-08","dir":"Changelog","previous_headings":"","what":"ctrdata 0.4 (2015-10-08)","title":"ctrdata 0.4 (2015-10-08)","text":"Renamed functions consistency ease--use","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-03-2015-10-06","dir":"Changelog","previous_headings":"","what":"ctrdata 0.3 (2015-10-06)","title":"ctrdata 0.3 (2015-10-06)","text":"Added functionality download xml data CTGOV, includes data csv format","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-028","dir":"Changelog","previous_headings":"","what":"ctrdata 0.2.8","title":"ctrdata 0.2.8","text":"Changed extended history queries included database. New function dbCTRQueryHistory()","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-027","dir":"Changelog","previous_headings":"","what":"ctrdata 0.2.7","title":"ctrdata 0.2.7","text":"Added function merging variables different registers optionally merge values new values Note function findCTRkey renamed dbFindCTRkey acts database","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-025","dir":"Changelog","previous_headings":"","what":"ctrdata 0.2.5","title":"ctrdata 0.2.5","text":"Added function selecting preferred language versions trials EUCTR Improved use automatic proxy configuration script","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-022","dir":"Changelog","previous_headings":"","what":"ctrdata 0.2.2","title":"ctrdata 0.2.2","text":"Added proxy function improved installation cygwin MS Windows","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-02-2015-09-19","dir":"Changelog","previous_headings":"","what":"ctrdata 0.2 (2015-09-19)","title":"ctrdata 0.2 (2015-09-19)","text":"Now also working MS Windows","code":""},{"path":"https://rfhb.github.io/ctrdata/news/index.html","id":"ctrdata-01-2015-09-15","dir":"Changelog","previous_headings":"","what":"ctrdata 0.1 (2015-09-15)","title":"ctrdata 0.1 (2015-09-15)","text":"First version basic functionality Limited testing Works Mac OS X (10.10.x)","code":""}]
